,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-02-23 16:21:11,2022-02-18,BIIB,Vounatsos Michel,CEO,F - Tax,$209.79,-2746,67261,-4%,"-$576,083",,,,,BIIB
1,D,2022-02-23 16:21:11,2022-02-18,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,6191,67261,+10%,+$0,,,,,BIIB
2,D,2022-02-23 16:20:19,2022-02-18,BIIB,Murphy Nicole,"Head of Pharm Ops, Tech",F - Tax,$209.79,-110,1658,-6%,"-$23,077",,,,,BIIB
3,D,2022-02-23 16:20:19,2022-02-18,BIIB,Murphy Nicole,"Head of Pharm Ops, Tech",M - OptEx,$0.00,371,1658,+29%,+$0,,,,,BIIB
4,D,2022-02-23 16:19:12,2022-02-18,BIIB,McDonnell Michael R,"EVP, CFO",F - Tax,$209.79,-977,4427,-18%,"-$204,965",,,,,BIIB
5,D,2022-02-23 16:19:12,2022-02-18,BIIB,McDonnell Michael R,"EVP, CFO",M - OptEx,$0.00,1981,4427,+81%,+$0,,,,,BIIB
6,D,2022-02-23 16:18:07,2022-02-18,BIIB,Kramer Robin,Chief Accounting Officer,F - Tax,$209.79,-117,1737,-6%,"-$24,545",,,,,BIIB
7,D,2022-02-23 16:18:07,2022-02-18,BIIB,Kramer Robin,Chief Accounting Officer,M - OptEx,$0.00,396,1737,+30%,+$0,,,,,BIIB
8,D,2022-02-23 16:16:59,2022-02-18,BIIB,Izzar Rachid,Head of Alzheimer's Disease,F - Tax,$209.79,-175,1754,-9%,"-$36,713",,,,,BIIB
9,D,2022-02-23 16:16:59,2022-02-18,BIIB,Izzar Rachid,Head of Alzheimer's Disease,M - OptEx,$0.00,594,1754,+51%,+$0,,,,,BIIB
10,D,2022-02-23 16:15:56,2022-02-18,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",F - Tax,$209.79,-879,7364,-11%,"-$184,405",,,,,BIIB
11,D,2022-02-23 16:15:56,2022-02-18,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",M - OptEx,$0.00,1981,7364,+37%,+$0,,,,,BIIB
12,D,2022-02-23 16:15:01,2022-02-18,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$209.79,-616,11219,-5%,"-$129,231",,,,,BIIB
13,D,2022-02-23 16:15:01,2022-02-18,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,1387,11219,+14%,+$0,,,,,BIIB
14,D,2022-02-23 16:14:06,2022-02-18,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",F - Tax,$209.79,-659,44928,-1%,"-$138,252",,,,,BIIB
15,D,2022-02-23 16:14:06,2022-02-18,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",M - OptEx,$0.00,1485,44928,+3%,+$0,,,,,BIIB
16,D,2022-02-15 16:17:24,2022-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",F - Tax,$214.59,-2056,44102,-4%,"-$441,197",,,,,BIIB
17,D,2022-02-15 16:17:24,2022-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",M - OptEx,$0.00,2280,44102,+5%,+$0,,,,,BIIB
18,D,2022-02-15 16:16:33,2022-02-12,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$214.59,-1252,10448,-11%,"-$268,667",,,,,BIIB
19,D,2022-02-15 16:16:33,2022-02-12,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,1672,10448,+19%,+$0,,,,,BIIB
20,D,2022-02-15 16:15:46,2022-02-12,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",F - Tax,$214.59,-2342,6262,-27%,"-$502,570",,,,,BIIB
21,D,2022-02-15 16:15:46,2022-02-12,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",M - OptEx,$0.00,2597,6262,+71%,+$0,,,,,BIIB
22,D,2022-02-15 16:14:45,2022-02-12,BIIB,Izzar Rachid,Head of Alzheimer's Disease,F - Tax,$214.59,-122,1335,-8%,"-$26,180",,,,,BIIB
23,D,2022-02-15 16:14:45,2022-02-12,BIIB,Izzar Rachid,Head of Alzheimer's Disease,M - OptEx,$0.00,351,1335,+36%,+$0,,,,,BIIB
24,D,2022-02-15 16:13:42,2022-02-12,BIIB,Kramer Robin,Chief Accounting Officer,F - Tax,$214.59,-171,1458,-10%,"-$36,695",,,,,BIIB
25,D,2022-02-15 16:13:42,2022-02-12,BIIB,Kramer Robin,Chief Accounting Officer,M - OptEx,$0.00,275,1458,+23%,+$0,,,,,BIIB
26,D,2022-02-15 16:12:51,2022-02-12,BIIB,Vounatsos Michel,CEO,F - Tax,$214.59,-8566,63816,-12%,"-$1,838,178",,,,,BIIB
27,D,2022-02-15 16:12:51,2022-02-12,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,8716,63816,+16%,+$0,,,,,BIIB
28,D,2022-02-15 16:11:47,2022-02-12,BIIB,Murphy Nicole,"Head of Pharm Ops, Tech",F - Tax,$214.59,-92,1397,-6%,"-$19,742",,,,,BIIB
29,D,2022-02-15 16:11:47,2022-02-12,BIIB,Murphy Nicole,"Head of Pharm Ops, Tech",M - OptEx,$0.00,263,1397,+23%,+$0,,,,,BIIB
30,,2022-01-21 16:50:34,2022-01-19,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",A - Grant,$0.00,658,6033,+12%,+$0,,,,,BIIB
31,,2022-01-21 16:48:41,2022-01-19,BIIB,Gregory Ginger,"EVP, HR",A - Grant,$0.00,1941,10028,+24%,+$0,,,,,BIIB
32,,2022-01-21 16:47:37,2022-01-19,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",A - Grant,$0.00,3088,6007,+106%,+$0,,,,,BIIB
33,,2022-01-21 16:46:38,2022-01-19,BIIB,Kramer Robin,Chief Accounting Officer,A - Grant,$0.00,244,1354,+22%,+$0,,,,,BIIB
34,,2022-01-21 16:45:42,2022-01-19,BIIB,Vounatsos Michel,CEO,A - Grant,$0.00,10594,63666,+20%,+$0,,,,,BIIB
35,,2022-01-21 16:44:46,2022-01-19,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",A - Grant,$0.00,2825,43878,+7%,+$0,,,,,BIIB
36,,2022-01-21 16:44:46,2021-08-09,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",G - Gift,$0.00,-523,43878,-1%,-$0,,,,,BIIB
37,D,2021-12-07 16:09:08,2021-12-03,BIIB,Kramer Robin,Chief Accounting Officer,F - Tax,$223.92,-100,1110,-8%,"-$22,392",,,,,BIIB
38,D,2021-12-07 16:09:08,2021-12-03,BIIB,Kramer Robin,Chief Accounting Officer,M - OptEx,$223.92,339,1110,+44%,"+$75,909",,,,,BIIB
39,D,2021-12-06 16:14:53,2021-12-02,BIIB,Izzar Rachid,Head of Alzheimer's Disease,F - Tax,$228.52,-165,1106,-13%,"-$37,706",,,,,BIIB
40,D,2021-12-06 16:14:53,2021-12-02,BIIB,Izzar Rachid,Head of Alzheimer's Disease,M - OptEx,$228.52,372,1106,+51%,"+$85,009",,,,,BIIB
41,D,2021-09-03 16:08:01,2021-09-01,BIIB,McDonnell Michael R,"EVP, CFO",F - Tax,$338.24,-2582,3423,-43%,"-$873,336",,,,,BIIB
42,D,2021-09-03 16:08:01,2021-09-01,BIIB,McDonnell Michael R,"EVP, CFO",M - OptEx,$338.24,6005,3423,-233%,"+$2,031,131",,,,,BIIB
43,,2021-07-02 17:35:33,2021-07-01,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,775,656729,0%,+$0,,,,,BIIB
44,,2021-07-02 17:34:31,2021-07-01,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,775,21872,+4%,+$0,,,,,BIIB
45,,2021-07-02 17:33:18,2021-07-01,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,775,17103,+5%,+$0,,,,,BIIB
46,,2021-07-02 17:32:31,2021-07-01,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,775,17844,+5%,+$0,,,,,BIIB
47,,2021-07-02 17:31:46,2021-07-01,BIIB,Posner Brian S,Dir,A - Grant,$0.00,775,8175,+10%,+$0,,,,,BIIB
48,,2021-07-02 17:30:52,2021-07-01,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,775,13729,+6%,+$0,,,,,BIIB
49,,2021-07-02 17:29:46,2021-07-01,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,775,13763,+6%,+$0,,,,,BIIB
50,,2021-07-02 17:28:47,2021-07-01,BIIB,Freire Maria C,Dir,A - Grant,$0.00,775,775,New,+$0,,,,,BIIB
51,,2021-07-02 17:27:58,2021-07-01,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1275,36046,+4%,+$0,,,,,BIIB
52,,2021-07-02 17:27:07,2021-07-01,BIIB,Hawkins William A,Dir,A - Grant,$0.00,775,2820,+38%,+$0,,,,,BIIB
53,,2021-07-02 17:26:25,2021-07-01,BIIB,Mantas Jesus B,Dir,A - Grant,$0.00,775,3718,+26%,+$0,,,,,BIIB
54,,2021-07-02 17:25:34,2021-07-01,BIIB,Jones William D /Ca/,Dir,A - Grant,$0.00,775,775,New,+$0,,,,,BIIB
55,D,2021-07-02 16:34:26,2021-07-01,BIIB,Kramer Robin,Chief Accounting Officer,F - Tax,$348.92,-74,871,-8%,"-$25,820",,,,,BIIB
56,D,2021-07-02 16:34:26,2021-07-01,BIIB,Kramer Robin,Chief Accounting Officer,M - OptEx,$348.92,251,871,+40%,"+$87,579",,,,,BIIB
57,,2021-06-09 19:05:57,2021-06-07,BIIB,Sandrock Alfred,"Head of Research, Development",S - Sale,$440.00,-7672,10169,-43%,"-$3,375,680",,,,,BIIB
58,,2021-06-09 19:04:54,2021-06-07,BIIB,Guindo Chirfi,"Head of Glob Prod Strat, Com",S - Sale,$440.00,-3087,2919,-51%,"-$1,358,280",,,,,BIIB
59,,2021-06-07 19:02:48,2021-06-04,BIIB,Posner Brian S,Dir,S - Sale,$274.17,-360,7400,-5%,"-$98,701",,,,,BIIB
60,D,2021-02-17 17:03:06,2021-02-12,BIIB,Vounatsos Michel,CEO,F - Tax,$278.03,-14473,52969,-21%,"-$4,023,928",,,,,BIIB
61,D,2021-02-17 17:03:06,2021-02-12,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,16289,52969,+44%,+$0,,,,,BIIB
62,D,2021-02-17 17:01:58,2021-02-12,BIIB,Sandrock Alfred,"EVP, Research, Development",F - Tax,$278.03,-3510,17738,-17%,"-$975,885",,,,,BIIB
63,D,2021-02-17 17:01:58,2021-02-12,BIIB,Sandrock Alfred,"EVP, Research, Development",M - OptEx,$0.00,4454,17738,+34%,+$0,,,,,BIIB
64,D,2021-02-17 16:59:50,2021-02-12,BIIB,Kramer Robin,"SVP, Chief Accounting Officer",F - Tax,$278.03,-115,591,-16%,"-$31,973",,,,,BIIB
65,D,2021-02-17 16:59:50,2021-02-12,BIIB,Kramer Robin,"SVP, Chief Accounting Officer",M - OptEx,$0.00,333,591,+129%,+$0,,,,,BIIB
66,D,2021-02-17 16:58:28,2021-02-12,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",F - Tax,$278.03,-940,6006,-14%,"-$261,348",,,,,BIIB
67,D,2021-02-17 16:58:28,2021-02-12,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",M - OptEx,$0.00,3156,6006,+111%,+$0,,,,,BIIB
68,D,2021-02-17 16:56:31,2021-02-12,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$278.03,-2182,7990,-21%,"-$606,661",,,,,BIIB
69,D,2021-02-17 16:56:31,2021-02-12,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,2923,7990,+58%,+$0,,,,,BIIB
70,D,2021-02-17 16:54:59,2021-02-12,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",F - Tax,$278.03,-715,5273,-12%,"-$198,791",,,,,BIIB
71,D,2021-02-17 16:54:59,2021-02-12,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,1573,5273,+43%,+$0,,,,,BIIB
72,D,2021-02-17 16:52:21,2021-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",F - Tax,$278.03,-3896,41576,-9%,"-$1,083,205",,,,,BIIB
73,D,2021-02-17 16:52:21,2021-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",M - OptEx,$0.00,4355,41576,+12%,+$0,,,,,BIIB
74,,2021-02-10 16:31:42,2021-02-09,BIIB,Mantas Jesus B,Dir,P - Purchase,$267.00,898,2943,+44%,"+$239,766",,,,,BIIB
75,,2021-01-29 16:47:04,2021-01-27,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",A - Grant,$0.00,4545,41117,+12%,+$0,,,,,BIIB
76,,2021-01-29 16:45:56,2021-01-27,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",A - Grant,$0.00,818,4415,+23%,+$0,,,,,BIIB
77,,2021-01-29 16:44:51,2021-01-27,BIIB,Gregory Ginger,"EVP, HR",A - Grant,$0.00,2558,7249,+55%,+$0,,,,,BIIB
78,,2021-01-29 16:43:36,2021-01-27,BIIB,Sandrock Alfred,"EVP, Research, Development",A - Grant,$0.00,3728,16794,+29%,+$0,,,,,BIIB
79,,2021-01-29 16:41:51,2021-01-27,BIIB,Vounatsos Michel,CEO,A - Grant,$0.00,16343,51153,+47%,+$0,,,,,BIIB
80,D,2020-12-07 21:08:59,2020-12-03,BIIB,Kramer Robin,"VP, Chief Accounting Officer",F - Tax,$244.09,-22,373,-6%,"-$5,370",,,,,BIIB
81,D,2020-12-07 21:08:59,2020-12-03,BIIB,Kramer Robin,"VP, Chief Accounting Officer",M - OptEx,$0.00,74,373,+25%,+$0,,,,,BIIB
82,D,2020-12-03 17:41:07,2020-12-01,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",F - Tax,$243.16,-562,3790,-13%,"-$136,656",,,,,BIIB
83,D,2020-12-03 17:41:07,2020-12-01,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",M - OptEx,$0.00,481,3790,+15%,+$0,,,,,BIIB
84,,2020-12-01 16:57:29,2020-11-30,BIIB,Vounatsos Michel,CEO,P - Purchase,$241.31,3100,34810,+10%,"+$748,047",,,,,BIIB
85,,2020-11-06 21:39:46,2020-11-04,BIIB,Sandrock Alfred,"EVP, Research, Development",S - Sale,$350.00,-1500,13066,-10%,"-$525,000",,,,,BIIB
86,D,2020-08-04 16:12:26,2020-07-31,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$274.69,-223,4691,-5%,"-$61,256",,,,,BIIB
87,D,2020-08-04 16:12:26,2020-07-31,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,212,4691,+5%,+$0,,,,,BIIB
88,,2020-06-05 17:24:36,2020-06-03,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,890,16328,+6%,+$0,,,,,BIIB
89,,2020-06-05 17:23:30,2020-06-03,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,890,17069,+6%,+$0,,,,,BIIB
90,,2020-06-05 17:21:44,2020-06-03,BIIB,Posner Brian S,Dir,A - Grant,$0.00,890,7885,+13%,+$0,,,,,BIIB
91,,2020-06-05 17:20:19,2020-06-03,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1470,34771,+4%,+$0,,,,,BIIB
92,,2020-06-05 17:19:11,2020-06-03,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,890,20632,+5%,+$0,,,,,BIIB
93,,2020-06-05 17:17:59,2020-06-03,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,890,12954,+7%,+$0,,,,,BIIB
94,,2020-06-05 17:16:48,2020-06-03,BIIB,Mantas Jesus B,Dir,A - Grant,$0.00,890,2045,+77%,+$0,,,,,BIIB
95,,2020-06-05 17:15:37,2020-06-03,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,890,12988,+7%,+$0,,,,,BIIB
96,,2020-06-05 17:14:22,2020-06-03,BIIB,Hawkins William A,Dir,A - Grant,$0.00,890,2045,+77%,+$0,,,,,BIIB
97,,2020-06-05 17:13:03,2020-06-03,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,890,21097,+4%,+$0,,,,,BIIB
98,,2020-06-05 17:09:02,2020-06-03,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,890,655954,0%,+$0,,,,,BIIB
99,D,2020-03-12 18:56:29,2020-03-11,BIIB,Sherwin Stephen A,Dir,M - OptEx,$58.46,12278,15438,+389%,"+$717,772",,,,,BIIB
100,D,2020-03-12 18:56:29,2020-03-11,BIIB,Sherwin Stephen A,Dir,S - Sale+OE,$295.22,-2434,15438,-14%,"-$718,574",,,,,BIIB
101,D,2020-02-19 18:20:59,2020-02-15,BIIB,Vounatsos Michel,CEO,F - Tax,$333.00,-2150,31625,-6%,"-$715,950",,,,,BIIB
102,D,2020-02-19 18:20:59,2020-02-15,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,4847,31625,+18%,+$0,,,,,BIIB
103,D,2020-02-19 18:17:51,2020-02-15,BIIB,Sandrock Alfred,"EVP, Research, Development",F - Tax,$333.00,-538,14481,-4%,"-$179,154",,,,,BIIB
104,D,2020-02-19 18:17:51,2020-02-15,BIIB,Sandrock Alfred,"EVP, Research, Development",M - OptEx,$0.00,1213,14481,+9%,+$0,,,,,BIIB
105,D,2020-02-19 18:13:54,2020-02-15,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",F - Tax,$333.00,-130,3512,-4%,"-$43,290",,,,,BIIB
106,D,2020-02-19 18:13:54,2020-02-15,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,441,3512,+14%,+$0,,,,,BIIB
107,D,2020-02-19 18:09:24,2020-02-15,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",F - Tax,$333.00,-689,36572,-2%,"-$229,437",,,,,BIIB
108,D,2020-02-19 18:09:24,2020-02-15,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",M - OptEx,$0.00,1553,36572,+4%,+$0,,,,,BIIB
109,D,2020-02-14 18:37:51,2020-02-12,BIIB,Kramer Robin,"VP, Chief Accounting Officer",F - Tax,$331.76,-46,236,-16%,"-$15,261",,,,,BIIB
110,D,2020-02-14 18:37:51,2020-02-12,BIIB,Kramer Robin,"VP, Chief Accounting Officer",M - OptEx,$0.00,132,236,+126%,+$0,,,,,BIIB
111,D,2020-02-14 18:36:19,2020-02-12,BIIB,Karp Daniel,"EVP, Corporate Development",F - Tax,$331.76,-294,930,-24%,"-$97,537",,,,,BIIB
112,D,2020-02-14 18:36:19,2020-02-12,BIIB,Karp Daniel,"EVP, Corporate Development",M - OptEx,$0.00,960,930,-3242%,+$0,,,,,BIIB
113,D,2020-02-14 18:34:41,2020-02-12,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",F - Tax,$331.76,-504,3871,-12%,"-$167,207",,,,,BIIB
114,D,2020-02-14 18:34:41,2020-02-12,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",M - OptEx,$0.00,1680,3871,+77%,+$0,,,,,BIIB
115,D,2020-02-14 18:32:59,2020-02-12,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$331.76,-1159,4603,-20%,"-$384,510",,,,,BIIB
116,D,2020-02-14 18:32:59,2020-02-12,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,3547,4603,+336%,+$0,,,,,BIIB
117,D,2020-02-14 18:30:15,2020-02-12,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",F - Tax,$331.76,-351,3201,-10%,"-$116,448",,,,,BIIB
118,D,2020-02-14 18:30:15,2020-02-12,BIIB,Galdes Alphonse,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,1154,3201,+56%,+$0,,,,,BIIB
119,D,2020-02-14 18:27:32,2020-02-12,BIIB,Capello Jeffrey D,"EVP, CFO",F - Tax,$331.76,-614,3118,-16%,"-$203,701",,,,,BIIB
120,D,2020-02-14 18:27:32,2020-02-12,BIIB,Capello Jeffrey D,"EVP, CFO",M - OptEx,$0.00,1919,3118,+160%,+$0,,,,,BIIB
121,D,2020-02-14 18:25:04,2020-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",F - Tax,$331.76,-2235,35708,-6%,"-$741,484",,,,,BIIB
122,D,2020-02-14 18:25:04,2020-02-12,BIIB,Alexander Susan H,"EVP Chief Legal Off, Corp Sec",M - OptEx,$0.00,5967,35708,+20%,+$0,,,,,BIIB
123,D,2020-02-14 18:19:07,2020-02-12,BIIB,Vounatsos Michel,CEO,F - Tax,$331.76,-4895,28928,-14%,"-$1,623,965",,,,,BIIB
124,D,2020-02-14 18:19:07,2020-02-12,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,11994,28928,+71%,+$0,,,,,BIIB
125,D,2020-02-14 18:16:35,2020-02-12,BIIB,Sandrock Alfred,"EVP, Research, Development",F - Tax,$331.76,-1901,13806,-12%,"-$630,676",,,,,BIIB
126,D,2020-02-14 18:16:35,2020-02-12,BIIB,Sandrock Alfred,"EVP, Research, Development",M - OptEx,$0.00,5216,13806,+61%,+$0,,,,,BIIB
127,D,2020-01-06 16:14:02,2020-01-02,BIIB,Capello Jeffrey D,"EVP, CFO",F - Tax,$294.20,-406,1813,-18%,"-$119,445",,,,,BIIB
128,D,2020-01-06 16:14:02,2020-01-02,BIIB,Capello Jeffrey D,"EVP, CFO",M - OptEx,$0.00,1302,1813,+255%,+$0,,,,,BIIB
129,D,2019-12-05 16:24:24,2019-12-03,BIIB,Kramer Robin,"VP, Chief Accounting Officer",F - Tax,$290.70,-25,150,-14%,"-$7,268",,,,,BIIB
130,D,2019-12-05 16:24:24,2019-12-03,BIIB,Kramer Robin,"VP, Chief Accounting Officer",M - OptEx,$0.00,84,150,+126%,+$0,,,,,BIIB
131,D,2019-12-03 17:59:49,2019-12-01,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",F - Tax,$299.81,-391,2695,-13%,"-$117,226",,,,,BIIB
132,D,2019-12-03 17:59:49,2019-12-01,BIIB,Guindo Chirfi,"EVP Glob. Prod Strat, Comm",M - OptEx,$0.00,543,2695,+25%,+$0,,,,,BIIB
133,,2019-12-03 17:58:26,2019-12-02,BIIB,Posner Brian S,Dir,S - Sale,$292.35,-1055,6995,-13%,"-$308,429",,,,,BIIB
134,D,2019-08-05 16:20:38,2019-08-01,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$243.06,-208,2215,-9%,"-$50,556",,,,,BIIB
135,D,2019-08-05 16:20:38,2019-08-01,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,179,2215,+9%,+$0,,,,,BIIB
136,D,2019-07-05 16:51:39,2019-07-02,BIIB,Karp Daniel,"EVP, Corporate Development",F - Tax,$236.37,-58,264,-18%,"-$13,709",,,,,BIIB
137,D,2019-07-05 16:51:39,2019-07-02,BIIB,Karp Daniel,"EVP, Corporate Development",M - OptEx,$0.00,196,264,+287%,+$0,,,,,BIIB
138,,2019-06-20 18:02:55,2019-06-19,BIIB,Mantas Jesus B,Dir,A - Grant,$0.00,1155,1155,New,+$0,,,,,BIIB
139,,2019-06-20 18:01:49,2019-06-19,BIIB,Hawkins William A,Dir,A - Grant,$0.00,1155,1155,New,+$0,,,,,BIIB
140,,2019-06-20 18:00:22,2019-06-19,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,1155,6319,+22%,+$0,,,,,BIIB
141,,2019-06-20 17:59:16,2019-06-19,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,1155,12132,+11%,+$0,,,,,BIIB
142,,2019-06-20 17:57:42,2019-06-19,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,1155,16179,+8%,+$0,,,,,BIIB
143,,2019-06-20 17:55:49,2019-06-19,BIIB,Posner Brian S,Dir,A - Grant,$0.00,1155,8050,+17%,+$0,,,,,BIIB
144,,2019-06-20 17:54:16,2019-06-19,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1905,33301,+6%,+$0,,,,,BIIB
145,,2019-06-20 17:52:52,2019-06-19,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,1155,19742,+6%,+$0,,,,,BIIB
146,,2019-06-20 17:51:23,2019-06-19,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,1155,12064,+11%,+$0,,,,,BIIB
147,,2019-06-20 17:50:00,2019-06-19,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,1155,12098,+11%,+$0,,,,,BIIB
148,,2019-06-20 17:48:44,2019-06-19,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,1155,20207,+6%,+$0,,,,,BIIB
149,,2019-06-20 17:47:26,2019-06-19,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,1155,655064,0%,+$0,,,,,BIIB
150,D,2019-06-04 16:56:28,2019-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$219.29,-960,8025,-11%,"-$210,518",,,,,BIIB
151,D,2019-06-04 16:56:28,2019-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,1126,8025,+16%,+$0,,,,,BIIB
152,D,2019-05-06 16:20:38,2019-05-02,BIIB,Vounatsos Michel,CEO,F - Tax,$230.52,-658,21829,-3%,"-$151,682",,,,,BIIB
153,D,2019-05-06 16:20:38,2019-05-02,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,1480,21829,+7%,+$0,,,,,BIIB
154,M,2019-05-02 17:06:09,2019-04-30,BIIB,Denner Alexander J,Dir,P - Purchase,$229.94,118342,653909,+22%,"+$27,211,824",,,,,BIIB
155,,2019-05-02 16:30:28,2019-05-01,BIIB,Vounatsos Michel,CEO,P - Purchase,$231.48,4351,21007,+26%,"+$1,007,169",,,,,BIIB
156,D,2019-03-19 16:08:36,2019-03-18,BIIB,Pangia Robert W,Dir,M - OptEx,$52.22,6114,18587,+49%,"+$319,273",,,,,BIIB
157,D,2019-03-19 16:08:36,2019-03-18,BIIB,Pangia Robert W,Dir,S - Sale+OE,$328.55,-6114,18587,-25%,"-$2,008,755",,,,,BIIB
158,D,2019-03-05 16:17:14,2019-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$334.10,-658,7235,-8%,"-$219,838",,,,,BIIB
159,D,2019-03-05 16:17:14,2019-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,568,7235,+9%,+$0,,,,,BIIB
160,D,2019-02-20 18:10:24,2019-02-15,BIIB,Vounatsos Michel,CEO,F - Tax,$332.87,-2340,16574,-12%,"-$778,916",,,,,BIIB
161,D,2019-02-20 18:10:24,2019-02-15,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,5269,16574,+47%,+$0,,,,,BIIB
162,D,2019-02-20 18:08:56,2019-02-15,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$332.87,-586,9485,-6%,"-$195,062",,,,,BIIB
163,D,2019-02-20 18:08:56,2019-02-15,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,1318,9485,+16%,+$0,,,,,BIIB
164,D,2019-02-20 18:07:30,2019-02-15,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$332.87,-643,7325,-8%,"-$214,035",,,,,BIIB
165,D,2019-02-20 18:07:30,2019-02-15,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,1448,7325,+25%,+$0,,,,,BIIB
166,D,2019-02-20 17:54:24,2019-02-15,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$332.87,-749,7777,-9%,"-$249,320",,,,,BIIB
167,D,2019-02-20 17:54:24,2019-02-15,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,1685,7777,+28%,+$0,,,,,BIIB
168,D,2019-02-20 17:53:03,2019-02-15,BIIB,Alexander Susan H,"EVP GC, Sec.",F - Tax,$332.87,-749,28027,-3%,"-$249,320",,,,,BIIB
169,D,2019-02-20 17:53:03,2019-02-15,BIIB,Alexander Susan H,"EVP GC, Sec.",M - OptEx,$0.00,1685,28027,+6%,+$0,,,,,BIIB
170,,2019-02-15 16:21:23,2019-02-14,BIIB,Posner Brian S,Dir,G - Gift,$0.00,-315,6895,-4%,-$0,,,,,BIIB
171,D,2019-02-14 18:33:56,2019-02-12,BIIB,Vounatsos Michel,CEO,F - Tax,$319.43,-2622,13645,-16%,"-$837,545",,,,,BIIB
172,D,2019-02-14 18:33:56,2019-02-12,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,6899,13645,+102%,+$0,,,,,BIIB
173,D,2019-02-14 18:29:50,2019-02-12,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$319.43,-2518,8753,-22%,"-$804,325",,,,,BIIB
174,D,2019-02-14 18:29:50,2019-02-12,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,4643,8753,+113%,+$0,,,,,BIIB
175,D,2019-02-14 18:17:41,2019-02-12,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$319.43,-919,6520,-12%,"-$293,556",,,,,BIIB
176,D,2019-02-14 18:17:41,2019-02-12,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,3062,6520,+89%,+$0,,,,,BIIB
177,D,2019-02-14 18:10:01,2019-02-12,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$319.43,-551,2244,-20%,"-$176,006",,,,,BIIB
178,D,2019-02-14 18:10:01,2019-02-12,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,1836,2244,+450%,+$0,,,,,BIIB
179,D,2019-02-14 18:07:47,2019-02-12,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$319.43,-1267,6841,-16%,"-$404,718",,,,,BIIB
180,D,2019-02-14 18:07:47,2019-02-12,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,3827,6841,+127%,+$0,,,,,BIIB
181,D,2019-02-14 18:04:24,2019-02-12,BIIB,Alexander Susan H,"EVP GC, Sec.",F - Tax,$319.43,-1021,27091,-4%,"-$326,138",,,,,BIIB
182,D,2019-02-14 18:04:24,2019-02-12,BIIB,Alexander Susan H,"EVP GC, Sec.",M - OptEx,$0.00,3268,27091,+14%,+$0,,,,,BIIB
183,M,2019-02-01 16:19:28,2019-01-30,BIIB,Denner Alexander J,Dir,P - Purchase,$327.59,62800,535567,+13%,"+$20,572,406",,,,,BIIB
184,D,2019-01-04 16:17:58,2019-01-02,BIIB,Capello Jeffrey D,"EVP, CFO",F - Tax,$304.69,-414,917,-31%,"-$126,142",,,,,BIIB
185,D,2019-01-04 16:17:58,2019-01-02,BIIB,Capello Jeffrey D,"EVP, CFO",M - OptEx,$0.00,1331,917,-321%,+$0,,,,,BIIB
186,D,2018-12-04 20:21:37,2018-12-01,BIIB,Guindo Chirfi,"EVP Glob. Mkt Acc, Cust Innov",F - Tax,$333.72,-409,2543,-14%,"-$136,491",,,,,BIIB
187,D,2018-12-04 20:21:37,2018-12-01,BIIB,Guindo Chirfi,"EVP Glob. Mkt Acc, Cust Innov",M - OptEx,$0.00,602,2543,+31%,+$0,,,,,BIIB
188,,2018-12-03 17:21:51,2018-11-28,BIIB,Schenk Lynn,Dir,G - Gift,$0.00,-32,10977,0%,-$0,,,,,BIIB
189,,2018-11-05 16:15:34,2018-10-31,BIIB,Sherwin Stephen A,Dir,G - Gift,$0.00,-850,5164,-14%,-$0,,,,,BIIB
190,,2018-09-27 16:16:34,2018-09-26,BIIB,Ehlers Michael D,"EVP, Research, Development",S - Sale,$350.00,-1000,4281,-19%,"-$350,000",,,,,BIIB
191,D,2018-08-03 16:14:35,2018-08-01,BIIB,Gregory Ginger,"EVP, HR",F - Tax,$344.06,-163,959,-15%,"-$56,082",,,,,BIIB
192,D,2018-08-03 16:14:35,2018-08-01,BIIB,Gregory Ginger,"EVP, HR",M - OptEx,$0.00,262,959,+38%,+$0,,,,,BIIB
193,,2018-06-14 18:04:16,2018-06-12,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,880,472767,0%,+$0,,,,,BIIB
194,,2018-06-14 17:35:30,2018-06-12,BIIB,Posner Brian S,Dir,A - Grant,$0.00,880,7210,+14%,+$0,,,,,BIIB
195,,2018-06-14 17:33:50,2018-06-12,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,880,18587,+5%,+$0,,,,,BIIB
196,,2018-06-14 17:32:34,2018-06-12,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,880,10909,+9%,+$0,,,,,BIIB
197,,2018-06-14 17:31:06,2018-06-12,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,880,10943,+9%,+$0,,,,,BIIB
198,,2018-06-14 17:29:28,2018-06-12,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,880,19052,+5%,+$0,,,,,BIIB
199,,2018-06-14 17:27:50,2018-06-12,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1450,31396,+5%,+$0,,,,,BIIB
200,,2018-06-14 17:25:28,2018-06-12,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,880,15024,+6%,+$0,,,,,BIIB
201,,2018-06-14 17:23:45,2018-06-12,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,880,11009,+9%,+$0,,,,,BIIB
202,,2018-06-14 17:21:52,2018-06-12,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,880,6014,+17%,+$0,,,,,BIIB
203,D,2018-06-05 16:31:27,2018-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$297.09,-1076,5281,-17%,"-$319,669",,,,,BIIB
204,D,2018-06-05 16:31:27,2018-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,1384,5281,+36%,+$0,,,,,BIIB
205,D,2018-05-04 18:09:38,2018-05-02,BIIB,Vounatsos Michel,CEO,F - Tax,$274.13,-750,9368,-7%,"-$205,598",,,,,BIIB
206,D,2018-05-04 18:09:38,2018-05-02,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,1687,9368,+22%,+$0,,,,,BIIB
207,,2018-04-27 07:48:58,2018-04-25,BIIB,Denner Alexander J,Dir,P - Purchase,$269.91,48000,471887,+11%,"+$12,955,680",,,,,BIIB
208,D,2018-03-05 16:41:16,2018-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$282.35,-642,4302,-13%,"-$181,269",,,,,BIIB
209,D,2018-03-05 16:41:16,2018-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,532,4302,+14%,+$0,,,,,BIIB
210,,2018-02-28 17:39:47,2018-02-27,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",S - Sale,$290.83,-259,6553,-4%,"-$75,325",,,,,BIIB
211,D,2018-02-27 18:25:45,2018-02-23,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$292.78,-208,6812,-3%,"-$60,898",,,,,BIIB
212,D,2018-02-27 18:25:45,2018-02-23,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,467,6812,+7%,+$0,,,,,BIIB
213,D,2018-02-27 18:25:45,2018-02-23,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",S - Sale+OE,$293.44,-908,6812,-12%,"-$266,444",,,,,BIIB
214,D,2018-02-27 18:24:23,2018-02-23,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$292.78,-28,4744,-1%,"-$8,198",,,,,BIIB
215,D,2018-02-27 18:24:23,2018-02-23,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,92,4744,+2%,+$0,,,,,BIIB
216,D,2018-02-27 18:22:56,2018-02-23,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",F - Tax,$292.78,-381,24844,-2%,"-$111,549",,,,,BIIB
217,D,2018-02-27 18:22:56,2018-02-23,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",M - OptEx,$0.00,857,24844,+4%,+$0,,,,,BIIB
218,D,2018-02-26 16:12:56,2018-02-22,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$284.81,-727,7461,-9%,"-$207,057",,,,,BIIB
219,D,2018-02-26 16:12:56,2018-02-22,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,1635,7461,+28%,+$0,,,,,BIIB
220,D,2018-02-26 16:11:36,2018-02-22,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$284.81,-58,4680,-1%,"-$16,519",,,,,BIIB
221,D,2018-02-26 16:11:36,2018-02-22,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,194,4680,+4%,+$0,,,,,BIIB
222,D,2018-02-26 16:10:05,2018-02-22,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",F - Tax,$284.81,-727,24368,-3%,"-$207,057",,,,,BIIB
223,D,2018-02-26 16:10:05,2018-02-22,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",M - OptEx,$0.00,1635,24368,+7%,+$0,,,,,BIIB
224,,2018-02-21 16:10:42,2018-02-20,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",S - Sale,$292.00,-743,6553,-10%,"-$216,956",,,,,BIIB
225,,2018-02-20 20:09:51,2018-02-15,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",S - Sale,$298.85,-1294,7296,-15%,"-$386,712",,,,,BIIB
226,D,2018-02-20 16:27:02,2018-02-15,BIIB,Vounatsos Michel,CEO,F - Tax,$299.38,-1877,8356,-18%,"-$561,936",,,,,BIIB
227,D,2018-02-20 16:27:02,2018-02-15,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,5354,8356,+178%,+$0,,,,,BIIB
228,D,2018-02-20 16:25:08,2018-02-15,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$299.38,-596,8590,-6%,"-$178,430",,,,,BIIB
229,D,2018-02-20 16:25:08,2018-02-15,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,1339,8590,+18%,+$0,,,,,BIIB
230,D,2018-02-20 16:23:16,2018-02-15,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$299.38,-442,4412,-9%,"-$132,326",,,,,BIIB
231,D,2018-02-20 16:23:16,2018-02-15,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,1472,4412,+50%,+$0,,,,,BIIB
232,D,2018-02-20 16:20:46,2018-02-15,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$299.38,-509,4898,-9%,"-$152,384",,,,,BIIB
233,D,2018-02-20 16:20:46,2018-02-15,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,1712,4898,+54%,+$0,,,,,BIIB
234,D,2018-02-20 16:18:57,2018-02-15,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$299.38,-56,4544,-1%,"-$16,765",,,,,BIIB
235,D,2018-02-20 16:18:57,2018-02-15,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,161,4544,+4%,+$0,,,,,BIIB
236,D,2018-02-20 16:17:02,2018-02-15,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",F - Tax,$299.38,-510,23460,-2%,"-$152,684",,,,,BIIB
237,D,2018-02-20 16:17:02,2018-02-15,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",M - OptEx,$0.00,1712,23460,+8%,+$0,,,,,BIIB
238,D,2018-02-14 18:37:07,2018-02-12,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",F - Tax,$316.63,-1316,7847,-14%,"-$416,685",,,,,BIIB
239,D,2018-02-14 18:37:07,2018-02-12,BIIB,Sandrock Alfred,"EVP, Chief Medical Officer",M - OptEx,$0.00,2012,7847,+34%,+$0,,,,,BIIB
240,D,2018-01-10 17:28:35,2018-01-09,BIIB,Pangia Robert W,Dir,M - OptEx,$57.83,5832,17707,+49%,"+$337,265",,,,,BIIB
241,D,2018-01-10 17:28:35,2018-01-09,BIIB,Pangia Robert W,Dir,S - Sale+OE,$329.65,-5832,17707,-25%,"-$1,922,519",,,,,BIIB
242,,2018-01-02 16:21:54,2017-12-29,BIIB,Vounatsos Michel,CEO,P - Purchase,$320.55,780,4879,+19%,"+$250,029",,,,,BIIB
243,D,2017-12-05 16:41:53,2017-12-01,BIIB,Guindo Chirfi,"EVP Glob. Mkt Acc, Cust Innov",A - Grant,$0.00,2350,2350,New,+$0,,,,,BIIB
244,,2017-12-05 16:36:16,2017-12-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$319.35,-157,4439,-3%,"-$50,138",,,,,BIIB
245,,2017-12-05 16:29:20,2017-11-29,BIIB,Sherwin Stephen A,Dir,G - Gift,$0.00,-850,5134,-14%,-$0,,,,,BIIB
246,M,2017-11-30 07:30:26,2017-11-28,BIIB,Denner Alexander J,Dir,P - Purchase,$317.36,30000,423887,+8%,"+$9,520,800",,,,,BIIB
247,,2017-08-31 21:45:20,2017-08-31,BIIB,Denner Alexander J,Dir,A - Grant,$316.56,933,393887,0%,"+$295,350",,,,,BIIB
248,D,2017-08-03 16:34:49,2017-08-01,BIIB,Gregory Ginger,"EVP, HR",A - Grant,$0.00,860,860,New,+$0,,,,,BIIB
249,,2017-07-26 16:22:34,2017-07-25,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",S - Sale,$290.01,-4974,22258,-18%,"-$1,442,510",,,,,BIIB
250,,2017-07-20 17:00:14,2017-07-19,BIIB,Alexander Susan H,"EVP Chief Legal Corp Svc, Sec",S - Sale,$285.00,-7758,27232,-22%,"-$2,211,030",,,,,BIIB
251,,2017-06-12 16:29:17,2017-06-09,BIIB,Posner Brian S,Dir,S - Sale,$256.31,-1084,6330,-15%,"-$277,840",,,,,BIIB
252,,2017-06-09 17:58:24,2017-06-07,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,1055,14144,+8%,+$0,,,,,BIIB
253,,2017-06-09 17:57:02,2017-06-07,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,1055,18172,+6%,+$0,,,,,BIIB
254,,2017-06-09 17:55:33,2017-06-07,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,1055,10029,+12%,+$0,,,,,BIIB
255,,2017-06-09 17:54:16,2017-06-07,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,1055,5984,+21%,+$0,,,,,BIIB
256,,2017-06-09 17:52:27,2017-06-07,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1740,29946,+6%,+$0,,,,,BIIB
257,,2017-06-09 17:50:56,2017-06-07,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,1055,17707,+6%,+$0,,,,,BIIB
258,,2017-06-09 17:49:32,2017-06-07,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,1055,10063,+12%,+$0,,,,,BIIB
259,,2017-06-09 17:48:01,2017-06-07,BIIB,Posner Brian S,Dir,A - Grant,$0.00,1055,7414,+17%,+$0,,,,,BIIB
260,,2017-06-09 17:46:35,2017-06-07,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,1055,10129,+12%,+$0,,,,,BIIB
261,,2017-06-09 17:45:12,2017-06-07,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,1055,393887,0%,+$0,,,,,BIIB
262,D,2017-06-05 16:38:17,2017-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",F - Tax,$252.38,-747,3616,-17%,"-$188,528",,,,,BIIB
263,D,2017-06-05 16:38:17,2017-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",M - OptEx,$0.00,1259,3616,+53%,+$0,,,,,BIIB
264,D,2017-05-04 16:16:01,2017-05-02,BIIB,Vounatsos Michel,CEO,F - Tax,$271.34,-564,4099,-12%,"-$153,036",-2.0,-4.0,,,BIIB
265,D,2017-05-04 16:16:01,2017-05-02,BIIB,Vounatsos Michel,CEO,M - OptEx,$0.00,1736,4099,+73%,+$0,-2.0,-4.0,,,BIIB
266,,2017-05-02 16:18:26,2017-05-01,BIIB,Vounatsos Michel,CEO,P - Purchase,$271.35,1402,2927,+92%,"+$380,433",0.0,-4.0,,,BIIB
267,,2017-05-01 17:47:49,2017-04-27,BIIB,Denner Alexander J,Dir,P - Purchase,$278.50,73858,392832,+23%,"+$20,569,476",0.0,-3.0,,,BIIB
268,,2017-04-27 16:23:52,2017-04-25,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$290.00,-9892,10813,-48%,"-$2,868,680",-2.0,-2.0,,,BIIB
269,,2017-04-04 16:18:38,2017-04-03,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale,$274.08,-1981,7060,-22%,"-$542,952",-1.0,-2.0,-1.0,,BIIB
270,,2017-03-14 19:32:15,2017-03-13,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$291.55,-9891,20705,-32%,"-$2,883,721",0.0,-6.0,-8.0,,BIIB
271,D,2017-03-03 18:07:27,2017-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",A - Grant,$0.00,2730,3291,+486%,+$0,-1.0,-2.0,-8.0,,BIIB
272,D,2017-03-03 18:07:27,2017-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",F - Tax,$293.26,-157,3291,-5%,"-$46,042",-1.0,-2.0,-8.0,,BIIB
273,D,2017-03-03 18:07:27,2017-03-01,BIIB,McKenzie Paul,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,481,3291,+17%,+$0,-1.0,-2.0,-8.0,,BIIB
274,,2017-03-03 18:02:37,2017-03-01,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale,$290.07,-973,9041,-10%,"-$282,238",-1.0,-2.0,-8.0,,BIIB
275,D,2017-03-02 17:24:18,2017-02-28,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$279.35,-3054,30596,-9%,"-$853,135",1.0,0.0,-8.0,,BIIB
276,D,2017-03-02 17:24:18,2017-02-28,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,6780,30596,+28%,+$0,1.0,0.0,-8.0,,BIIB
277,D,2017-03-02 17:22:19,2017-02-28,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",F - Tax,$278.17,-2981,10014,-23%,"-$829,217",1.0,0.0,-8.0,,BIIB
278,D,2017-03-02 17:22:19,2017-02-28,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",M - OptEx,$0.00,4785,10014,+92%,+$0,1.0,0.0,-8.0,,BIIB
279,D,2017-03-02 17:20:45,2017-02-28,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$278.54,-2409,34990,-6%,"-$670,996",1.0,0.0,-8.0,,BIIB
280,D,2017-03-02 17:20:45,2017-02-28,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,5559,34990,+19%,+$0,1.0,0.0,-8.0,,BIIB
281,D,2017-03-02 17:18:20,2017-02-28,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$285.23,-89,4505,-2%,"-$25,386",1.0,0.0,-8.0,,BIIB
282,D,2017-03-02 17:18:20,2017-02-28,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,681,4505,+18%,+$0,1.0,0.0,-8.0,,BIIB
283,D,2017-03-02 17:16:06,2017-02-28,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",F - Tax,$286.64,-738,8752,-8%,"-$211,542",1.0,0.0,-8.0,,BIIB
284,D,2017-03-02 17:16:06,2017-02-28,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",M - OptEx,$0.00,2064,8752,+31%,+$0,1.0,0.0,-8.0,,BIIB
285,D,2017-03-02 17:12:03,2017-02-28,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$278.66,-2456,7177,-25%,"-$684,399",1.0,0.0,-8.0,,BIIB
286,D,2017-03-02 17:12:03,2017-02-28,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,5696,7177,+385%,+$0,1.0,0.0,-8.0,,BIIB
287,,2017-03-01 16:18:57,2017-02-27,BIIB,Vounatsos Michel,CEO,P - Purchase,$285.39,1333,1434,>999%,"+$380,425",0.0,-1.0,-9.0,,BIIB
288,D,2017-01-10 16:15:29,2017-01-09,BIIB,Pangia Robert W,Dir,M - OptEx,$52.22,5450,16628,+49%,"+$284,599",-4.0,-5.0,-10.0,,BIIB
289,D,2017-01-10 16:15:29,2017-01-09,BIIB,Pangia Robert W,Dir,S - Sale+OE,$295.39,-5450,16628,-25%,"-$1,609,876",-4.0,-5.0,-10.0,,BIIB
290,,2016-12-05 16:34:15,2016-12-01,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",F - Tax,$295.78,-171,7360,-2%,"-$50,578",0.0,-1.0,1.0,,BIIB
291,,2016-12-05 16:34:15,2016-12-01,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",S - Sale,$296.53,-48,7360,-1%,"-$14,233",0.0,-1.0,1.0,,BIIB
292,,2016-12-05 16:32:24,2016-12-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",A - Grant,$0.00,930,3884,+31%,+$0,0.0,-1.0,1.0,,BIIB
293,,2016-12-05 16:32:24,2016-12-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$295.78,-53,3884,-1%,"-$15,676",0.0,-1.0,1.0,,BIIB
294,,2016-11-14 16:32:23,2016-11-08,BIIB,Sherwin Stephen A,Dir,G - Gift,$0.00,-1000,4905,-17%,-$0,0.0,-1.0,-11.0,,BIIB
295,,2016-10-05 16:24:33,2016-10-04,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",S - Sale,$311.94,-262,7579,-3%,"-$81,728",-1.0,-4.0,-10.0,-13.0,BIIB
296,D,2016-10-04 17:02:53,2016-10-01,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",F - Tax,$313.03,-1888,7841,-19%,"-$591,001",-1.0,-2.0,-9.0,-12.0,BIIB
297,D,2016-10-04 17:02:53,2016-10-01,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",M - OptEx,$0.00,1982,7841,+34%,+$0,-1.0,-2.0,-9.0,-12.0,BIIB
298,D,2016-10-04 17:02:53,2016-10-03,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",S - Sale+OE,$313.00,-380,7841,-5%,"-$118,940",-1.0,-2.0,-9.0,-12.0,BIIB
299,D,2016-09-26 16:24:29,2016-09-22,BIIB,Dorsa Caroline,Dir,M - OptEx,$53.64,27570,17093,-263%,"+$1,478,855",2.0,1.0,-6.0,-11.0,BIIB
300,D,2016-09-26 16:24:29,2016-09-22,BIIB,Dorsa Caroline,Dir,S - Sale+OE,$314.00,-27570,17093,-62%,"-$8,656,980",2.0,1.0,-6.0,-11.0,BIIB
301,,2016-07-22 17:03:49,2016-07-21,BIIB,Scangos George A,CEO,S - Sale,$280.00,-157,65535,0%,"-$43,960",0.0,0.0,10.0,-3.0,BIIB
302,,2016-06-09 17:23:08,2016-06-08,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,1060,318950,0%,+$0,-2.0,-5.0,0.0,16.0,BIIB
303,,2016-06-09 16:46:33,2016-06-08,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,1060,5905,+22%,+$0,-2.0,-5.0,0.0,16.0,BIIB
304,,2016-06-09 16:45:23,2016-06-08,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,1060,9050,+13%,+$0,-2.0,-5.0,0.0,16.0,BIIB
305,,2016-06-09 16:44:12,2016-06-08,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,1060,13065,+9%,+$0,-2.0,-5.0,0.0,16.0,BIIB
306,,2016-06-09 16:43:12,2016-06-08,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1590,28170,+6%,+$0,-2.0,-5.0,0.0,16.0,BIIB
307,,2016-06-09 16:41:12,2016-06-08,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,1060,8950,+13%,+$0,-2.0,-5.0,0.0,16.0,BIIB
308,,2016-06-09 16:39:49,2016-06-08,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,1060,8984,+13%,+$0,-2.0,-5.0,0.0,16.0,BIIB
309,,2016-06-09 16:38:14,2016-06-08,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,1060,17093,+7%,+$0,-2.0,-5.0,0.0,16.0,BIIB
310,,2016-06-09 16:37:00,2016-06-08,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,1060,16628,+7%,+$0,-2.0,-5.0,0.0,16.0,BIIB
311,,2016-06-09 16:33:51,2016-06-08,BIIB,Posner Brian S,Dir,A - Grant,$0.00,1060,6335,+20%,+$0,-2.0,-5.0,0.0,16.0,BIIB
312,,2016-06-07 16:09:07,2016-06-06,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",S - Sale,$290.00,-555,2402,-19%,"-$160,950",1.0,-3.0,-1.0,16.0,BIIB
313,D,2016-06-06 20:48:53,2016-06-02,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",F - Tax,$289.73,-534,2957,-15%,"-$154,716",-13.0,-15.0,-16.0,2.0,BIIB
314,D,2016-06-06 20:48:53,2016-06-02,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",M - OptEx,$0.00,1643,2957,+125%,+$0,-13.0,-15.0,-16.0,2.0,BIIB
315,,2016-06-06 20:14:16,2016-06-03,BIIB,Scangos George A,CEO,S - Sale,$290.00,-842,65692,-1%,"-$244,180",-13.0,-15.0,-16.0,2.0,BIIB
316,D,2016-06-02 16:44:39,2016-06-01,BIIB,Ehlers Michael D,"EVP, Research, Development",A - Grant,$0.00,3034,3034,New,+$0,0.0,-12.0,-17.0,5.0,BIIB
317,M,2016-06-02 16:39:14,2016-05-31,BIIB,Scangos George A,CEO,S - Sale,$289.74,-3855,66534,-5%,"-$1,116,961",0.0,-12.0,-17.0,5.0,BIIB
318,,2016-05-27 08:59:28,2016-05-25,BIIB,Scangos George A,CEO,S - Sale,$280.00,-157,70389,0%,"-$43,960",0.0,3.0,-20.0,8.0,BIIB
319,,2016-05-04 17:03:32,2016-05-02,BIIB,Scangos George A,CEO,S - Sale,$274.74,-487,70546,-1%,"-$133,798",1.0,4.0,10.0,6.0,BIIB
320,D,2016-05-02 16:36:50,2016-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$274.99,-113,3007,-4%,"-$31,074",0.0,-4.0,6.0,6.0,BIIB
321,D,2016-05-02 16:36:50,2016-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,348,3007,+13%,+$0,0.0,-4.0,6.0,6.0,BIIB
322,,2016-04-07 17:03:19,2016-04-06,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",S - Sale,$275.00,-102,1848,-5%,"-$28,050",-1.0,0.0,-3.0,14.0,BIIB
323,,2016-04-07 17:01:30,2016-04-06,BIIB,Scangos George A,CEO,S - Sale,$280.00,-157,71033,0%,"-$43,960",-1.0,0.0,-3.0,14.0,BIIB
324,D,2016-04-05 17:06:19,2016-04-02,BIIB,Artavanis-Tsakonas Spyridon,"EVP, Chief Scientific Officer",F - Tax,$260.54,-459,3150,-13%,"-$119,588",5.0,0.0,3.0,18.0,BIIB
325,D,2016-04-05 17:06:19,2016-04-02,BIIB,Artavanis-Tsakonas Spyridon,"EVP, Chief Scientific Officer",M - OptEx,$0.00,975,3150,+45%,+$0,5.0,0.0,3.0,18.0,BIIB
326,,2016-04-05 17:04:17,2016-04-01,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",A - Grant,$0.00,8444,39045,+28%,+$0,5.0,0.0,3.0,18.0,BIIB
327,,2016-04-05 17:02:16,2016-04-01,BIIB,Scangos George A,CEO,S - Sale,$258.83,-487,71190,-1%,"-$126,050",5.0,0.0,3.0,18.0,BIIB
328,,2016-03-03 16:36:54,2016-03-01,BIIB,Scangos George A,CEO,S - Sale,$261.37,-487,71677,-1%,"-$127,287",-2.0,-5.0,-3.0,14.0,BIIB
329,AD,2016-03-03 16:27:51,2015-02-12,BIIB,Scangos George A,CEO,M - OptEx,$0.00,9189,54222,+20%,+$0,-2.0,-5.0,-3.0,14.0,BIIB
330,,2016-02-26 16:08:52,2016-02-25,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale,$261.90,-183,7990,-2%,"-$47,928",-2.0,2.0,-5.0,17.0,BIIB
331,,2016-02-26 16:06:38,2016-02-25,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",S - Sale,$261.90,-84,8127,-1%,"-$22,000",-2.0,2.0,-5.0,17.0,BIIB
332,D,2016-02-25 17:13:08,2016-02-23,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$258.99,-273,26870,-1%,"-$70,704",1.0,4.0,-3.0,22.0,BIIB
333,D,2016-02-25 17:13:08,2016-02-23,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,579,26870,+2%,+$0,1.0,4.0,-3.0,22.0,BIIB
334,D,2016-02-25 17:09:07,2016-02-23,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$258.99,-22,2687,-1%,"-$5,698",1.0,4.0,-3.0,22.0,BIIB
335,D,2016-02-25 17:09:07,2016-02-23,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,66,2687,+3%,+$0,1.0,4.0,-3.0,22.0,BIIB
336,D,2016-02-25 17:07:41,2016-02-23,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$258.99,-48,2549,-2%,"-$12,432",1.0,4.0,-3.0,22.0,BIIB
337,D,2016-02-25 17:07:41,2016-02-23,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,145,2549,+6%,+$0,1.0,4.0,-3.0,22.0,BIIB
338,D,2016-02-25 17:05:31,2016-02-23,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$258.99,-300,31840,-1%,"-$77,697",1.0,4.0,-3.0,22.0,BIIB
339,D,2016-02-25 17:05:31,2016-02-23,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,636,31840,+2%,+$0,1.0,4.0,-3.0,22.0,BIIB
340,D,2016-02-25 17:04:16,2016-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$258.99,-382,30516,-1%,"-$98,934",1.0,4.0,-3.0,22.0,BIIB
341,D,2016-02-25 17:04:16,2016-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,810,30516,+3%,+$0,1.0,4.0,-3.0,22.0,BIIB
342,D,2016-02-25 17:02:48,2016-02-23,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",F - Tax,$258.99,-98,1865,-5%,"-$25,381",1.0,4.0,-3.0,22.0,BIIB
343,D,2016-02-25 17:02:48,2016-02-23,BIIB,Koppel Adam,"EVP, Strategy, Bus. Dev.",M - OptEx,$0.00,301,1865,+19%,+$0,1.0,4.0,-3.0,22.0,BIIB
344,D,2016-02-25 17:01:39,2016-02-23,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$258.99,-300,3937,-7%,"-$77,697",1.0,4.0,-3.0,22.0,BIIB
345,D,2016-02-25 17:01:39,2016-02-23,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,636,3937,+19%,+$0,1.0,4.0,-3.0,22.0,BIIB
346,D,2016-02-25 16:59:28,2016-02-23,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$258.99,-273,8326,-3%,"-$70,704",1.0,4.0,-3.0,22.0,BIIB
347,D,2016-02-25 16:59:28,2016-02-23,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,579,8326,+7%,+$0,1.0,4.0,-3.0,22.0,BIIB
348,D,2016-02-25 16:57:42,2016-02-23,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",F - Tax,$258.99,-162,8211,-2%,"-$41,956",1.0,4.0,-3.0,22.0,BIIB
349,D,2016-02-25 16:57:42,2016-02-23,BIIB,Karaboutis Adriana,"EVP, Tech, Bus. Sol, Corp Aff",M - OptEx,$0.00,498,8211,+6%,+$0,1.0,4.0,-3.0,22.0,BIIB
350,D,2016-02-25 16:52:58,2016-02-23,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",F - Tax,$258.99,-164,8173,-2%,"-$42,474",1.0,4.0,-3.0,22.0,BIIB
351,D,2016-02-25 16:52:58,2016-02-23,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",M - OptEx,$0.00,347,8173,+4%,+$0,1.0,4.0,-3.0,22.0,BIIB
352,D,2016-02-25 16:51:50,2016-02-23,BIIB,Scangos George A,CEO,F - Tax,$258.99,-1395,72173,-2%,"-$361,291",1.0,4.0,-3.0,22.0,BIIB
353,D,2016-02-25 16:51:50,2016-02-23,BIIB,Scangos George A,CEO,M - OptEx,$0.00,2964,72173,+4%,+$0,1.0,4.0,-3.0,22.0,BIIB
354,,2016-02-19 16:20:00,2016-02-17,BIIB,Scangos George A,CEO,S - Sale,$256.16,-487,70604,-1%,"-$124,750",2.0,0.0,-4.0,20.0,BIIB
355,,2016-02-19 16:18:37,2016-02-17,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale,$256.16,-722,7990,-8%,"-$184,948",2.0,0.0,-4.0,20.0,BIIB
356,D,2016-02-17 18:03:21,2016-02-12,BIIB,Scangos George A,CEO,A - Grant,$0.00,11390,71091,+19%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
357,D,2016-02-17 18:03:21,2016-02-12,BIIB,Scangos George A,CEO,F - Tax,$247.22,-11815,71091,-14%,"-$2,920,904",-2.0,-3.0,-6.0,19.0,BIIB
358,D,2016-02-17 18:03:21,2016-02-12,BIIB,Scangos George A,CEO,M - OptEx,$0.00,13701,71091,+24%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
359,D,2016-02-17 18:01:06,2016-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$247.22,-1552,30088,-5%,"-$383,685",-2.0,-3.0,-6.0,19.0,BIIB
360,D,2016-02-17 18:01:06,2016-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,3298,30088,+12%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
361,D,2016-02-17 18:00:04,2016-02-12,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$247.22,-1369,3601,-28%,"-$338,444",-2.0,-3.0,-6.0,19.0,BIIB
362,D,2016-02-17 18:00:04,2016-02-12,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,3316,3601,>999%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
363,D,2016-02-17 17:59:02,2016-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$247.22,-26,2643,-1%,"-$6,428",-2.0,-3.0,-6.0,19.0,BIIB
364,D,2016-02-17 17:59:02,2016-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,425,2643,+19%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
365,D,2016-02-17 17:57:55,2016-02-12,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",F - Tax,$247.22,-1827,8712,-17%,"-$451,671",-2.0,-3.0,-6.0,19.0,BIIB
366,D,2016-02-17 17:57:55,2016-02-12,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",M - OptEx,$0.00,2799,8712,+47%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
367,D,2016-02-17 17:56:43,2016-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$247.22,-1314,8020,-14%,"-$324,847",-2.0,-3.0,-6.0,19.0,BIIB
368,D,2016-02-17 17:56:43,2016-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,3194,8020,+66%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
369,D,2016-02-17 17:55:35,2016-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$247.22,-1328,31504,-4%,"-$328,308",-2.0,-3.0,-6.0,19.0,BIIB
370,D,2016-02-17 17:55:35,2016-02-12,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3289,31504,+12%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
371,D,2016-02-17 17:54:31,2016-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$247.22,-352,2452,-13%,"-$87,021",-2.0,-3.0,-6.0,19.0,BIIB
372,D,2016-02-17 17:54:31,2016-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,1057,2452,+76%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
373,D,2016-02-17 17:53:01,2016-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$247.22,-1699,26564,-6%,"-$420,027",-2.0,-3.0,-6.0,19.0,BIIB
374,D,2016-02-17 17:53:01,2016-02-12,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,3859,26564,+17%,+$0,-2.0,-3.0,-6.0,19.0,BIIB
375,D,2016-02-10 16:19:50,2016-02-09,BIIB,Scangos George A,CEO,F - Tax,$249.99,-5305,57815,-8%,"-$1,326,197",-3.0,5.0,0.0,25.0,BIIB
376,D,2016-02-10 16:19:50,2016-02-09,BIIB,Scangos George A,CEO,M - OptEx,$0.00,11274,57815,+24%,+$0,-3.0,5.0,0.0,25.0,BIIB
377,D,2016-02-10 16:17:09,2016-02-08,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",F - Tax,$250.77,-426,7740,-5%,"-$106,828",-3.0,5.0,0.0,25.0,BIIB
378,D,2016-02-10 16:17:09,2016-02-08,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",M - OptEx,$0.00,1278,7740,+20%,+$0,-3.0,5.0,0.0,25.0,BIIB
379,D,2016-02-10 16:17:09,2016-02-09,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale+OE,$246.54,-852,7740,-10%,"-$210,052",-3.0,5.0,0.0,25.0,BIIB
380,AD,2016-02-09 17:08:59,2016-02-01,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,2466,2466,New,+$0,1.0,3.0,2.0,25.0,BIIB
381,D,2016-02-09 16:58:01,2016-02-08,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$250.77,-822,29543,-3%,"-$206,133",1.0,3.0,2.0,25.0,BIIB
382,D,2016-02-09 16:58:01,2016-02-08,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,2498,29543,+9%,+$0,1.0,3.0,2.0,25.0,BIIB
383,D,2016-02-09 16:53:46,2016-02-08,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$250.77,-1047,24404,-4%,"-$262,556",1.0,3.0,2.0,25.0,BIIB
384,D,2016-02-09 16:53:46,2016-02-08,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,3194,24404,+15%,+$0,1.0,3.0,2.0,25.0,BIIB
385,D,2016-02-09 16:51:13,2016-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$250.77,-1324,28342,-4%,"-$332,019",1.0,3.0,2.0,25.0,BIIB
386,D,2016-02-09 16:51:13,2016-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,4026,28342,+17%,+$0,1.0,3.0,2.0,25.0,BIIB
387,D,2016-02-09 16:48:17,2016-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$250.77,-890,6140,-13%,"-$223,185",1.0,3.0,2.0,25.0,BIIB
388,D,2016-02-09 16:48:17,2016-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,2709,6140,+79%,+$0,1.0,3.0,2.0,25.0,BIIB
389,D,2016-02-02 16:05:36,2016-02-01,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$273.45,-812,1654,-33%,"-$222,041",2.0,-6.0,3.0,13.0,BIIB
390,D,2016-02-02 16:05:36,2016-02-01,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$273.45,2466,1654,-304%,"+$674,328",2.0,-6.0,3.0,13.0,BIIB
391,,2015-12-07 16:20:16,2015-12-03,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",F - Tax,$275.44,-393,7740,-5%,"-$108,248",2.0,1.0,4.0,-10.0,BIIB
392,,2015-12-07 16:20:16,2015-12-04,BIIB,Sandrock Alfred,"EVP CMO Neuro, Neurodegenerat",S - Sale,$277.00,-441,7740,-5%,"-$122,157",2.0,1.0,4.0,-10.0,BIIB
393,,2015-12-03 16:19:35,2015-12-01,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",F - Tax,$290.04,-171,7875,-2%,"-$49,597",3.0,3.0,7.0,5.0,BIIB
394,,2015-12-03 16:19:35,2015-12-02,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",S - Sale,$289.14,-48,7875,-1%,"-$13,879",3.0,3.0,7.0,5.0,BIIB
395,,2015-12-03 16:17:12,2015-12-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",A - Grant,$0.00,483,2244,+27%,+$0,3.0,3.0,7.0,5.0,BIIB
396,M,2015-10-26 19:03:51,2015-10-22,BIIB,Denner Alexander J,Dir,P - Purchase,$277.47,310000,317890,>999%,"+$86,015,000",6.0,6.0,7.0,3.0,BIIB
397,,2015-10-06 16:40:32,2015-10-05,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",S - Sale,$291.43,-269,8094,-3%,"-$78,395",1.0,-4.0,8.0,1.0,BIIB
398,D,2015-10-05 16:10:50,2015-10-01,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",F - Tax,$287.30,-1666,8363,-17%,"-$478,642",-4.0,-6.0,6.0,-7.0,BIIB
399,D,2015-10-05 16:10:50,2015-10-01,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",M - OptEx,$0.00,1939,8363,+30%,+$0,-4.0,-6.0,6.0,-7.0,BIIB
400,D,2015-10-05 16:10:50,2015-10-02,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",S - Sale+OE,$283.38,-417,8363,-5%,"-$118,169",-4.0,-6.0,6.0,-7.0,BIIB
401,,2015-07-27 17:03:14,2015-07-27,BIIB,Papadopoulos Stelios,Dir,P - Purchase,$304.88,10000,26580,+60%,"+$3,048,775",3.0,3.0,-10.0,-16.0,BIIB
402,,2015-06-23 16:14:19,2015-06-22,BIIB,Posner Brian S,Dir,S - Sale,$415.00,-470,5275,-8%,"-$195,050",-1.0,-5.0,-6.0,-29.0,BIIB
403,,2015-06-22 16:15:02,2015-06-19,BIIB,Williams Douglas E,"EVP Research, Development",S - Sale,$410.00,-3841,11817,-25%,"-$1,574,810",0.0,-2.0,-2.0,-29.0,BIIB
404,,2015-06-16 18:54:36,2015-06-15,BIIB,Posner Brian S,Dir,S - Sale,$386.64,-400,5745,-7%,"-$154,656",1.0,8.0,3.0,-27.0,BIIB
405,,2015-06-11 16:34:45,2015-06-10,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,695,4845,+17%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
406,,2015-06-11 16:33:40,2015-06-10,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1040,16580,+7%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
407,,2015-06-11 16:32:35,2015-06-10,BIIB,Posner Brian S,Dir,A - Grant,$0.00,695,6145,+13%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
408,,2015-06-11 16:31:20,2015-06-10,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,695,7990,+10%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
409,,2015-06-11 16:30:10,2015-06-10,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,695,7890,+10%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
410,,2015-06-11 16:28:56,2015-06-10,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,695,15568,+5%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
411,,2015-06-11 16:27:45,2015-06-10,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,695,16033,+5%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
412,,2015-06-11 16:24:00,2015-06-10,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,695,7890,+10%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
413,,2015-06-11 16:22:44,2015-06-10,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,695,7924,+10%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
414,,2015-06-11 16:21:38,2015-06-10,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,695,12005,+6%,+$0,-1.0,-1.0,-1.0,-27.0,BIIB
415,D,2015-06-04 17:49:40,2015-06-02,BIIB,Koppel Adam,"SVP, Chief Strategy Officer",F - Tax,$387.62,-852,1662,-34%,"-$330,252",1.0,1.0,5.0,-24.0,BIIB
416,D,2015-06-04 17:49:40,2015-06-02,BIIB,Koppel Adam,"SVP, Chief Strategy Officer",M - OptEx,$0.00,2384,1662,-330%,+$0,1.0,1.0,5.0,-24.0,BIIB
417,,2015-06-02 16:10:59,2015-06-01,BIIB,Scangos George A,CEO,S - Sale,$398.87,-1362,51846,-3%,"-$543,261",0.0,0.0,4.0,-24.0,BIIB
418,D,2015-05-05 16:36:23,2015-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$386.22,-113,1761,-6%,"-$43,643",-1.0,3.0,0.0,-25.0,BIIB
419,D,2015-05-05 16:36:23,2015-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$386.22,347,1761,+25%,"+$134,018",-1.0,3.0,0.0,-25.0,BIIB
420,,2015-05-05 16:34:22,2015-05-01,BIIB,Scangos George A,CEO,S - Sale,$377.52,-1362,53208,-2%,"-$514,182",-1.0,3.0,0.0,-25.0,BIIB
421,D,2015-04-03 16:24:26,2015-04-02,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$412.44,-460,1674,-22%,"-$189,722",1.0,3.0,-7.0,-31.0,BIIB
422,D,2015-04-03 16:24:26,2015-04-02,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,975,1674,+139%,+$0,1.0,3.0,-7.0,-31.0,BIIB
423,,2015-04-02 16:29:42,2015-04-01,BIIB,Scangos George A,CEO,S - Sale,$423.20,-1362,54570,-2%,"-$576,398",0.0,3.0,-6.0,-29.0,BIIB
424,,2015-03-30 16:13:23,2015-03-27,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$430.12,-430,8574,-5%,"-$184,952",-2.0,-4.0,-13.0,-34.0,BIIB
425,D,2015-03-26 16:31:31,2015-03-25,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$65.85,5066,25567,+25%,"+$333,571",0.0,-4.0,-6.0,-30.0,BIIB
426,D,2015-03-26 16:31:31,2015-03-25,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$449.06,-12010,25567,-32%,"-$5,393,211",0.0,-4.0,-6.0,-30.0,BIIB
427,D,2015-03-23 16:33:43,2015-03-20,BIIB,Rowinsky Eric K,Dir,M - OptEx,$59.82,11667,11310,-3268%,"+$697,920",-2.0,-7.0,-9.0,-31.0,BIIB
428,D,2015-03-23 16:33:43,2015-03-20,BIIB,Rowinsky Eric K,Dir,S - Sale+OE,$475.00,-11667,11310,-51%,"-$5,541,825",-2.0,-7.0,-9.0,-31.0,BIIB
429,D,2015-03-20 17:03:00,2015-03-19,BIIB,Rowinsky Eric K,Dir,M - OptEx,$59.82,2333,11310,+26%,"+$139,560",-3.0,-11.0,-12.0,-35.0,BIIB
430,D,2015-03-20 17:03:00,2015-03-19,BIIB,Rowinsky Eric K,Dir,S - Sale+OE,$436.14,-2333,11310,-17%,"-$1,017,508",-3.0,-11.0,-12.0,-35.0,BIIB
431,D,2015-03-18 17:03:31,2015-03-17,BIIB,Rowinsky Eric K,Dir,M - OptEx,$59.82,4667,11310,+70%,"+$279,180",1.0,6.0,0.0,-25.0,BIIB
432,D,2015-03-18 17:03:31,2015-03-17,BIIB,Rowinsky Eric K,Dir,S - Sale+OE,$425.45,-4667,11310,-29%,"-$1,985,589",1.0,6.0,0.0,-25.0,BIIB
433,,2015-03-17 20:10:19,2015-03-16,BIIB,Dipietro Kenneth,EVP HR,S - Sale,$415.46,-803,0,-100%,"-$333,614",0.0,9.0,1.0,-26.0,BIIB
434,,2015-03-16 20:39:12,2015-03-13,BIIB,Scangos George A,CEO,S - Sale,$412.69,-537,55932,-1%,"-$221,613",1.0,13.0,1.0,-26.0,BIIB
435,D,2015-03-11 16:17:36,2015-03-06,BIIB,Sherwin Stephen A,Dir,G - Gift,$0.00,-275,4150,-6%,-$0,0.0,4.0,4.0,-24.0,BIIB
436,D,2015-03-11 16:17:36,2015-03-10,BIIB,Sherwin Stephen A,Dir,M - OptEx,$59.82,6000,4150,-324%,"+$358,920",0.0,4.0,4.0,-24.0,BIIB
437,D,2015-03-11 16:17:36,2015-03-10,BIIB,Sherwin Stephen A,Dir,S - Sale+OE,$409.67,-6000,4150,-59%,"-$2,458,020",0.0,4.0,4.0,-24.0,BIIB
438,D,2015-03-11 16:15:04,2015-03-09,BIIB,Rowinsky Eric K,Dir,M - OptEx,$59.82,4666,11310,+70%,"+$279,120",0.0,4.0,4.0,-24.0,BIIB
439,D,2015-03-11 16:15:04,2015-03-09,BIIB,Rowinsky Eric K,Dir,S - Sale+OE,$417.23,-4666,11310,-29%,"-$1,946,795",0.0,4.0,4.0,-24.0,BIIB
440,D,2015-03-11 16:13:43,2015-03-10,BIIB,Pangia Robert W,Dir,M - OptEx,$47.71,3625,14873,+32%,"+$172,954",0.0,4.0,4.0,-24.0,BIIB
441,D,2015-03-11 16:13:43,2015-03-10,BIIB,Pangia Robert W,Dir,S - Sale+OE,$413.40,-3625,14873,-20%,"-$1,498,578",0.0,4.0,4.0,-24.0,BIIB
442,,2015-03-03 16:44:01,2015-03-01,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$409.59,-2826,9004,-24%,"-$1,157,501",0.0,1.0,2.0,-26.0,BIIB
443,,2015-03-03 16:44:01,2015-03-02,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$409.49,-3174,9004,-26%,"-$1,299,715",0.0,1.0,2.0,-26.0,BIIB
444,,2015-03-03 16:39:10,2015-03-02,BIIB,Scangos George A,CEO,S - Sale,$410.67,-825,56469,-1%,"-$338,803",0.0,1.0,2.0,-26.0,BIIB
445,A,2015-02-23 16:24:37,2015-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$392.11,-8,1302,-1%,"-$3,137",-1.0,0.0,14.0,-24.0,BIIB
446,,2015-02-20 16:28:57,2015-02-19,BIIB,Scangos George A,CEO,S - Sale,$401.04,-537,57294,-1%,"-$215,358",0.0,1.0,17.0,-23.0,BIIB
447,,2015-02-18 16:45:25,2015-02-17,BIIB,Scangos George A,CEO,S - Sale,$389.11,-825,57831,-1%,"-$321,016",1.0,1.0,7.0,-21.0,BIIB
448,,2015-02-18 16:41:02,2015-02-17,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$389.11,-2128,4321,-33%,"-$828,026",1.0,1.0,7.0,-21.0,BIIB
449,,2015-02-18 16:37:20,2015-02-17,BIIB,Dipietro Kenneth,EVP HR,S - Sale,$389.11,-1188,803,-60%,"-$462,263",1.0,1.0,7.0,-21.0,BIIB
450,,2015-02-18 16:36:06,2015-02-17,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$389.11,-418,15004,-3%,"-$162,648",1.0,1.0,7.0,-21.0,BIIB
451,D,2015-02-17 21:32:11,2015-02-12,BIIB,Scangos George A,CEO,A - Grant,$0.00,10149,58656,+21%,+$0,1.0,3.0,7.0,-22.0,BIIB
452,D,2015-02-17 21:32:11,2015-02-12,BIIB,Scangos George A,CEO,F - Tax,$392.11,-12125,58656,-17%,"-$4,754,334",1.0,3.0,7.0,-22.0,BIIB
453,D,2015-02-17 21:32:11,2015-02-12,BIIB,Scangos George A,CEO,M - OptEx,$0.00,15599,58656,+36%,+$0,1.0,3.0,7.0,-22.0,BIIB
454,D,2015-02-17 21:16:56,2015-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$392.11,-20,1446,-1%,"-$7,842",1.0,3.0,7.0,-22.0,BIIB
455,D,2015-02-17 21:16:56,2015-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,471,1446,+48%,+$0,1.0,3.0,7.0,-22.0,BIIB
456,D,2015-02-17 20:54:49,2015-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$392.11,-1712,6449,-21%,"-$671,292",1.0,3.0,7.0,-22.0,BIIB
457,D,2015-02-17 20:54:49,2015-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,3634,6449,+129%,+$0,1.0,3.0,7.0,-22.0,BIIB
458,D,2015-02-17 20:50:59,2015-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$392.11,-394,1159,-25%,"-$154,491",1.0,3.0,7.0,-22.0,BIIB
459,D,2015-02-17 20:50:59,2015-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,1201,1159,-2861%,+$0,1.0,3.0,7.0,-22.0,BIIB
460,D,2015-02-17 20:47:55,2015-02-12,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$392.11,-757,15422,-5%,"-$296,827",1.0,3.0,7.0,-22.0,BIIB
461,D,2015-02-17 20:47:55,2015-02-12,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$0.00,1605,15422,+12%,+$0,1.0,3.0,7.0,-22.0,BIIB
462,D,2015-02-17 20:44:22,2015-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$392.11,-2026,22257,-8%,"-$794,415",1.0,3.0,7.0,-22.0,BIIB
463,D,2015-02-17 20:44:22,2015-02-12,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,4299,22257,+24%,+$0,1.0,3.0,7.0,-22.0,BIIB
464,D,2015-02-17 20:40:32,2015-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$392.11,-1761,32511,-5%,"-$690,506",1.0,3.0,7.0,-22.0,BIIB
465,D,2015-02-17 20:40:32,2015-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,3738,32511,+13%,+$0,1.0,3.0,7.0,-22.0,BIIB
466,D,2015-02-17 20:37:24,2015-02-12,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$392.11,-2450,15658,-14%,"-$960,670",1.0,3.0,7.0,-22.0,BIIB
467,D,2015-02-17 20:37:24,2015-02-12,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,5200,15658,+50%,+$0,1.0,3.0,7.0,-22.0,BIIB
468,D,2015-02-17 20:34:42,2015-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$392.11,-1776,27867,-6%,"-$696,387",1.0,3.0,7.0,-22.0,BIIB
469,D,2015-02-17 20:34:42,2015-02-12,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3769,27867,+16%,+$0,1.0,3.0,7.0,-22.0,BIIB
470,D,2015-02-17 20:30:51,2015-02-12,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$392.11,-1773,1991,-47%,"-$695,211",1.0,3.0,7.0,-22.0,BIIB
471,D,2015-02-17 20:30:51,2015-02-12,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,3764,1991,-212%,+$0,1.0,3.0,7.0,-22.0,BIIB
472,D,2015-02-17 20:26:09,2015-02-12,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$392.11,-1697,8132,-17%,"-$665,411",1.0,3.0,7.0,-22.0,BIIB
473,D,2015-02-17 20:26:09,2015-02-12,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,3601,8132,+79%,+$0,1.0,3.0,7.0,-22.0,BIIB
474,,2015-02-11 16:26:48,2015-02-10,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$398.11,-1143,14574,-7%,"-$455,039",1.0,3.0,4.0,-19.0,BIIB
475,DM,2015-02-11 16:25:53,2015-02-09,BIIB,Scangos George A,CEO,F - Tax,$395.76,-13811,45033,-23%,"-$5,465,785",1.0,3.0,4.0,-19.0,BIIB
476,DM,2015-02-11 16:25:53,2015-02-09,BIIB,Scangos George A,CEO,M - OptEx,$0.00,30103,45033,+202%,+$0,1.0,3.0,4.0,-19.0,BIIB
477,D,2015-02-10 17:14:00,2015-02-08,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$402.00,-1634,12908,-11%,"-$656,868",-1.0,1.0,3.0,-20.0,BIIB
478,D,2015-02-10 17:14:00,2015-02-08,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,3468,12908,+37%,+$0,-1.0,1.0,3.0,-20.0,BIIB
479,DM,2015-02-10 17:12:54,2015-02-08,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$398.45,-2660,25874,-9%,"-$1,059,889",-1.0,1.0,3.0,-20.0,BIIB
480,DM,2015-02-10 17:12:54,2015-02-08,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,6407,25874,+33%,+$0,-1.0,1.0,3.0,-20.0,BIIB
481,DM,2015-02-10 17:11:50,2015-02-08,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$398.84,-1102,15717,-7%,"-$439,517",-1.0,1.0,3.0,-20.0,BIIB
482,DM,2015-02-10 17:11:50,2015-02-08,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$0.00,3101,15717,+25%,+$0,-1.0,1.0,3.0,-20.0,BIIB
483,D,2015-02-10 17:11:50,2015-02-09,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale+OE,$398.05,-856,15717,-5%,"-$340,731",-1.0,1.0,3.0,-20.0,BIIB
484,D,2015-02-10 17:10:41,2015-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$402.00,-1275,4527,-22%,"-$512,550",-1.0,1.0,3.0,-20.0,BIIB
485,D,2015-02-10 17:10:41,2015-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,2705,4527,+148%,+$0,-1.0,1.0,3.0,-20.0,BIIB
486,DM,2015-02-10 17:08:50,2015-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$399.47,-1743,6228,-22%,"-$696,283",-1.0,1.0,3.0,-20.0,BIIB
487,DM,2015-02-10 17:08:50,2015-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4460,6228,+252%,+$0,-1.0,1.0,3.0,-20.0,BIIB
488,DM,2015-02-10 17:07:37,2015-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$398.98,-3747,30534,-11%,"-$1,494,979",-1.0,1.0,3.0,-20.0,BIIB
489,DM,2015-02-10 17:07:37,2015-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,8714,30534,+40%,+$0,-1.0,1.0,3.0,-20.0,BIIB
490,DM,2015-02-10 17:06:26,2015-02-08,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$398.63,-3353,19984,-14%,"-$1,336,591",-1.0,1.0,3.0,-20.0,BIIB
491,DM,2015-02-10 17:06:26,2015-02-08,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,7882,19984,+65%,+$0,-1.0,1.0,3.0,-20.0,BIIB
492,,2015-02-10 17:04:04,2015-02-06,BIIB,Posner Brian S,Dir,G - Gift,$0.00,-250,5450,-4%,-$0,-1.0,1.0,3.0,-20.0,BIIB
493,,2015-02-03 18:35:53,2015-02-02,BIIB,Dipietro Kenneth,EVP HR,S - Sale,$389.03,-1656,0,-100%,"-$644,234",-1.0,1.0,5.0,-18.0,BIIB
494,D,2015-02-02 19:46:41,2015-02-01,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$389.16,-807,1656,-33%,"-$314,052",1.0,3.0,6.0,-18.0,BIIB
495,D,2015-02-02 19:46:41,2015-02-01,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,2463,1656,-305%,+$0,1.0,3.0,6.0,-18.0,BIIB
496,D,2015-02-02 19:43:16,2015-02-01,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$389.16,-2059,11074,-16%,"-$801,280",1.0,3.0,6.0,-18.0,BIIB
497,D,2015-02-02 19:43:16,2015-02-01,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,5157,11074,+87%,+$0,1.0,3.0,6.0,-18.0,BIIB
498,D,2015-02-02 19:40:12,2015-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$389.16,-2060,3097,-40%,"-$801,670",1.0,3.0,6.0,-18.0,BIIB
499,D,2015-02-02 19:40:12,2015-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,5157,3097,-250%,+$0,1.0,3.0,6.0,-18.0,BIIB
500,,2014-12-16 16:36:45,2014-12-15,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",S - Sale,$346.50,-1981,352,-85%,"-$686,417",2.0,8.0,4.0,20.0,BIIB
501,,2014-12-05 17:20:08,2014-12-03,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$347.34,-393,14574,-3%,"-$136,505",1.0,0.0,-2.0,13.0,BIIB
502,,2014-12-05 17:20:08,2014-12-04,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$345.88,-440,14574,-3%,"-$152,187",1.0,0.0,-2.0,13.0,BIIB
503,,2014-12-03 16:34:12,2014-12-01,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",A - Grant,$0.00,1087,8507,+15%,+$0,-2.0,0.0,-2.0,11.0,BIIB
504,,2014-12-03 16:32:59,2014-12-02,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$335.65,-1749,0,-100%,"-$587,052",-2.0,0.0,-2.0,11.0,BIIB
505,,2014-12-03 16:31:38,2014-12-01,BIIB,Sherwin Stephen A,Dir,G - Gift,$0.00,-405,4425,-8%,-$0,-2.0,0.0,-2.0,11.0,BIIB
506,,2014-11-12 16:24:49,2014-11-11,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$330.00,-1750,1749,-50%,"-$577,500",-1.0,-5.0,7.0,23.0,BIIB
507,,2014-11-04 16:18:07,2014-11-03,BIIB,Scangos George A,CEO,S - Sale,$320.78,-1128,28741,-4%,"-$361,840",-1.0,2.0,8.0,19.0,BIIB
508,D,2014-10-02 16:46:56,2014-10-01,BIIB,Karaboutis Adriana,"EVP, Tech., Bus. Solutions",A - Grant,$0.00,7420,7420,New,+$0,2.0,1.0,0.0,29.0,BIIB
509,,2014-10-02 16:44:32,2014-10-01,BIIB,Scangos George A,CEO,S - Sale,$330.97,-1127,29869,-4%,"-$373,003",2.0,1.0,0.0,29.0,BIIB
510,,2014-10-02 16:42:55,2014-10-01,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$330.97,-1750,3499,-33%,"-$579,198",2.0,1.0,0.0,29.0,BIIB
511,,2014-09-22 16:47:39,2014-09-18,BIIB,Holtzman Steven H,EVP Corporate Development,G - Gift,$0.00,-500,5249,-9%,-$0,1.0,1.0,-6.0,41.0,BIIB
512,,2014-09-04 16:15:20,2014-09-02,BIIB,Scangos George A,CEO,S - Sale,$345.47,-1128,30996,-4%,"-$389,690",-1.0,-1.0,-4.0,26.0,BIIB
513,,2014-08-04 16:43:40,2014-08-01,BIIB,Scangos George A,CEO,S - Sale,$332.93,-1128,32124,-3%,"-$375,545",0.0,-1.0,5.0,19.0,BIIB
514,,2014-07-25 12:26:29,2014-07-24,BIIB,Posner Brian S,Dir,G - Gift,$0.00,-300,5700,-5%,-$0,0.0,-1.0,1.0,6.0,BIIB
515,,2014-07-18 17:59:09,2014-07-16,BIIB,Scangos George A,CEO,S - Sale,$312.37,-12316,33252,-27%,"-$3,847,149",-1.0,11.0,13.0,12.0,BIIB
516,D,2014-07-17 16:45:32,2014-07-15,BIIB,Scangos George A,CEO,F - Tax,$312.00,-10062,45568,-18%,"-$3,139,344",2.0,13.0,12.0,16.0,BIIB
517,D,2014-07-17 16:45:32,2014-07-15,BIIB,Scangos George A,CEO,M - OptEx,$0.00,21339,45568,+88%,+$0,2.0,13.0,12.0,16.0,BIIB
518,,2014-06-23 16:37:04,2014-06-20,BIIB,Posner Brian S,Dir,S - Sale,$315.00,-605,6000,-9%,"-$190,575",0.0,1.0,-3.0,13.0,BIIB
519,,2014-06-16 16:59:30,2014-06-12,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,870,15338,+6%,+$0,-1.0,4.0,1.0,11.0,BIIB
520,,2014-06-16 16:57:51,2014-06-12,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,870,4830,+22%,+$0,-1.0,4.0,1.0,11.0,BIIB
521,,2014-06-16 16:53:14,2014-06-12,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,870,7295,+14%,+$0,-1.0,4.0,1.0,11.0,BIIB
522,,2014-06-16 16:48:12,2014-06-12,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,870,8530,+11%,+$0,-1.0,4.0,1.0,11.0,BIIB
523,,2014-06-16 16:42:58,2014-06-12,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,870,7195,+14%,+$0,-1.0,4.0,1.0,11.0,BIIB
524,,2014-06-16 16:41:41,2014-06-12,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,870,11310,+8%,+$0,-1.0,4.0,1.0,11.0,BIIB
525,,2014-06-16 16:39:41,2014-06-12,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1305,15540,+9%,+$0,-1.0,4.0,1.0,11.0,BIIB
526,,2014-06-16 16:37:41,2014-06-12,BIIB,Posner Brian S,Dir,A - Grant,$0.00,870,6605,+15%,+$0,-1.0,4.0,1.0,11.0,BIIB
527,,2014-06-16 16:37:41,2014-06-13,BIIB,Posner Brian S,Dir,S - Sale,$310.50,-700,6605,-10%,"-$217,350",-1.0,4.0,1.0,11.0,BIIB
528,,2014-06-16 16:36:17,2014-06-12,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,870,7195,+14%,+$0,-1.0,4.0,1.0,11.0,BIIB
529,,2014-06-16 16:34:47,2014-06-12,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,870,14873,+6%,+$0,-1.0,4.0,1.0,11.0,BIIB
530,,2014-06-03 16:29:09,2014-06-02,BIIB,Scangos George A,CEO,S - Sale,$318.93,-484,34291,-1%,"-$154,362",1.0,0.0,2.0,-3.0,BIIB
531,,2014-05-20 16:16:05,2014-05-19,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$289.15,-1221,5749,-18%,"-$353,052",2.0,7.0,7.0,5.0,BIIB
532,,2014-05-02 16:22:06,2014-05-01,BIIB,Scangos George A,CEO,S - Sale,$285.56,-2123,34775,-6%,"-$606,241",3.0,0.0,13.0,11.0,BIIB
533,D,2014-05-02 16:20:08,2014-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$286.75,-113,916,-11%,"-$32,403",3.0,0.0,13.0,11.0,BIIB
534,D,2014-05-02 16:20:08,2014-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$286.75,347,916,+61%,"+$99,502",3.0,0.0,13.0,11.0,BIIB
535,,2014-04-21 17:07:37,2014-04-17,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$291.00,-1221,6970,-15%,"-$355,311",3.0,-4.0,-2.0,2.0,BIIB
536,D,2014-04-03 16:27:57,2014-04-02,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$309.70,-433,2244,-16%,"-$134,100",-4.0,0.0,-6.0,7.0,BIIB
537,D,2014-04-03 16:27:57,2014-04-02,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,975,2244,+77%,+$0,-4.0,0.0,-6.0,7.0,BIIB
538,D,2014-04-02 16:19:07,2014-04-01,BIIB,Pangia Robert W,Dir,M - OptEx,$47.55,6250,14003,+81%,"+$297,188",-3.0,-8.0,-7.0,7.0,BIIB
539,D,2014-04-02 16:19:07,2014-04-01,BIIB,Pangia Robert W,Dir,S - Sale+OE,$308.42,-6250,14003,-31%,"-$1,927,625",-3.0,-8.0,-7.0,7.0,BIIB
540,,2014-04-02 16:16:34,2014-04-01,BIIB,Scangos George A,CEO,S - Sale,$308.42,-2123,36898,-5%,"-$654,776",-3.0,-8.0,-7.0,7.0,BIIB
541,,2014-04-01 16:15:26,2014-03-31,BIIB,Posner Brian S,Dir,S - Sale,$296.76,-3000,6435,-32%,"-$890,275",0.0,-5.0,-7.0,7.0,BIIB
542,D,2014-03-21 16:17:51,2014-03-20,BIIB,Dorsa Caroline,Dir,M - OptEx,$53.64,10000,14468,+224%,"+$536,400",-2.0,-3.0,-6.0,3.0,BIIB
543,D,2014-03-21 16:17:51,2014-03-20,BIIB,Dorsa Caroline,Dir,S - Sale+OE,$348.88,-10000,14468,-41%,"-$3,488,813",-2.0,-3.0,-6.0,3.0,BIIB
544,,2014-03-21 16:15:44,2014-03-19,BIIB,Williams Douglas E,"EVP Research, Development",S - Sale,$352.29,-3505,7976,-31%,"-$1,234,776",-2.0,-3.0,-6.0,3.0,BIIB
545,,2014-03-18 17:08:22,2014-03-17,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$334.83,-1221,8191,-13%,"-$408,827",-1.0,-11.0,-19.0,-9.0,BIIB
546,,2014-03-12 19:20:54,2014-03-10,BIIB,Scangos George A,CEO,S - Sale,$333.77,-26124,39021,-40%,"-$8,719,378",-2.0,4.0,-12.0,-4.0,BIIB
547,,2014-03-12 19:16:57,2014-03-10,BIIB,Leaming Nancy,Dir,S - Sale,$327.65,-2000,7660,-21%,"-$655,300",-2.0,4.0,-12.0,-4.0,BIIB
548,,2014-03-12 19:15:24,2014-03-11,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",S - Sale,$336.83,-8428,3511,-71%,"-$2,838,766",-2.0,4.0,-12.0,-4.0,BIIB
549,,2014-03-05 15:12:00,2014-03-04,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$342.58,-3171,15407,-17%,"-$1,086,321",-1.0,-2.0,-10.0,0.0,BIIB
550,,2014-03-04 15:22:05,2014-03-03,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$340.68,-2829,18578,-13%,"-$963,784",1.0,0.0,-8.0,1.0,BIIB
551,,2014-03-04 15:19:48,2014-03-03,BIIB,Scangos George A,CEO,S - Sale,$335.79,-2942,65145,-4%,"-$987,894",1.0,0.0,-8.0,1.0,BIIB
552,,2014-02-27 16:19:51,2014-02-26,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$342.17,-1048,21407,-5%,"-$358,594",-1.0,-1.0,-10.0,0.0,BIIB
553,D,2014-02-25 14:21:41,2014-02-23,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$347.11,-940,22455,-4%,"-$326,283",0.0,-2.0,-10.0,-2.0,BIIB
554,D,2014-02-25 14:21:41,2014-02-23,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$0.00,1988,22455,+10%,+$0,0.0,-2.0,-10.0,-2.0,BIIB
555,D,2014-02-25 14:17:14,2014-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$347.11,-1228,25478,-5%,"-$426,251",0.0,-2.0,-10.0,-2.0,BIIB
556,D,2014-02-25 14:17:14,2014-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,2598,25478,+11%,+$0,0.0,-2.0,-10.0,-2.0,BIIB
557,D,2014-02-25 14:11:42,2014-02-23,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$347.11,-2018,15455,-12%,"-$700,468",0.0,-2.0,-10.0,-2.0,BIIB
558,D,2014-02-25 14:11:42,2014-02-23,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,4280,15455,+38%,+$0,0.0,-2.0,-10.0,-2.0,BIIB
559,D,2014-02-25 14:07:05,2014-02-23,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$347.11,-1803,22127,-8%,"-$625,839",0.0,-2.0,-10.0,-2.0,BIIB
560,D,2014-02-25 14:07:05,2014-02-23,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3821,22127,+21%,+$0,0.0,-2.0,-10.0,-2.0,BIIB
561,,2014-02-19 16:23:21,2014-02-18,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$327.90,-1222,9412,-11%,"-$400,694",2.0,5.0,6.0,5.0,BIIB
562,D,2014-02-14 16:48:14,2014-02-12,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$323.04,-1685,11481,-13%,"-$544,322",2.0,6.0,5.0,3.0,BIIB
563,D,2014-02-14 16:48:14,2014-02-12,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,3573,11481,+45%,+$0,2.0,6.0,5.0,3.0,BIIB
564,D,2014-02-14 16:46:23,2014-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$323.04,-1324,13193,-9%,"-$427,705",2.0,6.0,5.0,3.0,BIIB
565,D,2014-02-14 16:46:23,2014-02-12,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,2807,13193,+27%,+$0,2.0,6.0,5.0,3.0,BIIB
566,D,2014-02-14 16:45:08,2014-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",F - Tax,$323.04,-239,1702,-12%,"-$77,207",2.0,6.0,5.0,3.0,BIIB
567,D,2014-02-14 16:45:08,2014-02-12,BIIB,Artavanis-Tsakonas Spyridon,"SVP, Chief Scientific Officer",M - OptEx,$0.00,714,1702,+72%,+$0,2.0,6.0,5.0,3.0,BIIB
568,D,2014-02-14 16:43:42,2014-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$323.04,-1010,20109,-5%,"-$326,270",2.0,6.0,5.0,3.0,BIIB
569,D,2014-02-14 16:43:42,2014-02-12,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,2142,20109,+12%,+$0,2.0,6.0,5.0,3.0,BIIB
570,D,2014-02-14 16:42:13,2014-02-12,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",A - Grant,$0.00,7740,21407,+57%,+$0,2.0,6.0,5.0,3.0,BIIB
571,D,2014-02-14 16:42:13,2014-02-12,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$323.04,-367,21407,-2%,"-$118,556",2.0,6.0,5.0,3.0,BIIB
572,D,2014-02-14 16:42:13,2014-02-12,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$0.00,792,21407,+4%,+$0,2.0,6.0,5.0,3.0,BIIB
573,D,2014-02-14 16:42:13,2014-02-13,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale+OE,$316.42,-425,21407,-2%,"-$134,478",2.0,6.0,5.0,3.0,BIIB
574,D,2014-02-14 16:39:12,2014-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$323.04,-1010,10634,-9%,"-$326,270",2.0,6.0,5.0,3.0,BIIB
575,D,2014-02-14 16:39:12,2014-02-12,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,2142,10634,+25%,+$0,2.0,6.0,5.0,3.0,BIIB
576,D,2014-02-14 16:38:06,2014-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$323.04,-8,682,-1%,"-$2,584",2.0,6.0,5.0,3.0,BIIB
577,D,2014-02-14 16:38:06,2014-02-12,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,315,682,+86%,+$0,2.0,6.0,5.0,3.0,BIIB
578,D,2014-02-14 16:37:09,2014-02-12,BIIB,Scangos George A,CEO,F - Tax,$323.04,-4333,68087,-6%,"-$1,399,732",2.0,6.0,5.0,3.0,BIIB
579,D,2014-02-14 16:37:09,2014-02-12,BIIB,Scangos George A,CEO,M - OptEx,$0.00,9189,68087,+16%,+$0,2.0,6.0,5.0,3.0,BIIB
580,D,2014-02-14 16:37:09,2014-02-13,BIIB,Scangos George A,CEO,S - Sale+OE,$316.81,-486,68087,-1%,"-$153,970",2.0,6.0,5.0,3.0,BIIB
581,D,2014-02-14 16:36:07,2014-02-12,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$323.04,-956,0,-100%,"-$308,826",2.0,6.0,5.0,3.0,BIIB
582,D,2014-02-14 16:36:07,2014-02-12,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,2246,0,-100%,+$0,2.0,6.0,5.0,3.0,BIIB
583,D,2014-02-14 16:36:07,2014-02-13,BIIB,Dipietro Kenneth,EVP HR,S - Sale+OE,$316.81,-1290,0,-100%,"-$408,685",2.0,6.0,5.0,3.0,BIIB
584,D,2014-02-14 16:34:58,2014-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$323.04,-1059,24108,-4%,"-$342,099",2.0,6.0,5.0,3.0,BIIB
585,D,2014-02-14 16:34:58,2014-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,2246,24108,+10%,+$0,2.0,6.0,5.0,3.0,BIIB
586,D,2014-02-14 16:33:52,2014-02-12,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$323.04,-1059,11939,-8%,"-$342,099",2.0,6.0,5.0,3.0,BIIB
587,D,2014-02-14 16:33:52,2014-02-12,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,2246,11939,+23%,+$0,2.0,6.0,5.0,3.0,BIIB
588,,2014-02-12 17:03:05,2014-02-11,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$314.31,-2085,13667,-13%,"-$655,336",2.0,2.0,3.0,1.0,BIIB
589,,2014-02-12 17:00:51,2014-02-11,BIIB,Scangos George A,CEO,S - Sale,$314.31,-2456,63717,-4%,"-$771,945",2.0,2.0,3.0,1.0,BIIB
590,DM,2014-02-11 19:55:16,2014-02-09,BIIB,Scangos George A,CEO,F - Tax,$315.54,-13730,66173,-17%,"-$4,332,364",1.0,5.0,6.0,0.0,BIIB
591,DM,2014-02-11 19:55:16,2014-02-09,BIIB,Scangos George A,CEO,M - OptEx,$0.00,30103,66173,+83%,+$0,1.0,5.0,6.0,0.0,BIIB
592,DM,2014-02-11 19:52:52,2014-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$315.54,-2104,10752,-16%,"-$663,896",1.0,5.0,6.0,0.0,BIIB
593,DM,2014-02-11 19:52:52,2014-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4460,10752,+71%,+$0,1.0,5.0,6.0,0.0,BIIB
594,DM,2014-02-11 19:49:27,2014-02-08,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$315.54,-3259,11710,-22%,"-$1,028,345",1.0,5.0,6.0,0.0,BIIB
595,DM,2014-02-11 19:49:27,2014-02-08,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,7882,11710,+206%,+$0,1.0,5.0,6.0,0.0,BIIB
596,D,2014-02-11 19:47:13,2014-02-08,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$315.54,-1636,9593,-15%,"-$516,223",1.0,5.0,6.0,0.0,BIIB
597,D,2014-02-11 19:47:13,2014-02-08,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,3468,9593,+57%,+$0,1.0,5.0,6.0,0.0,BIIB
598,D,2014-02-11 19:45:47,2014-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$315.54,-1276,9502,-12%,"-$402,629",1.0,5.0,6.0,0.0,BIIB
599,D,2014-02-11 19:45:47,2014-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,2705,9502,+40%,+$0,1.0,5.0,6.0,0.0,BIIB
600,DM,2014-02-11 19:43:16,2014-02-08,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$315.54,-1016,15752,-6%,"-$320,589",1.0,5.0,6.0,0.0,BIIB
601,DM,2014-02-11 19:43:16,2014-02-08,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$0.00,3101,15752,+25%,+$0,1.0,5.0,6.0,0.0,BIIB
602,DM,2014-02-11 18:07:44,2014-02-08,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$315.54,-2565,18977,-12%,"-$809,360",1.0,5.0,6.0,0.0,BIIB
603,DM,2014-02-11 18:07:44,2014-02-08,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,6407,18977,+51%,+$0,1.0,5.0,6.0,0.0,BIIB
604,DM,2014-02-11 18:07:39,2014-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$315.54,-3653,22921,-14%,"-$1,152,668",1.0,5.0,6.0,0.0,BIIB
605,DM,2014-02-11 18:07:39,2014-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,8714,22921,+61%,+$0,1.0,5.0,6.0,0.0,BIIB
606,,2014-02-05 16:36:54,2014-02-04,BIIB,Dipietro Kenneth,EVP HR,S - Sale,$299.01,-1655,0,-100%,"-$494,862",0.0,6.0,13.0,8.0,BIIB
607,D,2014-02-03 17:29:08,2014-02-01,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$312.64,-808,1655,-33%,"-$252,613",3.0,5.0,14.0,9.0,BIIB
608,D,2014-02-03 17:29:08,2014-02-01,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,2463,1655,-305%,+$0,3.0,5.0,14.0,9.0,BIIB
609,D,2014-02-03 17:25:11,2014-02-01,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$312.64,-1969,7761,-20%,"-$615,588",3.0,5.0,14.0,9.0,BIIB
610,D,2014-02-03 17:25:11,2014-02-01,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,5159,7761,+198%,+$0,3.0,5.0,14.0,9.0,BIIB
611,D,2014-02-03 17:20:48,2014-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$312.64,-1701,8396,-17%,"-$531,801",3.0,5.0,14.0,9.0,BIIB
612,D,2014-02-03 17:20:48,2014-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4586,8396,+120%,+$0,3.0,5.0,14.0,9.0,BIIB
613,D,2014-02-03 17:15:09,2014-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$312.64,-1971,8073,-20%,"-$616,213",3.0,5.0,14.0,9.0,BIIB
614,D,2014-02-03 17:15:09,2014-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,5159,8073,+177%,+$0,3.0,5.0,14.0,9.0,BIIB
615,,2014-01-22 16:49:37,2014-01-21,BIIB,Rowinsky Eric K,Dir,S - Sale,$310.09,-2020,10440,-16%,"-$626,382",1.0,-2.0,8.0,-2.0,BIIB
616,,2014-01-16 10:27:35,2014-01-15,BIIB,Schenk Lynn,Dir,S - Sale,$297.48,-1000,6425,-13%,"-$297,480",-1.0,6.0,11.0,1.0,BIIB
617,,2014-01-09 16:24:37,2014-01-08,BIIB,Young William,Dir,S - Sale,$285.11,-15000,18509,-45%,"-$4,276,590",3.0,2.0,9.0,10.0,BIIB
618,D,2014-01-07 12:22:21,2014-01-06,BIIB,Pangia Robert W,Dir,M - OptEx,$47.55,6250,14003,+81%,"+$297,188",-1.0,3.0,9.0,16.0,BIIB
619,D,2014-01-07 12:22:21,2014-01-06,BIIB,Pangia Robert W,Dir,S - Sale+OE,$278.03,-6250,14003,-31%,"-$1,737,688",-1.0,3.0,9.0,16.0,BIIB
620,D,2014-01-06 11:19:12,2014-01-02,BIIB,Sherwin Stephen A,Dir,M - OptEx,$59.82,5500,3960,-357%,"+$329,010",-1.0,8.0,11.0,17.0,BIIB
621,D,2014-01-06 11:19:12,2014-01-02,BIIB,Sherwin Stephen A,Dir,S - Sale+OE,$279.28,-5500,3960,-58%,"-$1,536,059",-1.0,8.0,11.0,17.0,BIIB
622,,2013-12-05 14:53:19,2013-12-03,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",F - Tax,$287.76,-394,13667,-3%,"-$113,377",0.0,-3.0,-4.0,11.0,BIIB
623,,2013-12-05 14:53:19,2013-12-04,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale,$285.90,-439,13667,-3%,"-$125,510",0.0,-3.0,-4.0,11.0,BIIB
624,,2013-12-04 12:05:12,2013-11-25,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",G - Gift,$0.00,-200,17860,-1%,-$0,-1.0,-1.0,-4.0,11.0,BIIB
625,,2013-12-02 15:28:15,2013-12-02,BIIB,Schenk Lynn,Dir,S - Sale,$291.71,-1000,7425,-12%,"-$291,710",1.0,0.0,-4.0,9.0,BIIB
626,D,2013-11-25 14:11:02,2013-11-22,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$49.95,4000,8710,+85%,"+$199,800",4.0,3.0,-2.0,8.0,BIIB
627,D,2013-11-25 14:11:02,2013-11-22,BIIB,Pawlicki Raymond,"SVP, CIO",S - Sale+OE,$288.00,-4000,8710,-31%,"-$1,152,000",4.0,3.0,-2.0,8.0,BIIB
628,,2013-11-05 12:18:08,2013-11-01,BIIB,Schenk Lynn,Dir,S - Sale,$245.00,-1000,8425,-11%,"-$245,000",2.0,-2.0,19.0,18.0,BIIB
629,,2013-11-05 12:13:46,2013-11-01,BIIB,Scangos George A,CEO,S - Sale,$245.57,-2239,49800,-4%,"-$549,831",2.0,-2.0,19.0,18.0,BIIB
630,D,2013-10-23 17:03:15,2013-10-22,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$60.56,15030,14500,-2836%,"+$910,217",-1.0,1.0,-2.0,17.0,BIIB
631,D,2013-10-23 17:03:15,2013-10-22,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale+OE,$250.11,-15030,14500,-51%,"-$3,759,123",-1.0,1.0,-2.0,17.0,BIIB
632,,2013-10-02 17:09:50,2013-10-01,BIIB,Schenk Lynn,Dir,S - Sale,$242.85,-1000,9425,-10%,"-$242,850",-5.0,-8.0,1.0,26.0,BIIB
633,,2013-10-02 16:35:36,2013-10-01,BIIB,Scangos George A,CEO,S - Sale,$242.85,-2239,52039,-4%,"-$543,741",-5.0,-8.0,1.0,26.0,BIIB
634,,2013-10-02 13:36:27,2013-09-30,BIIB,Dipietro Kenneth,EVP HR,S - Sale,$242.00,-1440,0,-100%,"-$348,480",1.0,-8.0,2.0,26.0,BIIB
635,D,2013-09-19 14:14:55,2013-09-18,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$49.65,26785,7087,-136%,"+$1,329,875",1.0,-2.0,0.0,41.0,BIIB
636,D,2013-09-19 14:14:55,2013-09-18,BIIB,Clancy Paul J,"EVP, CFO",S - Sale+OE,$245.00,-26785,7087,-79%,"-$6,562,325",1.0,-2.0,0.0,41.0,BIIB
637,D,2013-09-18 16:34:57,2013-09-16,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$56.11,99030,7087,-108%,"+$5,556,895",1.0,-1.0,-2.0,43.0,BIIB
638,D,2013-09-18 16:34:57,2013-09-16,BIIB,Clancy Paul J,"EVP, CFO",S - Sale+OE,$238.27,-99030,7087,-93%,"-$23,596,311",1.0,-1.0,-2.0,43.0,BIIB
639,,2013-09-18 16:31:35,2013-09-17,BIIB,Holtzman Steven H,EVP Corporate Development,S - Sale,$238.98,-3501,4885,-42%,"-$836,669",1.0,-1.0,-2.0,43.0,BIIB
640,D,2013-09-18 16:28:38,2013-09-16,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",M - OptEx,$49.65,9820,14500,+210%,"+$487,563",1.0,-1.0,-2.0,43.0,BIIB
641,D,2013-09-18 16:28:38,2013-09-16,BIIB,Sandrock Alfred,"Grp SVP, Chief Medical Officer",S - Sale+OE,$240.10,-9820,14500,-40%,"-$2,357,821",1.0,-1.0,-2.0,43.0,BIIB
642,D,2013-09-18 16:26:11,2013-09-16,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$49.59,4000,8710,+85%,"+$198,360",1.0,-1.0,-2.0,43.0,BIIB
643,D,2013-09-18 16:26:11,2013-09-16,BIIB,Pawlicki Raymond,"SVP, CIO",S - Sale+OE,$238.03,-4000,8710,-31%,"-$952,120",1.0,-1.0,-2.0,43.0,BIIB
644,,2013-09-13 14:33:07,2013-09-11,BIIB,Schenk Lynn,Dir,S - Sale,$235.25,-900,10425,-8%,"-$211,726",0.0,6.0,0.0,42.0,BIIB
645,,2013-09-04 16:52:01,2013-09-03,BIIB,Scangos George A,CEO,S - Sale,$214.40,-2239,54278,-4%,"-$480,042",-1.0,-1.0,7.0,49.0,BIIB
646,,2013-08-28 12:30:01,2013-08-26,BIIB,Williams Douglas E,"EVP Research, Development",S - Sale,$211.35,-4368,4571,-49%,"-$923,168",1.0,11.0,17.0,66.0,BIIB
647,,2013-08-02 10:55:56,2013-08-01,BIIB,Scangos George A,CEO,S - Sale,$218.82,-2239,56517,-4%,"-$489,938",3.0,-2.0,-3.0,42.0,BIIB
648,,2013-07-18 11:24:04,2013-07-16,BIIB,Scangos George A,CEO,S - Sale,$223.94,-2239,58756,-4%,"-$501,402",-1.0,1.0,-8.0,32.0,BIIB
649,D,2013-07-16 18:19:26,2013-07-15,BIIB,Scangos George A,CEO,F - Tax,$224.33,-20011,60995,-25%,"-$4,489,068",1.0,4.0,-5.0,27.0,BIIB
650,D,2013-07-16 18:19:26,2013-07-15,BIIB,Scangos George A,CEO,M - OptEx,$0.00,21339,60995,+54%,+$0,1.0,4.0,-5.0,27.0,BIIB
651,,2013-06-17 15:46:48,2013-06-14,BIIB,Denner Alexander J,Dir,S - Sale,$212.00,-2900,6325,-31%,"-$614,800",-2.0,-6.0,5.0,31.0,BIIB
652,,2013-06-13 16:42:44,2013-06-12,BIIB,Young William,Dir,A - Grant,$0.00,2610,33509,+8%,+$0,1.0,-3.0,8.0,37.0,BIIB
653,,2013-06-13 16:40:58,2013-06-12,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,1305,6325,+26%,+$0,1.0,-3.0,8.0,37.0,BIIB
654,,2013-06-13 16:39:42,2013-06-12,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,1305,14003,+10%,+$0,1.0,-3.0,8.0,37.0,BIIB
655,,2013-06-13 16:38:06,2013-06-12,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,1305,12460,+12%,+$0,1.0,-3.0,8.0,37.0,BIIB
656,,2013-06-13 16:36:24,2013-06-12,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,1305,11325,+13%,+$0,1.0,-3.0,8.0,37.0,BIIB
657,,2013-06-13 16:34:23,2013-06-12,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,1305,3960,+49%,+$0,1.0,-3.0,8.0,37.0,BIIB
658,,2013-06-13 16:32:59,2013-06-12,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,1305,9660,+16%,+$0,1.0,-3.0,8.0,37.0,BIIB
659,,2013-06-13 16:31:18,2013-06-12,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,1305,14468,+10%,+$0,1.0,-3.0,8.0,37.0,BIIB
660,,2013-06-13 16:29:21,2013-06-12,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,1305,9225,+16%,+$0,1.0,-3.0,8.0,37.0,BIIB
661,,2013-06-13 16:27:05,2013-06-12,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,1305,14235,+10%,+$0,1.0,-3.0,8.0,37.0,BIIB
662,,2013-06-13 16:27:05,2013-06-11,BIIB,Papadopoulos Stelios,Dir,S - Sale,$219.62,-2020,14235,-12%,"-$443,632",1.0,-3.0,8.0,37.0,BIIB
663,,2013-06-13 16:23:16,2013-06-12,BIIB,Posner Brian S,Dir,A - Grant,$0.00,1305,9435,+16%,+$0,1.0,-3.0,8.0,37.0,BIIB
664,,2013-06-13 16:23:16,2013-06-11,BIIB,Posner Brian S,Dir,S - Sale,$219.62,-2020,9435,-18%,"-$443,632",1.0,-3.0,8.0,37.0,BIIB
665,,2013-06-11 15:55:00,2013-06-10,BIIB,Schenk Lynn,Dir,S - Sale,$225.82,-2000,10020,-17%,"-$451,633",0.0,-6.0,-1.0,31.0,BIIB
666,,2013-06-04 15:29:02,2013-06-03,BIIB,Scangos George A,CEO,S - Sale,$234.16,-1598,59667,-3%,"-$374,188",-3.0,-2.0,-5.0,28.0,BIIB
667,D,2013-06-04 15:26:10,2013-06-03,BIIB,Sherwin Stephen A,Dir,M - OptEx,$59.82,12825,2655,-126%,"+$767,192",-3.0,-2.0,-5.0,28.0,BIIB
668,D,2013-06-04 15:26:10,2013-06-03,BIIB,Sherwin Stephen A,Dir,S - Sale+OE,$233.26,-12825,2655,-83%,"-$2,991,605",-3.0,-2.0,-5.0,28.0,BIIB
669,D,2013-05-31 12:27:40,2013-05-29,BIIB,Mulligan Richard,Dir,M - OptEx,$53.43,3000,5020,+149%,"+$160,290",-1.0,-7.0,-10.0,21.0,BIIB
670,D,2013-05-31 12:26:05,2013-05-29,BIIB,Denner Alexander J,Dir,M - OptEx,$53.43,3000,7920,+61%,"+$160,290",-1.0,-7.0,-10.0,21.0,BIIB
671,D,2013-05-29 17:16:42,2013-05-28,BIIB,Mulligan Richard,Dir,M - OptEx,$53.43,37975,2020,-106%,"+$2,029,004",0.0,-8.0,-13.0,19.0,BIIB
672,D,2013-05-29 17:16:42,2013-05-28,BIIB,Mulligan Richard,Dir,S - Sale+OE,$240.69,-37975,2020,-95%,"-$9,140,100",0.0,-8.0,-13.0,19.0,BIIB
673,D,2013-05-29 17:15:06,2013-05-28,BIIB,Denner Alexander J,Dir,M - OptEx,$53.43,37975,4920,-115%,"+$2,029,004",0.0,-8.0,-13.0,19.0,BIIB
674,D,2013-05-29 17:15:06,2013-05-28,BIIB,Denner Alexander J,Dir,S - Sale+OE,$240.57,-37975,4920,-89%,"-$9,135,697",0.0,-8.0,-13.0,19.0,BIIB
675,,2013-05-29 17:12:52,2013-05-28,BIIB,Pangia Robert W,Dir,S - Sale,$237.23,-5900,12698,-32%,"-$1,399,657",0.0,-8.0,-13.0,19.0,BIIB
676,,2013-05-07 13:36:16,2013-05-03,BIIB,Pawlicki Raymond,"SVP, CIO",F - Tax,$218.85,-866,8710,-9%,"-$189,524",-1.0,3.0,-1.0,13.0,BIIB
677,,2013-05-07 13:33:51,2013-05-03,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$218.85,-866,18060,-5%,"-$189,524",-1.0,3.0,-1.0,13.0,BIIB
678,D,2013-05-03 15:10:02,2013-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",F - Tax,$214.33,-114,375,-23%,"-$24,434",1.0,-4.0,5.0,15.0,BIIB
679,D,2013-05-03 15:10:02,2013-05-01,BIIB,Covino Gregory F,"VP, Chief Accounting Officer",M - OptEx,$0.00,347,375,>999%,+$0,1.0,-4.0,5.0,15.0,BIIB
680,,2013-05-03 15:07:47,2013-05-01,BIIB,Scangos George A,CEO,S - Sale,$215.39,-1598,61265,-3%,"-$344,193",1.0,-4.0,5.0,15.0,BIIB
681,M,2013-05-01 15:45:21,2013-04-29,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$222.75,-23612,7087,-77%,"-$5,259,506",-2.0,-3.0,9.0,16.0,BIIB
682,A,2013-04-03 12:31:15,2013-04-01,BIIB,Scangos George A,CEO,S - Sale,$193.66,-1598,62863,-2%,"-$309,469",-1.0,-3.0,8.0,21.0,BIIB
683,,2013-04-02 13:23:21,2013-04-01,BIIB,Scangos George A,CEO,S - Sale,$193.66,-1598,62863,-2%,"-$309,469",3.0,1.0,14.0,27.0,BIIB
684,,2013-03-25 14:20:17,2013-03-22,BIIB,Mulligan Richard,Dir,S - Sale,$176.88,-2900,2020,-59%,"-$512,952",-1.0,8.0,20.0,39.0,BIIB
685,,2013-03-25 14:18:26,2013-03-22,BIIB,Sherwin Stephen A,Dir,S - Sale,$176.88,-1500,2655,-36%,"-$265,320",-1.0,8.0,20.0,39.0,BIIB
686,,2013-03-19 15:15:23,2013-03-18,BIIB,Posner Brian S,Dir,S - Sale,$174.81,-4500,10150,-31%,"-$786,645",0.0,0.0,16.0,36.0,BIIB
687,,2013-03-13 14:56:27,2013-03-13,BIIB,Mulligan Richard,Dir,S - Sale,$175.38,-7980,4920,-62%,"-$1,399,527",0.0,0.0,14.0,30.0,BIIB
688,D,2013-03-12 14:22:34,2013-03-11,BIIB,Papadopoulos Stelios,Dir,M - OptEx,$58.44,46675,14950,-147%,"+$2,727,463",1.0,1.0,14.0,31.0,BIIB
689,D,2013-03-12 14:22:34,2013-03-11,BIIB,Papadopoulos Stelios,Dir,S - Sale+OE,$172.26,-46675,14950,-76%,"-$8,040,003",1.0,1.0,14.0,31.0,BIIB
690,,2013-03-04 16:42:37,2013-03-01,BIIB,Pawlicki Raymond,"SVP, CIO",F - Tax,$168.70,-630,9410,-6%,"-$106,281",1.0,1.0,17.0,26.0,BIIB
691,,2013-03-04 16:40:57,2013-03-01,BIIB,Scangos George A,CEO,S - Sale,$165.30,-1598,64461,-2%,"-$264,149",1.0,1.0,17.0,26.0,BIIB
692,D,2013-02-26 13:26:59,2013-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$164.40,-1227,18759,-6%,"-$201,719",0.0,5.0,10.0,31.0,BIIB
693,D,2013-02-26 13:26:59,2013-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,2598,18759,+16%,+$0,0.0,5.0,10.0,31.0,BIIB
694,D,2013-02-26 13:25:44,2013-02-23,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$164.40,-1803,15135,-11%,"-$296,413",0.0,5.0,10.0,31.0,BIIB
695,D,2013-02-26 13:25:44,2013-02-23,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3821,15135,+34%,+$0,0.0,5.0,10.0,31.0,BIIB
696,D,2013-02-26 13:24:43,2013-02-23,BIIB,Pawlicki Raymond,"SVP, CIO",F - Tax,$164.40,-722,10040,-7%,"-$118,697",0.0,5.0,10.0,31.0,BIIB
697,D,2013-02-26 13:24:43,2013-02-23,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$0.00,1529,10040,+18%,+$0,0.0,5.0,10.0,31.0,BIIB
698,D,2013-02-26 13:23:21,2013-02-23,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$164.40,-2021,30699,-6%,"-$332,252",0.0,5.0,10.0,31.0,BIIB
699,D,2013-02-26 13:23:21,2013-02-23,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,4281,30699,+16%,+$0,0.0,5.0,10.0,31.0,BIIB
700,D,2013-02-14 14:59:06,2013-02-13,BIIB,Scangos George A,CEO,S - Sale+OE,$163.39,-1598,66059,-2%,"-$261,097",-1.0,-2.0,7.0,27.0,BIIB
701,DM,2013-02-12 17:26:40,2013-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$164.44,-1692,5511,-23%,"-$278,232",0.0,1.0,7.0,25.0,BIIB
702,DM,2013-02-12 17:26:40,2013-02-08,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4108,5511,+293%,+$0,0.0,1.0,7.0,25.0,BIIB
703,DM,2013-02-12 17:24:14,2013-02-08,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$164.44,-2630,28439,-8%,"-$432,477",0.0,1.0,7.0,25.0,BIIB
704,DM,2013-02-12 17:24:14,2013-02-08,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,7457,28439,+36%,+$0,0.0,1.0,7.0,25.0,BIIB
705,D,2013-02-12 17:22:28,2013-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$164.44,-940,8386,-10%,"-$154,574",0.0,1.0,7.0,25.0,BIIB
706,D,2013-02-12 17:22:28,2013-02-08,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,2344,8386,+39%,+$0,0.0,1.0,7.0,25.0,BIIB
707,DM,2013-02-12 17:20:16,2013-02-08,BIIB,Pawlicki Raymond,"SVP, CIO",F - Tax,$164.44,-1416,9233,-13%,"-$232,847",0.0,1.0,7.0,25.0,BIIB
708,DM,2013-02-12 17:20:16,2013-02-08,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$0.00,2996,9233,+48%,+$0,0.0,1.0,7.0,25.0,BIIB
709,DM,2013-02-12 17:12:34,2013-02-08,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$164.44,-1977,13117,-13%,"-$325,098",0.0,1.0,7.0,25.0,BIIB
710,DM,2013-02-12 17:12:34,2013-02-08,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,6074,13117,+86%,+$0,0.0,1.0,7.0,25.0,BIIB
711,DM,2013-02-12 17:10:51,2013-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$164.44,-2969,17388,-15%,"-$488,222",0.0,1.0,7.0,25.0,BIIB
712,DM,2013-02-12 17:10:51,2013-02-08,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,8179,17388,+89%,+$0,0.0,1.0,7.0,25.0,BIIB
713,D,2013-02-12 17:08:39,2013-02-08,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$164.44,-1252,8939,-12%,"-$205,879",0.0,1.0,7.0,25.0,BIIB
714,D,2013-02-12 17:08:39,2013-02-08,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,3006,8939,+51%,+$0,0.0,1.0,7.0,25.0,BIIB
715,DM,2013-02-12 17:05:37,2013-02-09,BIIB,Scangos George A,CEO,F - Tax,$164.44,-12613,67657,-16%,"-$2,074,082",0.0,1.0,7.0,25.0,BIIB
716,DM,2013-02-12 17:05:37,2013-02-09,BIIB,Scangos George A,CEO,M - OptEx,$0.00,28600,67657,+73%,+$0,0.0,1.0,7.0,25.0,BIIB
717,D,2013-02-07 13:58:02,2013-02-06,BIIB,Pangia Robert W,Dir,M - OptEx,$66.29,2500,18598,+16%,"+$165,725",0.0,3.0,7.0,35.0,BIIB
718,D,2013-02-07 13:58:02,2013-02-06,BIIB,Pangia Robert W,Dir,S - Sale+OE,$165.55,-2500,18598,-12%,"-$413,875",0.0,3.0,7.0,35.0,BIIB
719,D,2013-02-07 13:55:46,2013-02-06,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$49.65,10000,7653,-426%,"+$496,500",0.0,3.0,7.0,35.0,BIIB
720,D,2013-02-07 13:55:46,2013-02-06,BIIB,Pawlicki Raymond,"SVP, CIO",S - Sale+OE,$165.55,-10000,7653,-57%,"-$1,655,500",0.0,3.0,7.0,35.0,BIIB
721,D,2013-02-05 18:23:13,2013-02-01,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$157.30,-1679,7185,-19%,"-$264,107",2.0,4.0,10.0,45.0,BIIB
722,D,2013-02-05 18:23:13,2013-02-01,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,5159,7185,+255%,+$0,2.0,4.0,10.0,45.0,BIIB
723,D,2013-02-05 16:25:13,2013-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,F - Tax,$157.30,-1678,6982,-19%,"-$263,949",2.0,4.0,10.0,45.0,BIIB
724,D,2013-02-05 16:25:13,2013-02-01,BIIB,Holtzman Steven H,EVP Corporate Development,M - OptEx,$0.00,5159,6982,+283%,+$0,2.0,4.0,10.0,45.0,BIIB
725,D,2013-02-05 16:23:50,2013-02-01,BIIB,Dipietro Kenneth,EVP HR,F - Tax,$157.30,-711,1440,-33%,"-$111,840",2.0,4.0,10.0,45.0,BIIB
726,D,2013-02-05 16:23:50,2013-02-01,BIIB,Dipietro Kenneth,EVP HR,M - OptEx,$0.00,2151,1440,-303%,+$0,2.0,4.0,10.0,45.0,BIIB
727,D,2013-02-05 16:22:19,2013-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$157.30,-1491,3095,-33%,"-$234,534",2.0,4.0,10.0,45.0,BIIB
728,D,2013-02-05 16:22:19,2013-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4586,3095,-308%,+$0,2.0,4.0,10.0,45.0,BIIB
729,,2013-01-24 17:08:11,2012-11-29,BIIB,Scangos George A,CEO,G - Gift,$0.00,-21512,46292,+87%,-$0,0.0,6.0,13.0,56.0,BIIB
730,M,2012-12-28 10:15:11,2012-12-26,BIIB,Denner Alexander J,Dir,S - Sale,$148.62,-7980,4920,-62%,"-$1,186,000",-1.0,-1.0,4.0,46.0,BIIB
731,,2012-11-02 15:49:58,2012-11-01,BIIB,Scangos George A,CEO,S - Sale,$139.42,-2472,51670,-5%,"-$344,640",0.0,-2.0,8.0,55.0,BIIB
732,,2012-10-02 13:10:27,2012-10-01,BIIB,Scangos George A,CEO,S - Sale,$149.16,-3654,54142,-6%,"-$545,031",0.0,1.0,-7.0,29.0,BIIB
733,D,2012-09-18 17:26:14,2012-09-17,BIIB,Pangia Robert W,Dir,M - OptEx,$66.29,5000,18598,+37%,"+$331,450",0.0,-1.0,-2.0,13.0,BIIB
734,D,2012-09-18 17:26:14,2012-09-17,BIIB,Pangia Robert W,Dir,S - Sale+OE,$155.00,-5000,18598,-21%,"-$775,000",0.0,-1.0,-2.0,13.0,BIIB
735,D,2012-09-10 14:20:30,2012-09-06,BIIB,Pangia Robert W,Dir,M - OptEx,$66.29,5000,18598,+37%,"+$331,450",-1.0,1.0,-1.0,16.0,BIIB
736,D,2012-09-10 14:20:30,2012-09-06,BIIB,Pangia Robert W,Dir,S - Sale+OE,$150.00,-5000,18598,-21%,"-$750,000",-1.0,1.0,-1.0,16.0,BIIB
737,,2012-09-05 15:20:09,2012-09-04,BIIB,Sherwin Stephen A,Dir,S - Sale,$145.90,-2000,4155,-32%,"-$291,800",0.0,3.0,4.0,17.0,BIIB
738,,2012-09-05 15:17:39,2012-09-04,BIIB,Scangos George A,CEO,S - Sale,$145.90,-3654,57796,-6%,"-$533,119",0.0,3.0,4.0,17.0,BIIB
739,,2012-08-03 11:12:49,2012-08-02,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$142.99,-1165,9020,-11%,"-$166,583",1.0,0.0,2.0,9.0,BIIB
740,,2012-08-02 15:24:45,2012-08-01,BIIB,Scangos George A,CEO,S - Sale,$146.30,-3655,61450,-6%,"-$534,727",0.0,1.0,1.0,8.0,BIIB
741,D,2012-07-30 14:58:14,2012-07-27,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$57.04,58070,10185,-121%,"+$3,312,157",-1.0,-3.0,-1.0,4.0,BIIB
742,D,2012-07-30 14:58:14,2012-07-27,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$150.00,-58070,10185,-85%,"-$8,710,500",-1.0,-3.0,-1.0,4.0,BIIB
743,,2012-07-18 15:35:47,2012-07-17,BIIB,Scangos George A,CEO,S - Sale,$146.04,-2472,65105,-4%,"-$361,011",-1.0,-4.0,1.0,-2.0,BIIB
744,D,2012-07-17 13:03:39,2012-07-16,BIIB,Scangos George A,CEO,F - Tax,$144.61,-17679,67577,-21%,"-$2,556,560",0.0,-4.0,0.0,-2.0,BIIB
745,D,2012-07-17 13:03:39,2012-07-16,BIIB,Scangos George A,CEO,M - OptEx,$0.00,21339,67577,+46%,+$0,0.0,-4.0,0.0,-2.0,BIIB
746,,2012-07-03 10:40:27,2012-07-02,BIIB,Scangos George A,CEO,S - Sale,$143.50,-1183,63917,-2%,"-$169,761",0.0,-1.0,-1.0,2.0,BIIB
747,D,2012-06-21 11:41:43,2012-06-19,BIIB,Pawlicki Raymond,"SVP, CIO",M - OptEx,$49.59,10000,7653,-426%,"+$495,900",-3.0,0.0,0.0,6.0,BIIB
748,D,2012-06-21 11:41:43,2012-06-19,BIIB,Pawlicki Raymond,"SVP, CIO",S - Sale+OE,$143.00,-10000,7653,-57%,"-$1,430,000",-3.0,0.0,0.0,6.0,BIIB
749,D,2012-06-18 13:53:43,2012-06-15,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$47.87,49800,10185,-126%,"+$2,383,838",1.0,1.0,4.0,9.0,BIIB
750,D,2012-06-18 13:53:43,2012-06-15,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$140.00,-49800,10185,-83%,"-$6,972,000",1.0,1.0,4.0,9.0,BIIB
751,D,2012-06-18 13:50:08,2012-06-15,BIIB,Pangia Robert W,Dir,M - OptEx,$36.94,5000,18598,+37%,"+$184,700",1.0,1.0,4.0,9.0,BIIB
752,D,2012-06-18 13:50:08,2012-06-15,BIIB,Pangia Robert W,Dir,S - Sale+OE,$140.00,-5000,18598,-21%,"-$700,000",1.0,1.0,4.0,9.0,BIIB
753,,2012-06-11 17:25:06,2012-06-08,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,2020,12020,+20%,+$0,1.0,6.0,9.0,16.0,BIIB
754,,2012-06-11 17:23:29,2012-06-08,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,2020,12900,+19%,+$0,1.0,6.0,9.0,16.0,BIIB
755,,2012-06-11 17:21:40,2012-06-08,BIIB,Young William,Dir,A - Grant,$0.00,4040,30899,+15%,+$0,1.0,6.0,9.0,16.0,BIIB
756,,2012-06-11 17:20:09,2012-06-08,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,2020,14950,+16%,+$0,1.0,6.0,9.0,16.0,BIIB
757,,2012-06-11 17:18:27,2012-06-08,BIIB,Posner Brian S,Dir,A - Grant,$0.00,2020,14650,+16%,+$0,1.0,6.0,9.0,16.0,BIIB
758,,2012-06-11 17:16:29,2012-06-08,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,2020,8355,+32%,+$0,1.0,6.0,9.0,16.0,BIIB
759,,2012-06-11 17:14:54,2012-06-08,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,2020,6155,+49%,+$0,1.0,6.0,9.0,16.0,BIIB
760,,2012-06-11 17:13:23,2012-06-08,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,2020,18598,+12%,+$0,1.0,6.0,9.0,16.0,BIIB
761,,2012-06-11 17:11:45,2012-06-08,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,2020,13163,+18%,+$0,1.0,6.0,9.0,16.0,BIIB
762,,2012-06-11 17:02:51,2012-06-08,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,2020,11155,+22%,+$0,1.0,6.0,9.0,16.0,BIIB
763,,2012-06-11 16:59:58,2012-06-08,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,2020,12900,+19%,+$0,1.0,6.0,9.0,16.0,BIIB
764,D,2012-06-11 11:22:36,2012-06-07,BIIB,Posner Brian S,Dir,M - OptEx,$71.38,2500,12630,+25%,"+$178,450",-1.0,5.0,8.0,15.0,BIIB
765,D,2012-06-11 11:22:36,2012-06-07,BIIB,Posner Brian S,Dir,S - Sale+OE,$135.00,-2500,12630,-17%,"-$337,500",-1.0,5.0,8.0,15.0,BIIB
766,D,2012-06-05 15:45:15,2012-06-04,BIIB,Pangia Robert W,Dir,M - OptEx,$36.94,5000,16578,+43%,"+$184,700",1.0,1.0,11.0,16.0,BIIB
767,D,2012-06-05 15:45:15,2012-06-04,BIIB,Pangia Robert W,Dir,S - Sale+OE,$130.00,-5000,16578,-23%,"-$650,000",1.0,1.0,11.0,16.0,BIIB
768,,2012-06-05 15:43:28,2012-06-04,BIIB,Sherwin Stephen A,Dir,S - Sale,$126.45,-2500,4135,-38%,"-$316,125",1.0,1.0,11.0,16.0,BIIB
769,D,2012-06-05 15:41:56,2012-06-04,BIIB,Posner Brian S,Dir,M - OptEx,$71.38,2400,12630,+23%,"+$171,312",1.0,1.0,11.0,16.0,BIIB
770,D,2012-06-05 15:41:56,2012-06-04,BIIB,Posner Brian S,Dir,S - Sale+OE,$126.45,-2400,12630,-16%,"-$303,480",1.0,1.0,11.0,16.0,BIIB
771,,2012-06-05 15:39:42,2012-06-04,BIIB,Pawlicki Raymond,"SVP, CIO",S - Sale,$126.45,-1068,7653,-12%,"-$135,049",1.0,1.0,11.0,16.0,BIIB
772,,2012-06-04 16:26:39,2012-06-01,BIIB,Scangos George A,CEO,S - Sale,$128.63,-1183,65100,-2%,"-$152,169",1.0,2.0,12.0,16.0,BIIB
773,,2012-05-04 14:03:40,2012-05-03,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$134.26,-765,12178,-6%,"-$102,709",-2.0,0.0,-3.0,3.0,BIIB
774,,2012-05-04 14:02:36,2012-05-03,BIIB,Pawlicki Raymond,"SVP, CIO",F - Tax,$134.26,-765,8721,-8%,"-$102,709",-2.0,0.0,-3.0,3.0,BIIB
775,D,2012-05-03 16:46:46,2012-05-02,BIIB,Schenk Lynn,Dir,M - OptEx,$53.43,5975,10000,+148%,"+$319,244",-2.0,-1.0,-6.0,4.0,BIIB
776,D,2012-05-03 16:46:46,2012-05-02,BIIB,Schenk Lynn,Dir,S - Sale+OE,$135.00,-14455,10000,-59%,"-$1,951,425",-2.0,-1.0,-6.0,4.0,BIIB
777,D,2012-05-03 16:34:14,2012-05-02,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$44.73,20000,10185,-204%,"+$894,600",-2.0,-1.0,-6.0,4.0,BIIB
778,D,2012-05-03 16:34:14,2012-05-02,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$135.00,-20000,10185,-66%,"-$2,700,000",-2.0,-1.0,-6.0,4.0,BIIB
779,D,2012-04-26 15:44:28,2012-04-25,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$44.73,16764,10185,-255%,"+$749,854",1.0,5.0,2.0,10.0,BIIB
780,D,2012-04-26 15:44:28,2012-04-25,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$130.00,-16764,10185,-62%,"-$2,179,320",1.0,5.0,2.0,10.0,BIIB
781,D,2012-04-06 15:28:18,2012-04-04,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$44.73,3236,10185,+47%,"+$144,746",-2.0,-3.0,3.0,19.0,BIIB
782,D,2012-04-06 15:28:18,2012-04-04,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$130.00,-3236,10185,-24%,"-$420,680",-2.0,-3.0,3.0,19.0,BIIB
783,D,2012-03-12 15:02:10,2012-03-08,BIIB,Pangia Robert W,Dir,M - OptEx,$35.21,7500,16578,+83%,"+$264,050",0.0,0.0,4.0,26.0,BIIB
784,D,2012-03-12 15:02:10,2012-03-08,BIIB,Pangia Robert W,Dir,S - Sale+OE,$120.00,-7500,16578,-31%,"-$900,000",0.0,0.0,4.0,26.0,BIIB
785,M,2012-03-01 15:23:23,2012-02-28,BIIB,Gagnon Robert E.,"VP, Finance",S - Sale,$115.25,-1552,3999,-28%,"-$178,871",2.0,0.0,9.0,26.0,BIIB
786,M,2012-03-01 15:21:22,2005-09-19,BIIB,Pangia Robert W,Dir,G - Gift,$0.00,-402,16578,-2%,-$0,2.0,0.0,9.0,26.0,BIIB
787,,2012-02-28 16:01:30,2012-02-27,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$115.43,-4255,10185,-29%,"-$491,155",0.0,1.0,8.0,26.0,BIIB
788,DM,2012-02-27 16:20:01,2012-02-23,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$116.50,-4014,14440,-22%,"-$467,627",0.0,2.0,8.0,25.0,BIIB
789,D,2012-02-27 16:20:01,2012-02-23,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3822,14440,+36%,+$0,0.0,2.0,8.0,25.0,BIIB
790,D,2012-02-27 16:20:01,2012-02-24,BIIB,Alexander Susan H,"EVP, GC",S - Sale+OE,$115.53,-2145,14440,-13%,"-$247,812",0.0,2.0,8.0,25.0,BIIB
791,DM,2012-02-27 16:19:12,2012-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$116.52,-2663,12713,-17%,"-$310,283",0.0,2.0,8.0,25.0,BIIB
792,D,2012-02-27 16:19:12,2012-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,2600,12713,+26%,+$0,0.0,2.0,8.0,25.0,BIIB
793,DM,2012-02-27 16:18:24,2012-02-23,BIIB,Gagnon Robert E.,"VP, Finance",F - Tax,$116.56,-722,5551,-12%,"-$84,154",0.0,2.0,8.0,25.0,BIIB
794,DM,2012-02-27 16:18:24,2012-02-23,BIIB,Gagnon Robert E.,"VP, Finance",M - OptEx,$22.98,2277,5551,+70%,"+$52,331",0.0,2.0,8.0,25.0,BIIB
795,D,2012-02-27 16:18:24,2012-02-24,BIIB,Gagnon Robert E.,"VP, Finance",S - Sale+OE,$115.53,-1054,5551,-16%,"-$121,769",0.0,2.0,8.0,25.0,BIIB
796,DM,2012-02-27 16:17:30,2012-02-23,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$116.51,-4572,23612,-16%,"-$532,689",0.0,2.0,8.0,25.0,BIIB
797,D,2012-02-27 16:17:30,2012-02-23,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,4281,23612,+22%,+$0,0.0,2.0,8.0,25.0,BIIB
798,A,2012-02-22 12:03:03,2011-07-15,BIIB,Scangos George A,CEO,F - Tax,$104.00,-8791,54374,-14%,"-$914,264",1.0,1.0,4.0,25.0,BIIB
799,,2012-02-16 14:39:20,2012-02-14,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",S - Sale,$118.61,-1247,0,-100%,"-$147,907",1.0,-2.0,1.0,24.0,BIIB
800,,2012-02-16 14:37:45,2012-02-14,BIIB,Gagnon Robert E.,"VP, Finance",S - Sale,$118.61,-560,5050,-10%,"-$66,422",1.0,-2.0,1.0,24.0,BIIB
801,,2012-02-14 15:58:27,2012-02-13,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$118.01,-2842,16777,-14%,"-$335,384",0.0,-4.0,1.0,20.0,BIIB
802,D,2012-02-14 15:57:07,2012-02-09,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$117.78,-579,1247,-32%,"-$68,195",0.0,-4.0,1.0,20.0,BIIB
803,D,2012-02-14 15:57:07,2012-02-09,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,1826,1247,-315%,+$0,0.0,-4.0,1.0,20.0,BIIB
804,D,2012-02-13 16:28:35,2012-02-09,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$117.78,-1504,12776,-11%,"-$177,141",0.0,-3.0,2.0,22.0,BIIB
805,D,2012-02-13 16:28:35,2012-02-09,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,4692,12776,+58%,+$0,0.0,-3.0,2.0,22.0,BIIB
806,D,2012-02-13 16:27:29,2012-02-09,BIIB,Gagnon Robert E.,"VP, Finance",F - Tax,$117.78,-301,5610,-5%,"-$35,452",0.0,-3.0,2.0,22.0,BIIB
807,D,2012-02-13 16:27:29,2012-02-09,BIIB,Gagnon Robert E.,"VP, Finance",M - OptEx,$0.00,861,5610,+18%,+$0,0.0,-3.0,2.0,22.0,BIIB
808,D,2012-02-13 16:26:30,2012-02-09,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$117.78,-1257,19619,-6%,"-$148,049",0.0,-3.0,2.0,22.0,BIIB
809,D,2012-02-13 16:26:30,2012-02-09,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3911,19619,+25%,+$0,0.0,-3.0,2.0,22.0,BIIB
810,D,2012-02-13 16:24:21,2012-02-10,BIIB,Scangos George A,CEO,F - Tax,$118.14,-7007,66283,-10%,"-$827,807",0.0,-3.0,2.0,22.0,BIIB
811,D,2012-02-13 16:24:21,2012-02-10,BIIB,Scangos George A,CEO,M - OptEx,$0.00,18833,66283,+40%,+$0,0.0,-3.0,2.0,22.0,BIIB
812,D,2012-02-13 16:21:04,2012-02-09,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$117.78,-1957,23903,-8%,"-$230,495",0.0,-3.0,2.0,22.0,BIIB
813,D,2012-02-13 16:21:04,2012-02-09,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,4692,23903,+24%,+$0,0.0,-3.0,2.0,22.0,BIIB
814,,2012-02-08 15:07:03,2012-02-06,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",S - Sale,$121.03,-3110,0,-100%,"-$376,403",-2.0,-2.0,-1.0,20.0,BIIB
815,D,2012-02-03 14:56:06,2012-02-01,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$52.95,21400,21168,-9224%,"+$1,133,088",1.0,-3.0,-2.0,19.0,BIIB
816,D,2012-02-03 14:56:06,2012-02-01,BIIB,Clancy Paul J,"EVP, CFO",S - Sale+OE,$120.00,-21400,21168,-50%,"-$2,568,000",1.0,-3.0,-2.0,19.0,BIIB
817,D,2012-02-03 14:55:09,2012-02-01,BIIB,Williams Douglas E,"EVP Research, Development",F - Tax,$121.26,-1656,3906,-30%,"-$200,807",1.0,-3.0,-2.0,19.0,BIIB
818,D,2012-02-03 14:55:09,2012-02-01,BIIB,Williams Douglas E,"EVP Research, Development",M - OptEx,$0.00,5159,3906,-412%,+$0,1.0,-3.0,-2.0,19.0,BIIB
819,D,2012-02-03 14:54:18,2012-02-01,BIIB,Holtzman Steven H,"EVP Corp Devel, Strategy",F - Tax,$121.26,-1658,3501,-32%,"-$201,049",1.0,-3.0,-2.0,19.0,BIIB
820,D,2012-02-03 14:54:18,2012-02-01,BIIB,Holtzman Steven H,"EVP Corp Devel, Strategy",M - OptEx,$0.00,5159,3501,-311%,+$0,1.0,-3.0,-2.0,19.0,BIIB
821,D,2012-02-03 14:53:26,2012-02-01,BIIB,Granata Francesco,EVP Global Commercial Operatio,F - Tax,$121.26,-1669,3529,-32%,"-$202,383",1.0,-3.0,-2.0,19.0,BIIB
822,D,2012-02-03 14:53:26,2012-02-01,BIIB,Granata Francesco,EVP Global Commercial Operatio,M - OptEx,$0.00,5198,3529,-311%,+$0,1.0,-3.0,-2.0,19.0,BIIB
823,D,2012-02-03 14:52:36,2012-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",F - Tax,$121.26,-1477,3110,-32%,"-$179,101",1.0,-3.0,-2.0,19.0,BIIB
824,D,2012-02-03 14:52:36,2012-02-01,BIIB,Kingsley Stuart A,"EVP, Global Comm. Operations",M - OptEx,$0.00,4587,3110,-311%,+$0,1.0,-3.0,-2.0,19.0,BIIB
825,D,2012-02-03 14:51:42,2012-02-01,BIIB,Leaming Nancy,Dir,M - OptEx,$59.17,5700,6335,+898%,"+$337,269",1.0,-3.0,-2.0,19.0,BIIB
826,D,2012-02-03 14:51:42,2012-02-01,BIIB,Leaming Nancy,Dir,S - Sale+OE,$120.00,-5700,6335,-47%,"-$684,000",1.0,-3.0,-2.0,19.0,BIIB
827,D,2012-01-24 15:55:59,2012-01-20,BIIB,Leaming Nancy,Dir,M - OptEx,$55.97,3000,6335,+90%,"+$167,910",1.0,0.0,0.0,20.0,BIIB
828,D,2012-01-24 15:55:59,2012-01-20,BIIB,Leaming Nancy,Dir,S - Sale+OE,$118.00,-3000,6335,-32%,"-$354,000",1.0,0.0,0.0,20.0,BIIB
829,D,2012-01-09 15:54:04,2012-01-06,BIIB,Leaming Nancy,Dir,M - OptEx,$55.97,3000,6335,+90%,"+$167,910",-1.0,0.0,5.0,24.0,BIIB
830,D,2012-01-09 15:54:04,2012-01-06,BIIB,Leaming Nancy,Dir,S - Sale+OE,$116.00,-3000,6335,-32%,"-$348,000",-1.0,0.0,5.0,24.0,BIIB
831,D,2012-01-09 15:52:37,2012-01-06,BIIB,Rowinsky Eric K,Dir,M - OptEx,$59.82,12992,9135,-337%,"+$777,181",-1.0,0.0,5.0,24.0,BIIB
832,D,2012-01-09 15:52:37,2012-01-06,BIIB,Rowinsky Eric K,Dir,S - Sale+OE,$116.00,-12992,9135,-59%,"-$1,507,072",-1.0,0.0,5.0,24.0,BIIB
833,D,2012-01-04 13:27:12,2012-01-03,BIIB,Leaming Nancy,Dir,M - OptEx,$55.97,4000,6335,+171%,"+$223,880",0.0,1.0,7.0,28.0,BIIB
834,D,2012-01-04 13:27:12,2012-01-03,BIIB,Leaming Nancy,Dir,S - Sale+OE,$114.00,-4000,6335,-39%,"-$456,000",0.0,1.0,7.0,28.0,BIIB
835,,2012-01-04 13:24:57,2012-01-03,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$112.35,-20244,21168,-49%,"-$2,274,401",0.0,1.0,7.0,28.0,BIIB
836,,2011-12-20 15:10:27,2011-12-19,BIIB,Sherwin Stephen A,Dir,S - Sale,$110.88,-2500,6635,-27%,"-$277,200",1.0,1.0,7.0,30.0,BIIB
837,,2011-12-08 14:05:52,2011-12-06,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$112.31,-795,5050,-14%,"-$89,286",-2.0,-2.0,3.0,19.0,BIIB
838,,2011-12-02 14:10:20,2011-12-01,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$116.48,-371,5845,-6%,"-$43,214",-3.0,-6.0,-3.0,12.0,BIIB
839,,2011-11-14 11:26:23,2011-11-09,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$112.04,-796,6216,-11%,"-$89,184",1.0,-5.0,-3.0,21.0,BIIB
840,,2011-11-04 11:50:49,2011-11-02,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$113.43,-371,7012,-5%,"-$42,083",0.0,-2.0,-2.0,16.0,BIIB
841,D,2011-11-03 10:52:19,2011-11-01,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$72.87,2175,9588,+29%,"+$158,492",1.0,-2.0,0.0,15.0,BIIB
842,D,2011-11-03 10:52:19,2011-11-01,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$114.37,-2175,9588,-18%,"-$248,755",1.0,-2.0,0.0,15.0,BIIB
843,,2011-10-07 13:48:54,2011-10-05,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$97.66,-252,7383,-3%,"-$24,610",1.0,2.0,14.0,27.0,BIIB
844,D,2011-10-04 18:28:51,2011-10-01,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$93.15,-118,7635,-2%,"-$10,992",8.0,10.0,25.0,42.0,BIIB
845,D,2011-10-04 18:28:51,2011-10-03,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",M - OptEx,$49.59,778,7635,+11%,"+$38,581",8.0,10.0,25.0,42.0,BIIB
846,D,2011-10-04 18:28:51,2011-10-03,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale+OE,$92.55,-778,7635,-9%,"-$72,004",8.0,10.0,25.0,42.0,BIIB
847,D,2011-09-29 13:01:29,2011-09-27,BIIB,Young William,Dir,M - OptEx,$51.38,33250,26859,-520%,"+$1,708,441",-1.0,4.0,24.0,33.0,BIIB
848,D,2011-09-29 13:01:29,2011-09-27,BIIB,Young William,Dir,S - Sale+OE,$96.14,-33250,26859,-55%,"-$3,196,655",-1.0,4.0,24.0,33.0,BIIB
849,,2011-09-19 17:18:53,2011-09-16,BIIB,Leaming Nancy,Dir,S - Sale,$100.00,-3085,6335,-33%,"-$308,500",1.0,-6.0,2.0,20.0,BIIB
850,D,2011-09-02 12:45:52,2011-09-01,BIIB,Young William,Dir,M - OptEx,$46.68,35000,26859,-430%,"+$1,633,775",-2.0,-4.0,-5.0,27.0,BIIB
851,D,2011-09-02 12:45:52,2011-09-01,BIIB,Young William,Dir,S - Sale+OE,$95.00,-35000,26859,-57%,"-$3,325,000",-2.0,-4.0,-5.0,27.0,BIIB
852,D,2011-08-31 11:44:09,2011-08-29,BIIB,Posner Brian S,Dir,M - OptEx,$71.38,15000,12630,-633%,"+$1,070,700",1.0,-1.0,1.0,27.0,BIIB
853,D,2011-08-31 11:44:09,2011-08-29,BIIB,Posner Brian S,Dir,S - Sale+OE,$92.53,-15000,12630,-54%,"-$1,387,895",1.0,-1.0,1.0,27.0,BIIB
854,D,2011-08-31 11:42:54,2011-08-29,BIIB,Young William,Dir,M - OptEx,$68.15,10000,26859,+59%,"+$681,500",1.0,-1.0,1.0,27.0,BIIB
855,D,2011-08-31 11:42:54,2011-08-29,BIIB,Young William,Dir,S - Sale+OE,$92.58,-10000,26859,-27%,"-$925,784",1.0,-1.0,1.0,27.0,BIIB
856,,2011-08-03 11:24:44,2011-08-01,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$102.90,-835,16965,-5%,"-$85,922",-1.0,-10.0,-5.0,22.0,BIIB
857,,2011-08-03 11:24:44,2011-08-02,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$102.04,-1165,16965,-6%,"-$118,877",-1.0,-10.0,-5.0,22.0,BIIB
858,,2011-08-03 11:23:18,2011-08-01,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$102.90,-835,41412,-2%,"-$85,922",-1.0,-10.0,-5.0,22.0,BIIB
859,,2011-07-21 14:30:41,2011-07-20,BIIB,Scangos George A,CEO,S - Sale,$106.51,-12347,54457,-18%,"-$1,315,033",1.0,-2.0,-15.0,12.0,BIIB
860,DM,2011-07-19 16:29:14,2011-07-14,BIIB,Scangos George A,CEO,F - Tax,$104.00,-17702,66804,-21%,"-$1,841,008",-3.0,-3.0,-16.0,9.0,BIIB
861,D,2011-07-19 16:29:14,2011-07-15,BIIB,Scangos George A,CEO,M - OptEx,$0.00,21341,66804,+47%,+$0,-3.0,-3.0,-16.0,9.0,BIIB
862,,2011-07-01 13:51:32,2011-07-01,BIIB,Granata Francesco,EVP Global Commercial Operatio,S - Sale,$107.52,-2901,0,-100%,"-$311,918",1.0,0.0,-4.0,3.0,BIIB
863,,2011-06-14 17:20:11,2011-06-14,BIIB,Leaming Nancy,Dir,S - Sale,$92.62,-2300,9420,-20%,"-$213,022",-1.0,4.0,11.0,20.0,BIIB
864,,2011-06-03 16:33:53,2011-06-01,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,2900,10800,+37%,+$0,-1.0,-1.0,15.0,22.0,BIIB
865,,2011-06-02 15:58:56,2011-06-01,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,2900,11143,+35%,+$0,2.0,0.0,15.0,18.0,BIIB
866,,2011-06-02 15:57:50,2011-06-01,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,2900,11720,+33%,+$0,2.0,0.0,15.0,18.0,BIIB
867,,2011-06-02 15:56:18,2011-06-01,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,2900,16980,+21%,+$0,2.0,0.0,15.0,18.0,BIIB
868,,2011-06-02 15:54:59,2011-06-01,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,2900,10880,+36%,+$0,2.0,0.0,15.0,18.0,BIIB
869,,2011-06-02 15:54:04,2011-06-01,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,2900,12930,+29%,+$0,2.0,0.0,15.0,18.0,BIIB
870,,2011-06-02 15:53:07,2011-06-01,BIIB,Posner Brian S,Dir,A - Grant,$0.00,2900,12630,+30%,+$0,2.0,0.0,15.0,18.0,BIIB
871,,2011-06-02 15:51:09,2011-06-01,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,2900,9135,+47%,+$0,2.0,0.0,15.0,18.0,BIIB
872,,2011-06-02 15:50:08,2011-06-01,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,2900,18480,+19%,+$0,2.0,0.0,15.0,18.0,BIIB
873,,2011-06-02 15:48:48,2011-06-01,BIIB,Young William,Dir,A - Grant,$0.00,5800,26859,+28%,+$0,2.0,0.0,15.0,18.0,BIIB
874,,2011-06-02 15:47:23,2011-06-01,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,2900,9135,+47%,+$0,2.0,0.0,15.0,18.0,BIIB
875,D,2011-05-27 15:15:22,2011-05-25,BIIB,Posner Brian S,Dir,M - OptEx,$67.25,25975,9730,-160%,"+$1,746,844",0.0,1.0,12.0,18.0,BIIB
876,D,2011-05-27 15:15:22,2011-05-25,BIIB,Posner Brian S,Dir,S - Sale+OE,$94.09,-25975,9730,-73%,"-$2,444,027",0.0,1.0,12.0,18.0,BIIB
877,D,2011-05-27 15:13:36,2011-05-26,BIIB,Leaming Nancy,Dir,M - OptEx,$55.51,33175,8820,-136%,"+$1,841,628",0.0,1.0,12.0,18.0,BIIB
878,D,2011-05-27 15:13:36,2011-05-26,BIIB,Leaming Nancy,Dir,S - Sale+OE,$93.05,-33175,8820,-79%,"-$3,087,085",0.0,1.0,12.0,18.0,BIIB
879,D,2011-05-27 15:11:47,2011-05-26,BIIB,Pangia Robert W,Dir,M - OptEx,$56.88,15000,14080,-1630%,"+$853,200",0.0,1.0,12.0,18.0,BIIB
880,D,2011-05-27 15:11:47,2011-05-26,BIIB,Pangia Robert W,Dir,S - Sale+OE,$93.11,-15000,14080,-52%,"-$1,396,647",0.0,1.0,12.0,18.0,BIIB
881,,2011-05-09 16:38:12,2011-05-06,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$96.13,-967,7753,-11%,"-$92,960",-1.0,-2.0,-5.0,17.0,BIIB
882,,2011-05-04 14:53:15,2011-05-03,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$97.99,-450,8720,-5%,"-$44,096",-2.0,-1.0,-3.0,19.0,BIIB
883,,2011-05-04 14:53:15,2011-05-04,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$96.03,-215,8720,-2%,"-$20,646",-2.0,-1.0,-3.0,19.0,BIIB
884,,2011-05-04 14:51:16,2011-05-03,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$97.99,-765,9588,-7%,"-$74,962",-2.0,-1.0,-3.0,19.0,BIIB
885,,2011-05-03 13:03:14,2011-05-01,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$97.65,-101,9385,-1%,"-$9,863",-1.0,-1.0,-6.0,20.0,BIIB
886,,2011-05-03 13:01:03,2011-05-02,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$97.20,-20993,18965,-53%,"-$2,040,497",-1.0,-1.0,-6.0,20.0,BIIB
887,D,2011-04-29 15:03:18,2011-04-28,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$41.18,14766,42247,+54%,"+$608,119",-1.0,-4.0,-6.0,18.0,BIIB
888,D,2011-04-29 15:03:18,2011-04-28,BIIB,Clancy Paul J,"EVP, CFO",S - Sale+OE,$98.91,-19716,42247,-32%,"-$1,950,088",-1.0,-4.0,-6.0,18.0,BIIB
889,D,2011-04-25 14:02:25,2011-04-21,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$72.87,4350,10353,+72%,"+$316,985",1.0,-2.0,-4.0,2.0,BIIB
890,D,2011-04-25 14:02:25,2011-04-21,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$100.00,-4350,10353,-30%,"-$435,000",1.0,-2.0,-4.0,2.0,BIIB
891,D,2011-04-21 16:41:10,2011-04-20,BIIB,Schenk Lynn,Dir,M - OptEx,$61.84,37275,15580,-172%,"+$2,304,947",1.0,-1.0,-3.0,3.0,BIIB
892,D,2011-04-21 16:41:10,2011-04-20,BIIB,Schenk Lynn,Dir,S - Sale+OE,$85.22,-37275,15580,-71%,"-$3,176,461",1.0,-1.0,-3.0,3.0,BIIB
893,D,2011-04-15 11:50:33,2011-04-13,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$56.73,36234,10353,-140%,"+$2,055,646",1.0,21.0,17.0,23.0,BIIB
894,D,2011-04-15 11:50:33,2011-04-13,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$80.00,-36234,10353,-78%,"-$2,898,720",1.0,21.0,17.0,23.0,BIIB
895,D,2011-04-13 10:14:56,2011-04-11,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$47.92,6900,10353,+200%,"+$330,648",4.0,7.0,26.0,27.0,BIIB
896,D,2011-04-13 10:14:56,2011-04-11,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$78.00,-6900,10353,-40%,"-$538,200",4.0,7.0,26.0,27.0,BIIB
897,D,2011-04-08 10:38:29,2011-03-05,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$71.15,-25888,47197,-35%,"-$1,841,931",0.0,13.0,34.0,36.0,BIIB
898,D,2011-04-08 10:38:29,2011-03-05,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$58.99,28750,47197,+156%,"+$1,695,963",0.0,13.0,34.0,36.0,BIIB
899,D,2011-04-01 15:20:59,2011-03-31,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$43.50,2840,9818,+41%,"+$123,540",-1.0,-1.0,34.0,29.0,BIIB
900,D,2011-04-01 15:20:59,2011-03-31,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$73.00,-2840,9818,-22%,"-$207,320",-1.0,-1.0,34.0,29.0,BIIB
901,D,2011-03-03 15:17:02,2011-03-01,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$49.65,6250,10661,+142%,"+$310,313",2.0,2.0,5.0,34.0,BIIB
902,DM,2011-03-03 15:17:02,2011-03-01,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$69.43,-13761,10661,-56%,"-$955,427",2.0,2.0,5.0,34.0,BIIB
903,,2011-03-03 15:10:08,2011-03-02,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale,$70.10,-4041,9818,-29%,"-$283,259",2.0,2.0,5.0,34.0,BIIB
904,,2011-03-03 15:08:30,2011-03-02,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$70.02,-1402,9486,-13%,"-$98,164",2.0,2.0,5.0,34.0,BIIB
905,,2011-02-28 15:41:45,2011-02-24,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$67.26,-1980,39958,-5%,"-$133,175",1.0,5.0,4.0,34.0,BIIB
906,,2011-02-28 15:39:13,2011-02-24,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$67.26,-2164,44335,-5%,"-$145,551",1.0,5.0,4.0,34.0,BIIB
907,,2011-02-28 15:36:32,2011-02-24,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$67.26,-335,10888,-3%,"-$22,532",1.0,5.0,4.0,34.0,BIIB
908,,2011-02-28 15:34:28,2011-02-24,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$67.26,-2156,18172,-11%,"-$145,013",1.0,5.0,4.0,34.0,BIIB
909,,2011-02-28 15:32:19,2011-02-24,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$67.26,-1202,13859,-8%,"-$80,847",1.0,5.0,4.0,34.0,BIIB
910,D,2011-02-25 15:56:58,2011-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$66.76,-680,15061,-4%,"-$45,397",1.0,6.0,6.0,37.0,BIIB
911,D,2011-02-25 15:56:58,2011-02-23,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$0.00,2138,15061,+17%,+$0,1.0,6.0,6.0,37.0,BIIB
912,D,2011-02-25 15:55:57,2011-02-23,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$66.76,-1119,46499,-2%,"-$74,704",1.0,6.0,6.0,37.0,BIIB
913,D,2011-02-25 15:55:57,2011-02-23,BIIB,Clancy Paul J,"EVP, CFO",M - OptEx,$0.00,3521,46499,+8%,+$0,1.0,6.0,6.0,37.0,BIIB
914,D,2011-02-25 15:54:37,2011-02-23,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$66.76,-320,11223,-3%,"-$21,363",1.0,6.0,6.0,37.0,BIIB
915,DM,2011-02-25 15:54:37,2011-02-23,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",M - OptEx,$25.40,2060,11223,+22%,"+$52,331",1.0,6.0,6.0,37.0,BIIB
916,D,2011-02-25 15:54:37,2011-02-24,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale+OE,$66.99,-1054,11223,-9%,"-$70,606",1.0,6.0,6.0,37.0,BIIB
917,D,2011-02-25 15:53:27,2011-02-23,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$66.76,-1598,20328,-7%,"-$106,682",1.0,6.0,6.0,37.0,BIIB
918,DM,2011-02-25 15:53:27,2011-02-23,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$32.50,14755,20328,+265%,"+$479,540",1.0,6.0,6.0,37.0,BIIB
919,D,2011-02-25 15:53:27,2011-02-25,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$68.20,-9725,20328,-32%,"-$663,245",1.0,6.0,6.0,37.0,BIIB
920,D,2011-02-25 15:51:39,2011-02-23,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$66.76,-999,41938,-2%,"-$66,693",1.0,6.0,6.0,37.0,BIIB
921,D,2011-02-25 15:51:39,2011-02-23,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3144,41938,+8%,+$0,1.0,6.0,6.0,37.0,BIIB
922,,2011-02-18 15:09:16,2011-02-17,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$67.10,-732,10537,-6%,"-$49,115",0.0,0.0,3.0,31.0,BIIB
923,,2011-02-18 15:07:55,2011-02-17,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$67.08,-3194,16896,-16%,"-$214,242",0.0,0.0,3.0,31.0,BIIB
924,,2011-02-18 15:06:43,2011-02-17,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale,$67.08,-1843,13603,-12%,"-$123,620",0.0,0.0,3.0,31.0,BIIB
925,,2011-02-15 14:31:00,2011-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$65.83,-1486,20090,-7%,"-$97,823",0.0,0.0,2.0,36.0,BIIB
926,,2011-02-15 14:29:23,2011-02-12,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$65.83,-341,11269,-3%,"-$22,448",0.0,0.0,2.0,36.0,BIIB
927,,2011-02-15 14:27:50,2011-02-12,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$65.83,-910,15446,-6%,"-$59,905",0.0,0.0,2.0,36.0,BIIB
928,,2011-02-15 14:26:35,2011-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$65.83,-1686,44097,-4%,"-$110,989",0.0,0.0,2.0,36.0,BIIB
929,,2011-02-15 14:24:55,2011-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$65.83,-1515,39793,-4%,"-$99,732",0.0,0.0,2.0,36.0,BIIB
930,D,2011-02-03 17:14:02,2011-02-01,BIIB,Granata Francesco,EVP Global Commercial Operatio,F - Tax,$65.49,-1385,2901,-32%,"-$90,704",1.0,1.0,8.0,50.0,BIIB
931,D,2011-02-03 17:14:02,2011-02-01,BIIB,Granata Francesco,EVP Global Commercial Operatio,M - OptEx,$0.00,4286,2901,-309%,+$0,1.0,1.0,8.0,50.0,BIIB
932,D,2011-01-24 14:59:07,2011-01-20,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$49.65,6250,21576,+41%,"+$310,313",1.0,-3.0,0.0,58.0,BIIB
933,D,2011-01-24 14:59:07,2011-01-20,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$68.62,-6250,21576,-22%,"-$428,875",1.0,-3.0,0.0,58.0,BIIB
934,D,2011-01-05 14:45:53,2011-01-04,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",M - OptEx,$46.07,4307,10814,+66%,"+$198,415",0.0,3.0,-1.0,62.0,BIIB
935,D,2011-01-05 14:45:53,2011-01-04,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale+OE,$66.57,-5103,10814,-32%,"-$339,690",0.0,3.0,-1.0,62.0,BIIB
936,D,2011-01-04 15:58:49,2010-12-31,BIIB,Young William,Dir,F - Tax,$67.05,-13256,21059,-39%,"-$888,815",-1.0,0.0,-2.0,61.0,BIIB
937,D,2011-01-04 15:58:49,2010-12-31,BIIB,Young William,Dir,M - OptEx,$59.25,15000,21059,+248%,"+$888,750",-1.0,0.0,-2.0,61.0,BIIB
938,D,2011-01-03 09:57:05,2010-12-30,BIIB,Schenk Lynn,Dir,M - OptEx,$59.25,15000,15580,>999%,"+$888,750",0.0,0.0,-2.0,62.0,BIIB
939,D,2011-01-03 09:57:05,2010-12-30,BIIB,Schenk Lynn,Dir,S - Sale+OE,$66.80,-15000,15580,-49%,"-$1,001,988",0.0,0.0,-2.0,62.0,BIIB
940,D,2010-12-21 15:32:44,2010-12-17,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$49.31,19450,21576,+915%,"+$959,080",0.0,-2.0,1.0,45.0,BIIB
941,D,2010-12-21 15:32:44,2010-12-17,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$68.20,-19450,21576,-47%,"-$1,326,490",0.0,-2.0,1.0,45.0,BIIB
942,,2010-12-07 17:14:08,2010-12-06,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",S - Sale,$66.53,-796,11610,-6%,"-$52,957",0.0,-2.0,-1.0,39.0,BIIB
943,DM,2010-12-07 17:13:21,2010-12-03,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$44.24,30000,21576,-356%,"+$1,327,200",0.0,-2.0,-1.0,39.0,BIIB
944,DM,2010-12-07 17:13:21,2010-12-03,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$67.20,-30000,21576,-58%,"-$2,016,000",0.0,-2.0,-1.0,39.0,BIIB
945,,2010-12-03 13:46:52,2010-12-01,BIIB,Gagnon Robert E.,"Chief Acct Officer VP, Contr",F - Tax,$65.37,-371,12406,-3%,"-$24,252",0.0,-1.0,0.0,41.0,BIIB
946,,2010-11-10 14:21:18,2010-11-09,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale,$62.87,-773,16356,-5%,"-$48,597",2.0,1.0,5.0,52.0,BIIB
947,,2010-11-03 13:50:49,2010-11-01,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",F - Tax,$62.55,-360,17129,-2%,"-$22,518",0.0,1.0,6.0,53.0,BIIB
948,,2010-11-03 13:50:49,2010-11-02,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale,$63.04,-765,17129,-4%,"-$48,228",0.0,1.0,6.0,53.0,BIIB
949,D,2010-10-29 14:27:26,2010-10-28,BIIB,Pangia Robert W,Dir,M - OptEx,$59.25,15000,14080,-1630%,"+$888,750",-2.0,-2.0,1.0,53.0,BIIB
950,D,2010-10-29 14:27:26,2010-10-28,BIIB,Pangia Robert W,Dir,S - Sale+OE,$64.00,-15000,14080,-52%,"-$960,000",-2.0,-2.0,1.0,53.0,BIIB
951,D,2010-10-29 14:25:21,2010-10-28,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",M - OptEx,$33.97,6900,18254,+61%,"+$234,393",-2.0,-2.0,1.0,53.0,BIIB
952,D,2010-10-29 14:25:21,2010-10-28,BIIB,Cox John,"EVP Pharmaceutical Oper, Tech",S - Sale+OE,$63.00,-6900,18254,-27%,"-$434,700",-2.0,-2.0,1.0,53.0,BIIB
953,,2010-10-04 16:14:35,2010-10-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$56.53,-953,10681,-8%,"-$53,873",2.0,2.0,10.0,29.0,BIIB
954,,2010-09-07 16:05:07,2010-09-04,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$56.24,-1114,45783,-2%,"-$62,651",2.0,3.0,2.0,27.0,BIIB
955,,2010-08-17 16:35:17,2010-08-13,BIIB,Dorsa Caroline,Dir,P - Purchase,$56.41,177,8243,+2%,"+$9,985",-1.0,-4.0,3.0,19.0,BIIB
956,,2010-08-03 16:03:20,2010-08-02,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$56.85,-9542,11634,-45%,"-$542,457",0.0,0.0,-6.0,14.0,BIIB
957,,2010-08-03 16:01:49,2010-08-01,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$55.88,-835,46897,-2%,"-$46,660",0.0,0.0,-6.0,14.0,BIIB
958,,2010-08-03 16:00:17,2010-08-01,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$55.88,-835,41308,-2%,"-$46,660",0.0,0.0,-6.0,14.0,BIIB
959,,2010-08-03 15:58:16,2010-07-30,BIIB,Dorsa Caroline,Dir,P - Purchase,$54.57,183,8066,+2%,"+$9,986",0.0,1.0,-6.0,14.0,BIIB
960,,2010-07-19 14:21:33,2010-07-16,BIIB,Dorsa Caroline,Dir,P - Purchase,$53.71,185,7883,+2%,"+$9,936",3.0,3.0,8.0,30.0,BIIB
961,D,2010-07-19 14:18:25,2010-07-15,BIIB,Scangos George A,CEO,A - Grant,$0.00,63165,63165,New,+$0,3.0,3.0,8.0,30.0,BIIB
962,,2010-07-01 15:58:09,2010-06-30,BIIB,Dorsa Caroline,Dir,P - Purchase,$48.63,205,7698,+3%,"+$9,970",-2.0,7.0,18.0,40.0,BIIB
963,,2010-06-21 16:58:35,2010-06-18,BIIB,Dorsa Caroline,Dir,P - Purchase,$49.15,203,7493,+3%,"+$9,977",0.0,0.0,9.0,37.0,BIIB
964,,2010-06-11 13:17:15,2010-06-09,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,5735,7980,+255%,+$0,-4.0,2.0,7.0,40.0,BIIB
965,D,2010-06-10 19:54:59,2010-06-08,BIIB,Mullen James C,"CEO, Pres",F - Tax,$46.85,-35646,170503,-17%,"-$1,670,015",-4.0,0.0,8.0,40.0,BIIB
966,,2010-06-10 17:18:37,2010-06-09,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,5735,6235,>999%,+$0,-4.0,0.0,8.0,40.0,BIIB
967,,2010-06-10 17:17:45,2010-06-09,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,5735,7980,+255%,+$0,-4.0,0.0,8.0,40.0,BIIB
968,,2010-06-10 17:16:52,2010-06-09,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,5735,10030,+134%,+$0,-4.0,0.0,8.0,40.0,BIIB
969,,2010-06-10 17:15:59,2010-06-09,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,5735,6235,>999%,+$0,-4.0,0.0,8.0,40.0,BIIB
970,,2010-06-10 17:14:53,2010-06-09,BIIB,Posner Brian S,Dir,A - Grant,$0.00,5735,9730,+144%,+$0,-4.0,0.0,8.0,40.0,BIIB
971,,2010-06-10 17:14:04,2010-06-09,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,5735,14080,+69%,+$0,-4.0,0.0,8.0,40.0,BIIB
972,,2010-06-10 17:12:21,2010-06-09,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,5735,7290,+369%,+$0,-4.0,0.0,8.0,40.0,BIIB
973,,2010-06-10 17:11:21,2010-06-09,BIIB,Young William,Dir,A - Grant,$0.00,11470,19315,+146%,+$0,-4.0,0.0,8.0,40.0,BIIB
974,,2010-06-10 17:08:51,2010-06-09,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,5735,15580,+58%,+$0,-4.0,0.0,8.0,40.0,BIIB
975,,2010-06-10 17:07:26,2010-06-09,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,5735,8820,+186%,+$0,-4.0,0.0,8.0,40.0,BIIB
976,,2010-06-10 17:07:26,2010-06-08,BIIB,Leaming Nancy,Dir,S - Sale,$47.62,-900,8820,-9%,"-$42,859",-4.0,0.0,8.0,40.0,BIIB
977,,2010-06-10 17:06:00,2010-06-08,BIIB,Ross Bruce,Dir,S - Sale,$47.62,-2000,9900,-17%,"-$95,244",-4.0,0.0,8.0,40.0,BIIB
978,,2010-06-03 14:24:35,2010-06-01,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$47.22,-1253,47732,-3%,"-$59,167",2.0,-3.0,-3.0,32.0,BIIB
979,,2010-06-01 09:33:48,2010-05-28,BIIB,Dorsa Caroline,Dir,P - Purchase,$48.01,208,1555,+15%,"+$9,986",0.0,0.0,3.0,38.0,BIIB
980,,2010-05-17 15:12:14,2010-05-14,BIIB,Dorsa Caroline,Dir,P - Purchase,$51.19,195,1347,+17%,"+$9,982",1.0,-2.0,-4.0,29.0,BIIB
981,,2010-05-03 14:59:17,2010-04-30,BIIB,Dorsa Caroline,Dir,P - Purchase,$53.38,187,1152,+19%,"+$9,982",1.0,-5.0,-11.0,20.0,BIIB
982,,2010-04-26 16:07:41,2010-04-23,BIIB,Hamm Robert A,COO,S - Sale,$52.19,-5668,27212,-17%,"-$295,830",0.0,2.0,-8.0,12.0,BIIB
983,A,2010-04-20 16:14:18,2010-03-19,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$60.00,-3757,20642,-15%,"-$225,420",-2.0,-3.0,-6.0,7.0,BIIB
984,A,2010-04-16 16:14:32,2010-04-01,BIIB,Hamm Robert A,COO,A - Grant,$0.00,3624,32880,+12%,+$0,2.0,-3.0,-6.0,7.0,BIIB
985,,2010-04-05 15:08:18,2010-04-01,BIIB,Hamm Robert A,COO,F - Tax,$57.52,-1015,29256,-3%,"-$58,383",0.0,-2.0,-7.0,-2.0,BIIB
986,D,2010-03-24 16:03:17,2010-03-22,BIIB,Rowinsky Eric K,Dir,A - Grant,$0.00,500,500,New,+$0,-1.0,-2.0,-11.0,-1.0,BIIB
987,D,2010-03-24 16:02:03,2010-03-22,BIIB,Sherwin Stephen A,Dir,A - Grant,$0.00,500,500,New,+$0,-1.0,-2.0,-11.0,-1.0,BIIB
988,DM,2010-03-23 16:36:57,2010-03-19,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$50.87,440500,206149,-188%,"+$22,408,465",-2.0,-2.0,-12.0,-3.0,BIIB
989,DM,2010-03-23 16:36:57,2010-03-19,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$59.97,-440500,206149,-68%,"-$26,415,659",-2.0,-2.0,-12.0,-3.0,BIIB
990,,2010-03-23 16:34:49,2010-03-19,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$60.00,-4085,20314,-17%,"-$245,100",-2.0,-2.0,-12.0,-3.0,BIIB
991,,2010-03-04 13:28:53,2010-03-03,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$57.33,-4255,21042,-17%,"-$243,954",0.0,3.0,1.0,-5.0,BIIB
992,,2010-03-04 13:27:57,2010-03-02,BIIB,Lytton Michael,"EVP Corporate, Business Devel",A - Grant,$0.00,10499,18869,+125%,+$0,0.0,3.0,1.0,-5.0,BIIB
993,,2010-03-04 13:27:57,2010-03-02,BIIB,Lytton Michael,"EVP Corporate, Business Devel",F - Tax,$57.31,-2235,18869,-11%,"-$128,088",0.0,3.0,1.0,-5.0,BIIB
994,,2010-03-01 15:09:12,2010-02-25,BIIB,Mullen James C,"CEO, Pres",A - Grant,$0.00,48961,206149,+31%,+$0,3.0,4.0,6.0,-2.0,BIIB
995,,2010-03-01 15:09:12,2010-02-25,BIIB,Mullen James C,"CEO, Pres",F - Tax,$54.89,-13698,206149,-6%,"-$751,883",3.0,4.0,6.0,-2.0,BIIB
996,D,2010-02-25 17:13:25,2010-02-24,BIIB,Alexander Susan H,"EVP, GC",A - Grant,$0.00,9306,42143,+28%,+$0,0.0,3.0,6.0,-2.0,BIIB
997,D,2010-02-25 17:13:25,2010-02-24,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$55.29,-1981,42143,-4%,"-$109,529",0.0,3.0,6.0,-2.0,BIIB
998,D,2010-02-25 17:12:25,2010-02-24,BIIB,Hamm Robert A,COO,A - Grant,$0.00,9306,30271,+44%,+$0,0.0,3.0,6.0,-2.0,BIIB
999,D,2010-02-25 17:12:25,2010-02-24,BIIB,Hamm Robert A,COO,F - Tax,$55.29,-1981,30271,-6%,"-$109,529",0.0,3.0,6.0,-2.0,BIIB
1000,D,2010-02-25 17:10:35,2010-02-24,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",A - Grant,$0.00,9306,25297,+58%,+$0,0.0,3.0,6.0,-2.0,BIIB
1001,D,2010-02-25 17:10:35,2010-02-24,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$55.29,-1981,25297,-7%,"-$109,529",0.0,3.0,6.0,-2.0,BIIB
1002,D,2010-02-25 17:09:28,2010-02-24,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",A - Grant,$0.00,3990,24399,+20%,+$0,0.0,3.0,6.0,-2.0,BIIB
1003,D,2010-02-25 17:09:28,2010-02-24,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$55.29,-850,24399,-3%,"-$46,997",0.0,3.0,6.0,-2.0,BIIB
1004,D,2010-02-25 17:08:24,2010-02-24,BIIB,Clancy Paul J,"EVP, CFO",A - Grant,$0.00,9970,48985,+26%,+$0,0.0,3.0,6.0,-2.0,BIIB
1005,D,2010-02-25 17:08:24,2010-02-24,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$55.29,-2122,48985,-4%,"-$117,325",0.0,3.0,6.0,-2.0,BIIB
1006,,2010-02-19 14:55:16,2010-02-18,BIIB,Hamm Robert A,COO,S - Sale,$56.16,-6581,22946,-22%,"-$369,556",1.0,-2.0,7.0,1.0,BIIB
1007,,2010-02-19 14:53:32,2010-02-18,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$56.16,-6552,17972,-27%,"-$367,932",1.0,-2.0,7.0,1.0,BIIB
1008,,2010-02-17 16:13:37,2010-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$55.21,-2756,34818,-7%,"-$152,159",0.0,-2.0,6.0,-1.0,BIIB
1009,,2010-02-17 16:11:55,2010-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$55.21,-2454,41137,-6%,"-$135,485",0.0,-2.0,6.0,-1.0,BIIB
1010,,2010-02-17 16:10:55,2010-02-12,BIIB,Hamm Robert A,COO,F - Tax,$55.21,-3099,29527,-9%,"-$171,096",0.0,-2.0,6.0,-1.0,BIIB
1011,,2010-02-17 16:09:43,2010-02-12,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$55.21,-2002,21259,-9%,"-$110,530",0.0,-2.0,6.0,-1.0,BIIB
1012,,2010-02-17 16:08:39,2010-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$55.21,-3128,24524,-11%,"-$172,697",0.0,-2.0,6.0,-1.0,BIIB
1013,,2010-02-17 16:07:23,2010-02-13,BIIB,Mullen James C,"CEO, Pres",F - Tax,$55.21,-16435,170886,-9%,"-$907,376",0.0,-2.0,6.0,-1.0,BIIB
1014,,2010-01-19 14:24:33,2010-01-19,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$55.00,-1389,23261,-6%,"-$76,395",2.0,-3.0,4.0,-2.0,BIIB
1015,D,2010-01-06 12:09:55,2010-01-04,BIIB,Dorsa Caroline,Dir,A - Grant,$0.00,965,965,New,+$0,0.0,0.0,-1.0,-7.0,BIIB
1016,D,2009-12-24 14:37:22,2009-12-24,BIIB,Pangia Robert W,Dir,M - OptEx,$31.08,15000,8345,-225%,"+$466,250",0.0,3.0,2.0,-5.0,BIIB
1017,D,2009-12-24 14:37:22,2009-12-24,BIIB,Pangia Robert W,Dir,S - Sale+OE,$52.15,-15000,8345,-64%,"-$782,219",0.0,3.0,2.0,-5.0,BIIB
1018,,2009-12-18 16:01:08,2009-12-16,BIIB,Mullen James C,"CEO, Pres",S - Sale,$50.18,-147037,187321,-44%,"-$7,378,302",2.0,4.0,9.0,-1.0,BIIB
1019,,2009-11-05 14:50:32,2009-11-04,BIIB,Hamm Robert A,COO,S - Sale,$42.81,-2854,32626,-8%,"-$122,173",4.0,8.0,13.0,18.0,BIIB
1020,,2009-11-03 14:20:08,2009-11-01,BIIB,Hamm Robert A,COO,F - Tax,$42.13,-2046,35480,-5%,"-$86,198",2.0,7.0,12.0,24.0,BIIB
1021,D,2009-11-03 14:18:22,2009-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$42.13,-418,24650,-2%,"-$17,610",2.0,7.0,12.0,24.0,BIIB
1022,D,2009-11-03 14:18:22,2009-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",M - OptEx,$0.00,1000,24650,+4%,+$0,2.0,7.0,12.0,24.0,BIIB
1023,,2009-10-05 14:18:42,2009-10-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$49.34,-953,24068,-4%,"-$47,021",-1.0,0.0,-13.0,18.0,BIIB
1024,,2009-10-05 14:15:31,2009-10-02,BIIB,Pickett Cecil B,"Pres, R, D",F - Tax,$48.89,-18704,88732,-17%,"-$914,439",-1.0,0.0,-13.0,18.0,BIIB
1025,D,2009-09-30 16:53:42,2009-09-29,BIIB,Pangia Robert W,Dir,M - OptEx,$31.08,15000,8345,-225%,"+$466,250",-2.0,-3.0,-14.0,13.0,BIIB
1026,D,2009-09-30 16:53:42,2009-09-29,BIIB,Pangia Robert W,Dir,S - Sale+OE,$52.00,-15000,8345,-64%,"-$780,000",-2.0,-3.0,-14.0,13.0,BIIB
1027,,2009-09-08 11:44:13,2009-09-04,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$51.01,-1114,43591,-2%,"-$56,825",0.0,0.0,-4.0,13.0,BIIB
1028,A,2009-08-17 17:14:41,2009-04-08,BIIB,Pickett Cecil B,"Pres, R, D",S - Sale,$54.50,-17398,107436,-14%,"-$948,191",0.0,4.0,6.0,14.0,BIIB
1029,,2009-08-03 16:27:43,2009-08-01,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$47.55,-1183,44705,-3%,"-$56,252",1.0,-2.0,4.0,12.0,BIIB
1030,,2009-08-03 16:21:50,2009-08-01,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$47.55,-835,37574,-2%,"-$39,704",1.0,-2.0,4.0,12.0,BIIB
1031,,2009-06-25 08:39:41,2009-06-24,BIIB,Ross Bruce,Dir,S - Sale,$48.53,-1700,11900,-13%,"-$82,497",2.0,-5.0,-1.0,6.0,BIIB
1032,,2009-06-25 08:37:44,2009-06-24,BIIB,Leaming Nancy,Dir,S - Sale,$48.52,-820,3985,-17%,"-$39,788",2.0,-5.0,-1.0,6.0,BIIB
1033,,2009-06-24 11:26:11,2009-06-22,BIIB,Hamm Robert A,COO,S - Sale,$50.07,-3194,37526,-8%,"-$159,911",1.0,-7.0,0.0,5.0,BIIB
1034,D,2009-06-12 16:20:37,2009-06-10,BIIB,Denner Alexander J,Dir,A - Grant,$0.00,2245,2245,New,+$0,-2.0,1.0,-10.0,-6.0,BIIB
1035,D,2009-06-11 14:40:13,2009-06-10,BIIB,Mulligan Richard,Dir,A - Grant,$0.00,2245,2245,New,+$0,0.0,0.0,-13.0,-7.0,BIIB
1036,D,2009-06-11 12:50:31,2009-06-10,BIIB,Young William,Dir,A - Grant,$0.00,2245,7845,+40%,+$0,0.0,0.0,-13.0,-7.0,BIIB
1037,D,2009-06-11 12:49:06,2009-06-10,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,2245,8345,+37%,+$0,0.0,0.0,-13.0,-7.0,BIIB
1038,D,2009-06-05 11:12:15,2009-06-03,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,2245,4295,+110%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1039,D,2009-06-05 11:11:13,2009-06-03,BIIB,Ross Bruce,Dir,A - Grant,$0.00,4490,13600,+49%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1040,D,2009-06-05 11:10:23,2009-06-03,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,2245,4805,+88%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1041,D,2009-06-05 11:09:29,2009-06-03,BIIB,Posner Brian S,Dir,A - Grant,$0.00,2245,3995,+128%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1042,D,2009-06-05 11:08:03,2009-06-03,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,2245,9845,+30%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1043,D,2009-06-05 11:07:10,2009-06-03,BIIB,Sharp Philip A,Dir,A - Grant,$0.00,2245,470278,0%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1044,D,2009-06-05 11:06:13,2009-06-03,BIIB,Dekkers Marijn E,Dir,A - Grant,$0.00,2245,6595,+52%,+$0,-2.0,-3.0,-15.0,-10.0,BIIB
1045,,2009-06-03 14:57:01,2009-06-01,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$50.90,-1253,45888,-3%,"-$63,778",2.0,0.0,-11.0,-10.0,BIIB
1046,,2009-04-09 15:11:47,2009-04-08,BIIB,Pickett Cecil B,"Pres, R, D",S - Sale,$54.50,-17398,98737,-15%,"-$948,191",-1.0,-4.0,-9.0,-8.0,BIIB
1047,D,2009-04-02 15:39:29,2009-04-01,BIIB,Hamm Robert A,COO,A - Grant,$0.00,3660,40720,+10%,+$0,1.0,3.0,-11.0,-3.0,BIIB
1048,D,2009-02-26 17:46:54,2009-02-25,BIIB,Mullen James C,"CEO, Pres",A - Grant,$0.00,49455,334358,+17%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1049,,2009-02-26 17:40:17,2009-02-24,BIIB,Pickett Cecil B,"Pres, R, D",A - Grant,$0.00,30000,124834,+32%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1050,,2009-02-26 17:40:17,2009-02-24,BIIB,Pickett Cecil B,"Pres, R, D",F - Tax,$49.65,-12525,124834,-9%,"-$621,866",-3.0,-3.0,10.0,4.0,BIIB
1051,D,2009-02-26 17:33:32,2009-02-24,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",A - Grant,$0.00,9400,27230,+53%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1052,D,2009-02-26 17:32:33,2009-02-24,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",A - Grant,$0.00,4030,24600,+20%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1053,D,2009-02-26 17:31:20,2009-02-24,BIIB,Hasler Hans Peter,COO,A - Grant,$0.00,20140,53261,+61%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1054,D,2009-02-26 17:30:22,2009-02-24,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",A - Grant,$0.00,9400,37060,+34%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1055,D,2009-02-26 17:28:47,2009-02-24,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,6040,24752,+32%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1056,D,2009-02-26 17:27:30,2009-02-24,BIIB,Clancy Paul J,"EVP, CFO",A - Grant,$0.00,10070,47141,+27%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1057,D,2009-02-26 17:26:30,2009-02-24,BIIB,Alexander Susan H,"EVP, GC",A - Grant,$0.00,9400,38409,+32%,+$0,-3.0,-3.0,10.0,4.0,BIIB
1058,,2009-02-20 16:27:51,2009-02-19,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale,$50.90,-3412,27660,-11%,"-$173,675",-3.0,-6.0,-2.0,-3.0,BIIB
1059,,2009-02-20 16:26:35,2009-02-19,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$50.90,-3208,18712,-15%,"-$163,301",-3.0,-6.0,-2.0,-3.0,BIIB
1060,,2009-02-20 16:25:04,2009-02-19,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$50.93,-6606,17830,-27%,"-$336,453",-3.0,-6.0,-2.0,-3.0,BIIB
1061,,2009-02-20 16:23:20,2009-02-19,BIIB,Hasler Hans Peter,COO,S - Sale,$50.94,-11693,26858,-30%,"-$595,672",-3.0,-6.0,-2.0,-3.0,BIIB
1062,DM,2009-02-17 14:49:27,2009-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$52.56,-3550,27792,-11%,"-$186,605",-3.0,-6.0,-5.0,-7.0,BIIB
1063,D,2009-02-17 14:49:27,2009-02-15,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,2666,27792,+11%,+$0,-3.0,-6.0,-5.0,-7.0,BIIB
1064,,2009-02-17 14:48:10,2009-02-12,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$52.61,-2007,20570,-9%,"-$105,588",-3.0,-6.0,-5.0,-7.0,BIIB
1065,,2009-02-17 14:45:46,2009-02-12,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$52.61,-2402,35410,-6%,"-$126,369",-3.0,-6.0,-5.0,-7.0,BIIB
1066,,2009-02-17 14:43:30,2009-02-13,BIIB,Mullen James C,"CEO, Pres",F - Tax,$52.42,-17995,284903,-6%,"-$943,298",-3.0,-6.0,-5.0,-7.0,BIIB
1067,,2009-02-17 14:40:38,2009-02-12,BIIB,Hasler Hans Peter,COO,F - Tax,$52.61,-754,44814,-2%,"-$39,668",-3.0,-6.0,-5.0,-7.0,BIIB
1068,,2009-02-17 14:39:52,2009-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$52.61,-3074,24436,-11%,"-$161,723",-3.0,-6.0,-5.0,-7.0,BIIB
1069,,2009-02-17 14:39:05,2009-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$52.61,-3074,31072,-9%,"-$161,723",-3.0,-6.0,-5.0,-7.0,BIIB
1070,,2009-02-17 14:38:15,2009-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$52.61,-3036,21920,-12%,"-$159,724",-3.0,-6.0,-5.0,-7.0,BIIB
1071,,2009-02-13 16:17:59,2009-02-11,BIIB,Hasler Hans Peter,COO,S - Sale,$50.77,-5135,45568,-10%,"-$260,699",-2.0,-3.0,-9.0,-7.0,BIIB
1072,,2009-02-13 16:11:20,2009-02-11,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$50.81,-2258,24956,-8%,"-$114,729",-2.0,-3.0,-9.0,-7.0,BIIB
1073,,2009-02-13 16:09:37,2009-02-11,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$50.76,-5400,27510,-16%,"-$274,087",-2.0,-3.0,-9.0,-7.0,BIIB
1074,,2009-02-13 16:07:57,2009-02-11,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale,$50.76,-3670,34146,-10%,"-$186,282",-2.0,-3.0,-9.0,-7.0,BIIB
1075,D,2009-02-10 15:02:47,2009-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$52.48,-1375,27214,-5%,"-$72,160",-2.0,-2.0,-12.0,-8.0,BIIB
1076,D,2009-02-10 15:02:47,2009-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$0.00,3633,27214,+15%,+$0,-2.0,-2.0,-12.0,-8.0,BIIB
1077,D,2009-02-10 15:01:06,2009-02-07,BIIB,Mullen James C,"CEO, Pres",F - Tax,$52.48,-9228,302898,-3%,"-$484,285",-2.0,-2.0,-12.0,-8.0,BIIB
1078,D,2009-02-10 15:01:06,2009-02-07,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$0.00,26666,302898,+10%,+$0,-2.0,-2.0,-12.0,-8.0,BIIB
1079,,2009-02-10 15:00:05,2009-02-06,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$52.48,-529,39473,-1%,"-$27,762",-2.0,-2.0,-12.0,-8.0,BIIB
1080,D,2009-02-10 14:57:48,2009-02-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$52.48,-1796,37816,-5%,"-$94,254",-2.0,-2.0,-12.0,-8.0,BIIB
1081,D,2009-02-10 14:57:48,2009-02-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",M - OptEx,$0.00,5466,37816,+17%,+$0,-2.0,-2.0,-12.0,-8.0,BIIB
1082,D,2009-02-10 14:56:37,2009-02-06,BIIB,Hasler Hans Peter,COO,F - Tax,$52.48,-331,50703,-1%,"-$17,371",-2.0,-2.0,-12.0,-8.0,BIIB
1083,D,2009-02-10 14:56:37,2009-02-06,BIIB,Hasler Hans Peter,COO,M - OptEx,$0.00,5466,50703,+12%,+$0,-2.0,-2.0,-12.0,-8.0,BIIB
1084,D,2009-02-10 14:55:31,2009-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$52.48,-2600,32910,-7%,"-$136,448",-2.0,-2.0,-12.0,-8.0,BIIB
1085,D,2009-02-10 14:55:31,2009-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$0.00,8000,32910,+32%,+$0,-2.0,-2.0,-12.0,-8.0,BIIB
1086,,2009-02-06 09:54:52,2009-02-04,BIIB,Pickett Cecil B,"Pres, R, D",S - Sale,$53.00,-8698,107359,-7%,"-$460,994",-2.0,-1.0,-18.0,-12.0,BIIB
1087,D,2009-02-03 15:32:43,2009-01-30,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$48.65,-1146,29893,-4%,"-$55,753",5.0,4.0,-8.0,-3.0,BIIB
1088,D,2009-02-03 15:32:43,2009-01-30,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3333,29893,+13%,+$0,5.0,4.0,-8.0,-3.0,BIIB
1089,,2009-01-13 15:57:41,2009-01-13,BIIB,Leaming Nancy,Dir,S - Sale,$48.43,-340,2560,-12%,"-$16,466",-1.0,2.0,5.0,-5.0,BIIB
1090,,2008-11-07 14:36:49,2008-11-06,BIIB,Hasler Hans Peter,COO,S - Sale,$44.31,-845,45568,-2%,"-$37,446",4.0,5.0,8.0,10.0,BIIB
1091,,2008-11-07 14:33:42,2008-11-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale,$44.57,-2855,34146,-8%,"-$127,253",4.0,5.0,8.0,10.0,BIIB
1092,,2008-11-04 14:32:56,2008-11-01,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$42.55,-2045,37001,-5%,"-$87,015",2.0,1.0,-9.0,1.0,BIIB
1093,,2008-11-04 14:31:40,2008-11-01,BIIB,Hasler Hans Peter,COO,F - Tax,$42.55,-55,46413,0%,"-$2,340",2.0,1.0,-9.0,1.0,BIIB
1094,D,2008-11-04 14:29:58,2008-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$42.55,-318,22577,-1%,"-$13,531",2.0,1.0,-9.0,1.0,BIIB
1095,D,2008-11-04 14:29:58,2008-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",M - OptEx,$0.00,1000,22577,+5%,+$0,2.0,1.0,-9.0,1.0,BIIB
1096,,2008-10-06 17:06:56,2008-10-06,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$50.00,-2047,21895,-9%,"-$102,350",-6.0,-13.0,-6.0,0.0,BIIB
1097,,2008-10-06 09:19:39,2008-10-02,BIIB,Pickett Cecil B,"Pres, R, D",F - Tax,$49.68,-18704,116057,-14%,"-$929,215",-2.0,-15.0,-8.0,-2.0,BIIB
1098,,2008-10-02 15:27:00,2008-10-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$49.59,-953,23942,-4%,"-$47,259",0.0,-7.0,-19.0,5.0,BIIB
1099,,2008-09-29 15:21:36,2008-09-26,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$50.00,-734,22780,-3%,"-$36,700",-2.0,1.0,-19.0,6.0,BIIB
1100,,2008-09-23 10:37:12,2008-09-19,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$50.00,-1553,40002,-4%,"-$77,650",-2.0,2.0,-9.0,6.0,BIIB
1101,,2008-09-08 11:10:41,2008-09-04,BIIB,Clancy Paul J,"EVP, CFO",F - Tax,$48.16,-1114,41555,-3%,"-$53,650",-2.0,0.0,2.0,-10.0,BIIB
1102,,2008-08-11 13:10:04,2008-08-08,BIIB,Clancy Paul J,"EVP, CFO",S - Sale,$50.66,-568,42669,-1%,"-$28,777",2.0,10.0,-6.0,5.0,BIIB
1103,,2008-08-05 11:28:45,2008-07-29,BIIB,Dunn John Michael,"EVP, New Ventures",G - Gift,$0.00,-32,24956,0%,-$0,2.0,2.0,1.0,5.0,BIIB
1104,,2008-08-05 11:28:11,2008-08-01,BIIB,Clancy Paul J,CFO,A - Grant,$0.00,6000,43237,+16%,+$0,2.0,2.0,1.0,5.0,BIIB
1105,,2008-08-05 11:28:11,2008-08-01,BIIB,Clancy Paul J,CFO,F - Tax,$50.01,-265,43237,-1%,"-$13,253",2.0,2.0,1.0,5.0,BIIB
1106,,2008-08-05 11:27:25,2008-08-01,BIIB,Alexander Susan H,"EVP, GC",A - Grant,$0.00,6000,27706,+28%,+$0,2.0,2.0,1.0,5.0,BIIB
1107,D,2008-08-01 12:07:07,2008-07-31,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",M - OptEx,$47.77,1875,24895,+8%,"+$89,569",-29.0,-28.0,-27.0,-30.0,BIIB
1108,D,2008-08-01 12:07:07,2008-07-31,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale+OE,$72.77,-1875,24895,-7%,"-$136,444",-29.0,-28.0,-27.0,-30.0,BIIB
1109,D,2008-07-28 13:31:54,2008-07-25,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,1603,23514,+7%,"+$56,698",0.0,-28.0,-23.0,-30.0,BIIB
1110,D,2008-07-24 17:13:26,2008-07-23,BIIB,Posner Brian S,Dir,A - Grant,$0.00,1750,1750,New,+$0,-3.0,0.0,-25.0,-29.0,BIIB
1111,M,2008-07-24 09:10:18,2008-07-22,BIIB,Pickett Cecil B,"Pres, R, D",S - Sale,$70.50,-28162,134761,-17%,"-$1,985,502",0.0,0.0,-26.0,-29.0,BIIB
1112,,2008-07-24 09:07:37,2008-07-22,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$70.00,-682,24895,-3%,"-$47,740",0.0,0.0,-26.0,-29.0,BIIB
1113,D,2008-07-24 09:06:16,2008-07-22,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",M - OptEx,$49.31,12950,46468,+39%,"+$638,565",0.0,0.0,-26.0,-29.0,BIIB
1114,D,2008-07-24 09:06:16,2008-07-22,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",S - Sale+OE,$69.31,-12950,46468,-22%,"-$897,565",0.0,0.0,-26.0,-29.0,BIIB
1115,D,2008-07-24 09:03:40,2008-07-22,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",M - OptEx,$52.27,156086,39046,-133%,"+$8,158,826",0.0,0.0,-26.0,-29.0,BIIB
1116,D,2008-07-24 09:03:40,2008-07-22,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale+OE,$70.00,-156086,39046,-80%,"-$10,926,020",0.0,0.0,-26.0,-29.0,BIIB
1117,D,2008-07-24 09:01:27,2008-07-22,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$43.50,6485,24988,+35%,"+$282,098",0.0,0.0,-26.0,-29.0,BIIB
1118,D,2008-07-24 09:01:27,2008-07-22,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$71.50,-6485,24988,-21%,"-$463,678",0.0,0.0,-26.0,-29.0,BIIB
1119,,2008-07-24 08:58:56,2008-07-22,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$70.00,-2000,21706,-8%,"-$140,000",0.0,0.0,-26.0,-29.0,BIIB
1120,A,2008-07-22 13:05:03,2008-07-21,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$43.50,6485,31473,+26%,"+$282,098",7.0,4.0,-19.0,-26.0,BIIB
1121,DE,2008-07-22 11:28:30,2008-07-21,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$0.67,6485,24988,+35%,"+$4,350",7.0,4.0,-19.0,-26.0,BIIB
1122,DE,2008-07-22 11:28:30,2008-07-21,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$67.50,-6485,24988,-21%,"-$437,738",7.0,4.0,-19.0,-26.0,BIIB
1123,D,2008-07-22 11:27:00,2008-07-21,BIIB,Sharp Philip A,Dir,M - OptEx,$35.42,72500,468033,+18%,"+$2,567,950",7.0,4.0,-19.0,-26.0,BIIB
1124,D,2008-07-22 11:27:00,2008-07-21,BIIB,Sharp Philip A,Dir,S - Sale+OE,$68.00,-72500,468033,-13%,"-$4,930,000",7.0,4.0,-19.0,-26.0,BIIB
1125,D,2008-07-16 14:43:16,2008-07-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$59.39,6250,21911,+40%,"+$371,188",0.0,12.0,-17.0,-22.0,BIIB
1126,D,2008-07-16 14:43:16,2008-07-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$64.00,-6250,21911,-22%,"-$400,000",0.0,12.0,-17.0,-22.0,BIIB
1127,D,2008-07-10 14:08:08,2008-07-09,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",M - OptEx,$45.87,30175,25454,-639%,"+$1,384,248",0.0,4.0,-18.0,-23.0,BIIB
1128,D,2008-07-10 14:08:08,2008-07-09,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",S - Sale+OE,$62.07,-36837,25454,-59%,"-$2,286,605",0.0,4.0,-18.0,-23.0,BIIB
1129,D,2008-07-09 13:54:51,2008-07-09,BIIB,Sharp Philip A,Dir,A - Grant,$0.00,2050,468033,0%,+$0,-3.0,1.0,-20.0,-26.0,BIIB
1130,D,2008-07-09 13:53:53,2008-07-09,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,2050,7600,+37%,+$0,-3.0,1.0,-20.0,-26.0,BIIB
1131,,2008-07-09 13:52:59,2008-07-08,BIIB,Alexander Susan H,"EVP, GC",S - Sale,$60.00,-8599,23706,-27%,"-$515,940",-3.0,1.0,-20.0,-26.0,BIIB
1132,D,2008-07-09 13:50:41,2008-07-09,BIIB,Papadopoulos Stelios,Dir,A - Grant,$0.00,2050,2050,New,+$0,-3.0,1.0,-20.0,-26.0,BIIB
1133,,2008-07-02 10:35:17,2008-07-01,BIIB,Clancy Paul J,CFO,S - Sale,$56.01,-4208,37502,-10%,"-$235,679",-2.0,3.0,18.0,-20.0,BIIB
1134,D,2008-06-23 16:14:47,2008-06-19,BIIB,Young William,Dir,A - Grant,$0.00,2050,5600,+58%,+$0,2.0,1.0,25.0,-15.0,BIIB
1135,D,2008-06-23 16:14:05,2008-06-19,BIIB,Ross Bruce,Dir,A - Grant,$0.00,4100,9110,+82%,+$0,2.0,1.0,25.0,-15.0,BIIB
1136,D,2008-06-23 16:11:55,2008-06-19,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,2050,6100,+51%,+$0,2.0,1.0,25.0,-15.0,BIIB
1137,D,2008-06-23 16:11:04,2008-06-19,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,2050,2900,+241%,+$0,2.0,1.0,25.0,-15.0,BIIB
1138,D,2008-06-23 16:10:20,2008-06-19,BIIB,Glassberg Alan,Dir,A - Grant,$0.00,2050,5600,+58%,+$0,2.0,1.0,25.0,-15.0,BIIB
1139,D,2008-06-23 16:09:04,2008-06-19,BIIB,Dekkers Marijn E,Dir,A - Grant,$0.00,2050,4350,+89%,+$0,2.0,1.0,25.0,-15.0,BIIB
1140,D,2008-06-23 16:08:18,2008-06-19,BIIB,Best Lawrence C,Dir,A - Grant,$0.00,2050,5600,+58%,+$0,2.0,1.0,25.0,-15.0,BIIB
1141,,2008-06-04 15:20:26,2008-06-04,BIIB,Ross Bruce,Dir,S - Sale,$61.52,-1840,5010,-27%,"-$113,197",1.0,-2.0,-5.0,-37.0,BIIB
1142,D,2008-06-03 17:07:27,2008-06-02,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,1558,24962,+7%,"+$55,106",1.0,-1.0,-4.0,-32.0,BIIB
1143,D,2008-06-03 17:05:27,2008-06-02,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",A - Grant,$0.00,4400,46468,+10%,+$0,1.0,-1.0,-4.0,-32.0,BIIB
1144,,2008-06-02 15:53:51,2008-06-01,BIIB,Clancy Paul J,CFO,F - Tax,$62.75,-953,41710,-2%,"-$59,801",-2.0,-1.0,-11.0,-33.0,BIIB
1145,D,2008-05-01 11:03:02,2008-04-29,BIIB,Glassberg Alan,Dir,M - OptEx,$31.08,10000,3550,-155%,"+$310,833",3.0,2.0,3.0,-30.0,BIIB
1146,D,2008-05-01 11:03:02,2008-04-29,BIIB,Glassberg Alan,Dir,S - Sale+OE,$61.65,-10000,3550,-74%,"-$616,511",3.0,2.0,3.0,-30.0,BIIB
1147,,2008-04-17 12:05:07,2008-04-15,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale,$63.82,-3413,39046,-8%,"-$217,804",0.0,-2.0,-5.0,-31.0,BIIB
1148,D,2008-04-17 12:03:53,2008-04-15,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$44.59,12800,285460,+5%,"+$570,752",0.0,-2.0,-5.0,-31.0,BIIB
1149,D,2008-04-17 12:03:53,2008-04-15,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$64.95,-12800,285460,-4%,"-$831,360",0.0,-2.0,-5.0,-31.0,BIIB
1150,D,2008-04-15 15:09:23,2008-04-14,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$44.59,200,285460,0%,"+$8,918",2.0,2.0,-2.0,-33.0,BIIB
1151,DM,2008-04-15 15:09:23,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$65.22,-56370,285460,-16%,"-$3,676,265",2.0,2.0,-2.0,-33.0,BIIB
1152,,2008-04-15 15:08:18,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale,$65.02,-197315,341630,-37%,"-$12,829,104",2.0,2.0,-2.0,-33.0,BIIB
1153,,2008-04-15 15:07:19,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale,$64.89,-195162,538945,-27%,"-$12,664,864",2.0,2.0,-2.0,-33.0,BIIB
1154,,2008-04-15 15:06:15,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale,$64.57,-102019,734107,-12%,"-$6,586,855",2.0,2.0,-2.0,-33.0,BIIB
1155,,2008-04-15 15:05:21,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale,$64.38,-121157,836126,-13%,"-$7,800,280",2.0,2.0,-2.0,-33.0,BIIB
1156,D,2008-04-15 15:04:01,2008-04-11,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$41.24,745750,957283,+353%,"+$30,751,255",2.0,2.0,-2.0,-33.0,BIIB
1157,D,2008-04-15 15:04:01,2008-04-11,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$64.22,-73927,957283,-7%,"-$4,747,643",2.0,2.0,-2.0,-33.0,BIIB
1158,,2008-04-15 15:02:33,2008-04-14,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$64.20,-3212,23404,-12%,"-$206,196",2.0,2.0,-2.0,-33.0,BIIB
1159,,2008-04-10 15:02:47,2008-04-08,BIIB,Sharp Philip A,Dir,S - Sale,$64.86,-7500,465983,-2%,"-$486,470",3.0,2.0,-3.0,-28.0,BIIB
1160,,2008-04-10 15:01:50,2008-04-08,BIIB,Sharp Philip A,Dir,S - Sale,$64.61,-15650,473483,-3%,"-$1,011,198",3.0,2.0,-3.0,-28.0,BIIB
1161,D,2008-04-10 15:00:22,2008-04-08,BIIB,Sharp Philip A,Dir,M - OptEx,$35.42,100000,489133,+26%,"+$3,542,000",3.0,2.0,-3.0,-28.0,BIIB
1162,D,2008-04-10 15:00:22,2008-04-08,BIIB,Sharp Philip A,Dir,S - Sale+OE,$64.75,-76850,489133,-14%,"-$4,976,151",3.0,2.0,-3.0,-28.0,BIIB
1163,,2008-04-10 14:58:46,2008-04-08,BIIB,Pangia Robert W,Dir,S - Sale,$64.75,-11000,4050,-73%,"-$712,234",3.0,2.0,-3.0,-28.0,BIIB
1164,D,2008-04-10 14:57:31,2008-04-08,BIIB,Pangia Robert W,Dir,M - OptEx,$7.79,30000,15050,-201%,"+$233,751",3.0,2.0,-3.0,-28.0,BIIB
1165,D,2008-04-10 14:57:31,2008-04-08,BIIB,Pangia Robert W,Dir,S - Sale+OE,$64.31,-19000,15050,-56%,"-$1,221,959",3.0,2.0,-3.0,-28.0,BIIB
1166,,2008-04-10 14:56:06,2008-04-08,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",S - Sale,$64.53,-7663,42068,-15%,"-$494,486",3.0,2.0,-3.0,-28.0,BIIB
1167,D,2008-04-10 14:54:25,2008-04-08,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",M - OptEx,$43.94,17094,49731,+52%,"+$751,156",3.0,2.0,-3.0,-28.0,BIIB
1168,D,2008-04-10 14:54:25,2008-04-08,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",S - Sale+OE,$64.14,-20830,49731,-30%,"-$1,336,106",3.0,2.0,-3.0,-28.0,BIIB
1169,,2008-04-10 14:52:56,2008-04-08,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",S - Sale,$64.47,-6425,32116,-17%,"-$414,208",3.0,2.0,-3.0,-28.0,BIIB
1170,,2008-04-10 14:51:46,2008-04-08,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",S - Sale,$64.37,-2214,25577,-8%,"-$142,508",3.0,2.0,-3.0,-28.0,BIIB
1171,A,2008-03-07 17:02:55,2007-10-15,BIIB,Keller Thomas F,Dir,S - Sale,$82.00,-10350,1250,-89%,"-$848,700",-3.0,8.0,13.0,-14.0,BIIB
1172,,2008-03-07 12:33:38,2008-03-03,BIIB,Dunn John Michael,"EVP, New Ventures",G - Gift,$0.00,-45,26178,0%,-$0,-1.0,7.0,13.0,-15.0,BIIB
1173,,2008-02-22 13:29:00,2008-02-21,BIIB,Clancy Paul J,CFO,S - Sale,$60.22,-2183,42663,-5%,"-$131,461",0.0,1.0,2.0,-10.0,BIIB
1174,,2008-02-20 13:33:36,2008-02-19,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$63.20,-3344,26586,-11%,"-$211,330",1.0,1.0,-4.0,-10.0,BIIB
1175,,2008-02-19 16:54:01,2008-02-17,BIIB,Clancy Paul J,CFO,F - Tax,$62.20,-1017,44846,-2%,"-$63,257",1.0,1.0,-1.0,-10.0,BIIB
1176,D,2008-02-19 16:49:39,2008-02-15,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$62.20,-847,32305,-3%,"-$52,683",1.0,1.0,-1.0,-10.0,BIIB
1177,D,2008-02-19 16:49:39,2008-02-15,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,2667,32305,+9%,+$0,1.0,1.0,-1.0,-10.0,BIIB
1178,A,2008-02-15 15:43:00,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",A - Grant,$0.00,10430,21447,+95%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1179,A,2008-02-15 15:43:00,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$60.56,-1218,21447,-5%,"-$73,762",-1.0,-4.0,-7.0,-15.0,BIIB
1180,A,2008-02-15 15:43:00,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$60.95,-4286,21447,-17%,"-$261,239",-1.0,-4.0,-7.0,-15.0,BIIB
1181,A,2008-02-15 15:40:18,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",A - Grant,$0.00,14040,33590,+72%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1182,A,2008-02-15 15:40:18,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$60.56,-1656,33590,-5%,"-$100,287",-1.0,-4.0,-7.0,-15.0,BIIB
1183,A,2008-02-15 15:40:18,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$49.31,9725,33590,+41%,"+$479,540",-1.0,-4.0,-7.0,-15.0,BIIB
1184,A,2008-02-15 15:40:18,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$60.95,-11934,33590,-26%,"-$727,434",-1.0,-4.0,-7.0,-15.0,BIIB
1185,A,2008-02-15 15:38:02,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",A - Grant,$0.00,14040,42459,+49%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1186,A,2008-02-15 15:38:02,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$60.56,-1587,42459,-4%,"-$96,109",-1.0,-4.0,-7.0,-15.0,BIIB
1187,A,2008-02-15 15:38:02,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale,$60.91,-3679,42459,-8%,"-$224,100",-1.0,-4.0,-7.0,-15.0,BIIB
1188,A,2008-02-15 15:35:09,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,10430,26223,+66%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1189,A,2008-02-15 15:35:09,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$60.56,-1788,26223,-6%,"-$108,281",-1.0,-4.0,-7.0,-15.0,BIIB
1190,A,2008-02-15 15:35:09,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$60.96,-2267,26223,-8%,"-$138,202",-1.0,-4.0,-7.0,-15.0,BIIB
1191,A,2008-02-15 15:32:09,2008-02-12,BIIB,Clancy Paul J,CFO,A - Grant,$0.00,15690,45863,+52%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1192,A,2008-02-15 15:32:09,2008-02-12,BIIB,Clancy Paul J,CFO,F - Tax,$60.56,-742,45863,-2%,"-$44,936",-1.0,-4.0,-7.0,-15.0,BIIB
1193,A,2008-02-15 15:32:09,2008-02-12,BIIB,Clancy Paul J,CFO,S - Sale,$60.96,-958,45863,-2%,"-$58,397",-1.0,-4.0,-7.0,-15.0,BIIB
1194,D,2008-02-15 15:19:27,2008-02-13,BIIB,Mullen James C,"CEO, Pres",A - Grant,$0.00,59300,285460,+26%,+$0,-1.0,-4.0,-7.0,-15.0,BIIB
1195,D,2008-02-15 15:19:27,2008-02-13,BIIB,Mullen James C,"CEO, Pres",F - Tax,$63.24,-9742,285460,-3%,"-$616,084",-1.0,-4.0,-7.0,-15.0,BIIB
1196,D,2008-02-14 17:54:56,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",A - Grant,$0.00,10430,11017,>999%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1197,D,2008-02-14 17:54:56,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$60.56,-1218,11017,-10%,"-$73,762",-1.0,-4.0,-4.0,-16.0,BIIB
1198,D,2008-02-14 17:54:56,2008-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$60.95,-4286,11017,-28%,"-$261,239",-1.0,-4.0,-4.0,-16.0,BIIB
1199,,2008-02-14 17:54:05,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$61.11,-3200,16350,-16%,"-$195,562",-1.0,-4.0,-4.0,-16.0,BIIB
1200,D,2008-02-14 17:53:07,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",A - Grant,$0.00,14040,19550,+255%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1201,D,2008-02-14 17:53:07,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$60.56,-1656,19550,-8%,"-$100,287",-1.0,-4.0,-4.0,-16.0,BIIB
1202,D,2008-02-14 17:53:07,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$49.31,9725,19550,+99%,"+$479,540",-1.0,-4.0,-4.0,-16.0,BIIB
1203,D,2008-02-14 17:53:07,2008-02-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$60.95,-11934,19550,-38%,"-$727,434",-1.0,-4.0,-4.0,-16.0,BIIB
1204,,2008-02-14 17:52:06,2008-02-12,BIIB,Pickett Cecil B,"Pres, R, D",A - Grant,$0.00,27000,162923,+20%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1205,,2008-02-14 17:52:06,2008-02-12,BIIB,Pickett Cecil B,"Pres, R, D",F - Tax,$60.56,-9773,162923,-6%,"-$591,853",-1.0,-4.0,-4.0,-16.0,BIIB
1206,D,2008-02-14 17:51:07,2008-02-12,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",A - Grant,$0.00,8260,27326,+43%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1207,D,2008-02-14 17:51:07,2008-02-12,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$60.56,-1120,27326,-4%,"-$67,827",-1.0,-4.0,-4.0,-16.0,BIIB
1208,D,2008-02-14 17:49:32,2008-02-12,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",A - Grant,$0.00,10430,38077,+38%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1209,D,2008-02-14 17:49:32,2008-02-12,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",F - Tax,$60.56,-1788,38077,-4%,"-$108,281",-1.0,-4.0,-4.0,-16.0,BIIB
1210,D,2008-02-14 17:48:36,2008-02-12,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",A - Grant,$0.00,17340,53467,+48%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1211,D,2008-02-14 17:48:36,2008-02-12,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",F - Tax,$60.56,-404,53467,-1%,"-$24,466",-1.0,-4.0,-4.0,-16.0,BIIB
1212,D,2008-02-14 17:47:36,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",A - Grant,$0.00,14040,28419,+98%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1213,D,2008-02-14 17:47:36,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$60.56,-1587,28419,-5%,"-$96,109",-1.0,-4.0,-4.0,-16.0,BIIB
1214,D,2008-02-14 17:47:36,2008-02-12,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",S - Sale+OE,$60.91,-3679,28419,-11%,"-$224,100",-1.0,-4.0,-4.0,-16.0,BIIB
1215,D,2008-02-14 17:46:44,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,10430,15793,+194%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1216,D,2008-02-14 17:46:44,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$60.56,-1788,15793,-10%,"-$108,281",-1.0,-4.0,-4.0,-16.0,BIIB
1217,D,2008-02-14 17:46:44,2008-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$60.96,-2267,15793,-13%,"-$138,202",-1.0,-4.0,-4.0,-16.0,BIIB
1218,D,2008-02-14 17:45:47,2008-02-12,BIIB,Clancy Paul J,CFO,A - Grant,$0.00,15690,30173,+108%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1219,D,2008-02-14 17:45:47,2008-02-12,BIIB,Clancy Paul J,CFO,F - Tax,$60.56,-742,30173,-2%,"-$44,936",-1.0,-4.0,-4.0,-16.0,BIIB
1220,D,2008-02-14 17:45:47,2008-02-12,BIIB,Clancy Paul J,CFO,S - Sale+OE,$60.96,-958,30173,-3%,"-$58,397",-1.0,-4.0,-4.0,-16.0,BIIB
1221,D,2008-02-14 17:44:46,2008-02-12,BIIB,Alexander Susan H,"EVP, GC",A - Grant,$0.00,14040,30485,+85%,+$0,-1.0,-4.0,-4.0,-16.0,BIIB
1222,D,2008-02-14 17:44:46,2008-02-12,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$60.56,-1271,30485,-4%,"-$76,972",-1.0,-4.0,-4.0,-16.0,BIIB
1223,D,2008-02-08 16:37:59,2008-02-07,BIIB,Mullen James C,"CEO, Pres",F - Tax,$61.58,-9725,235902,-4%,"-$598,866",-1.0,2.0,-11.0,-19.0,BIIB
1224,D,2008-02-08 16:37:59,2008-02-07,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$0.00,26667,235902,+13%,+$0,-1.0,2.0,-11.0,-19.0,BIIB
1225,A,2008-02-08 16:36:35,2008-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$60.52,-2591,22955,-10%,"-$156,807",-1.0,2.0,-11.0,-19.0,BIIB
1226,A,2008-02-08 16:35:41,2008-02-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$60.52,-1788,33685,-5%,"-$108,210",-1.0,2.0,-11.0,-19.0,BIIB
1227,D,2008-02-07 17:33:21,2008-02-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$60.52,-2081,16521,-11%,"-$125,942",0.0,3.0,-9.0,-19.0,BIIB
1228,D,2008-02-07 17:33:21,2008-02-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$28.84,18292,16521,-1033%,"+$527,562",0.0,3.0,-9.0,-19.0,BIIB
1229,D,2008-02-07 17:33:21,2008-02-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$61.30,-11925,16521,-42%,"-$730,977",0.0,3.0,-9.0,-19.0,BIIB
1230,,2008-02-07 17:30:56,2008-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$61.69,-4400,22614,-16%,"-$271,417",0.0,3.0,-9.0,-19.0,BIIB
1231,D,2008-02-07 17:28:37,2008-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",F - Tax,$60.52,-3392,27014,-11%,"-$205,284",0.0,3.0,-9.0,-19.0,BIIB
1232,D,2008-02-07 17:28:37,2008-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$28.85,23000,27014,+573%,"+$663,600",0.0,3.0,-9.0,-19.0,BIIB
1233,D,2008-02-07 17:28:37,2008-02-06,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$61.04,-10600,27014,-28%,"-$647,020",0.0,3.0,-9.0,-19.0,BIIB
1234,D,2008-02-07 17:25:27,2008-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$60.52,-1366,19848,-6%,"-$82,670",0.0,3.0,-9.0,-19.0,BIIB
1235,D,2008-02-07 17:25:27,2008-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$0.00,3633,19848,+22%,+$0,0.0,3.0,-9.0,-19.0,BIIB
1236,D,2008-02-07 17:23:11,2008-02-06,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",F - Tax,$60.52,-331,36531,-1%,"-$20,032",0.0,3.0,-9.0,-19.0,BIIB
1237,D,2008-02-07 17:23:11,2008-02-06,BIIB,Hasler Hans Peter,"EVP, Global Neurology, Int'l",M - OptEx,$0.00,5467,36531,+18%,+$0,0.0,3.0,-9.0,-19.0,BIIB
1238,D,2008-02-07 17:20:12,2008-02-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",F - Tax,$60.52,-2335,33138,-7%,"-$141,314",0.0,3.0,-9.0,-19.0,BIIB
1239,D,2008-02-07 17:20:12,2008-02-06,BIIB,Hamm Robert A,"EVP, Pharma. Oper., Tech.",M - OptEx,$0.00,5467,33138,+20%,+$0,0.0,3.0,-9.0,-19.0,BIIB
1240,,2008-02-07 17:18:16,2008-02-06,BIIB,Clancy Paul J,CFO,F - Tax,$60.52,-522,31873,-2%,"-$31,591",0.0,3.0,-9.0,-19.0,BIIB
1241,D,2008-02-07 17:16:19,2008-02-06,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",F - Tax,$60.52,-2017,29435,-6%,"-$122,069",0.0,3.0,-9.0,-19.0,BIIB
1242,D,2008-02-07 17:16:19,2008-02-06,BIIB,Hasnain Faheem,"EVP, Oncology, Rheumatology SB",M - OptEx,$0.00,5467,29435,+23%,+$0,0.0,3.0,-9.0,-19.0,BIIB
1243,D,2008-01-31 17:29:05,2008-01-30,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$60.00,-1129,17716,-6%,"-$67,740",1.0,-1.0,-4.0,17.0,BIIB
1244,D,2008-01-31 17:29:05,2008-01-30,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3333,17716,+23%,+$0,1.0,-1.0,-4.0,17.0,BIIB
1245,D,2008-01-10 16:18:09,2008-01-08,BIIB,Leaming Nancy,Dir,A - Grant,$0.00,850,850,New,+$0,0.0,1.0,4.0,3.0,BIIB
1246,,2008-01-03 12:22:58,2007-12-31,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale,$57.34,-9800,18906,-34%,"-$561,911",1.0,5.0,11.0,4.0,BIIB
1247,D,2008-01-03 12:21:18,2007-12-31,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$43.50,36250,28706,-481%,"+$1,576,875",1.0,5.0,11.0,4.0,BIIB
1248,D,2008-01-03 12:21:18,2007-12-31,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$57.13,-26450,28706,-48%,"-$1,511,194",1.0,5.0,11.0,4.0,BIIB
1249,D,2008-01-03 12:19:26,2007-12-31,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$43.50,6869,12911,+114%,"+$298,802",1.0,5.0,11.0,4.0,BIIB
1250,D,2008-01-03 12:19:26,2007-12-31,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$57.22,-6869,12911,-35%,"-$393,039",1.0,5.0,11.0,4.0,BIIB
1251,D,2007-11-02 17:33:18,2007-11-01,BIIB,Hamm Robert A,"SVP, Neurology SBU",A - Grant,$0.00,14700,30006,+96%,+$0,-1.0,1.0,0.0,-15.0,BIIB
1252,D,2007-11-02 17:32:24,2007-11-01,BIIB,Hasnain Faheem,"SVP, Oncology SBU",A - Grant,$0.00,2700,25918,+12%,+$0,-1.0,1.0,0.0,-15.0,BIIB
1253,D,2007-11-02 17:31:26,2007-11-01,BIIB,Hasler Hans Peter,"SVP, International",A - Grant,$0.00,2700,31395,+9%,+$0,-1.0,1.0,0.0,-15.0,BIIB
1254,D,2007-11-02 17:28:55,2007-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",F - Tax,$72.87,-318,19947,-2%,"-$23,173",-1.0,1.0,0.0,-15.0,BIIB
1255,D,2007-11-02 17:28:55,2007-11-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",M - OptEx,$0.00,1000,19947,+5%,+$0,-1.0,1.0,0.0,-15.0,BIIB
1256,D,2007-10-17 15:30:09,2007-10-15,BIIB,Schenk Lynn,Dir,M - OptEx,$36.03,63000,5550,-110%,"+$2,269,857",0.0,0.0,-12.0,-17.0,BIIB
1257,D,2007-10-17 15:30:09,2007-10-15,BIIB,Schenk Lynn,Dir,S - Sale+OE,$82.00,-63000,5550,-92%,"-$5,166,000",0.0,0.0,-12.0,-17.0,BIIB
1258,D,2007-10-17 15:28:53,2007-10-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$65.77,89645,12911,-117%,"+$5,896,309",0.0,0.0,-12.0,-17.0,BIIB
1259,D,2007-10-17 15:28:53,2007-10-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$82.00,-89645,12911,-87%,"-$7,350,890",0.0,0.0,-12.0,-17.0,BIIB
1260,D,2007-10-17 15:27:57,2007-10-15,BIIB,Keller Thomas F,Dir,M - OptEx,$26.80,10350,4470,-176%,"+$277,380",0.0,0.0,-12.0,-17.0,BIIB
1261,D,2007-10-17 15:27:57,2007-10-15,BIIB,Keller Thomas F,Dir,S - Sale+OE,$82.00,-10350,4470,-70%,"-$848,700",0.0,0.0,-12.0,-17.0,BIIB
1262,D,2007-10-17 15:26:57,2007-10-15,BIIB,Hasler Hans Peter,"SVP, International",M - OptEx,$53.23,108750,28695,-136%,"+$5,788,838",0.0,0.0,-12.0,-17.0,BIIB
1263,D,2007-10-17 15:26:57,2007-10-15,BIIB,Hasler Hans Peter,"SVP, International",S - Sale+OE,$82.00,-108750,28695,-79%,"-$8,917,500",0.0,0.0,-12.0,-17.0,BIIB
1264,D,2007-10-17 15:26:06,2007-10-15,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$65.56,60500,20778,-152%,"+$3,966,315",0.0,0.0,-12.0,-17.0,BIIB
1265,D,2007-10-17 15:26:06,2007-10-15,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$82.00,-60500,20778,-74%,"-$4,961,000",0.0,0.0,-12.0,-17.0,BIIB
1266,D,2007-10-17 15:25:04,2007-10-15,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$67.57,18750,18906,>999%,"+$1,266,938",0.0,0.0,-12.0,-17.0,BIIB
1267,D,2007-10-17 15:25:04,2007-10-15,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$82.00,-18750,18906,-50%,"-$1,537,500",0.0,0.0,-12.0,-17.0,BIIB
1268,,2007-10-09 16:07:10,2007-10-04,BIIB,Hasnain Faheem,"SVP, Oncology SBU",F - Tax,$65.88,-3575,23011,-13%,"-$235,521",0.0,23.0,9.0,-4.0,BIIB
1269,,2007-10-03 17:38:08,2007-10-02,BIIB,Pickett Cecil B,"Pres, R, D",F - Tax,$65.66,-18704,145696,-11%,"-$1,228,105",1.0,3.0,14.0,-4.0,BIIB
1270,,2007-10-02 10:09:01,2007-10-01,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",A - Grant,$0.00,9000,19235,+88%,+$0,-3.0,-2.0,9.0,-7.0,BIIB
1271,D,2007-09-07 13:56:35,2007-09-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$57.33,66639,12911,-124%,"+$3,820,634",-1.0,-2.0,2.0,-16.0,BIIB
1272,D,2007-09-07 13:56:35,2007-09-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$65.00,-66639,12911,-84%,"-$4,331,535",-1.0,-2.0,2.0,-16.0,BIIB
1273,D,2007-09-05 13:28:01,2007-09-04,BIIB,Clancy Paul J,CFO,A - Grant,$0.00,8000,32395,+33%,+$0,-1.0,3.0,3.0,-6.0,BIIB
1274,D,2007-08-31 10:12:19,2007-08-30,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$49.03,46000,20778,-182%,"+$2,255,380",-1.0,2.0,5.0,-9.0,BIIB
1275,D,2007-08-31 10:12:19,2007-08-30,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$64.03,-46000,20778,-69%,"-$2,945,380",-1.0,2.0,5.0,-9.0,BIIB
1276,D,2007-08-31 10:10:26,2007-08-30,BIIB,Hasler Hans Peter,"SVP, International",M - OptEx,$44.24,10225,28695,+55%,"+$452,354",-1.0,2.0,5.0,-9.0,BIIB
1277,D,2007-08-31 10:10:26,2007-08-30,BIIB,Hasler Hans Peter,"SVP, International",S - Sale+OE,$64.24,-10225,28695,-26%,"-$656,854",-1.0,2.0,5.0,-9.0,BIIB
1278,D,2007-08-29 12:06:51,2007-08-27,BIIB,Hasler Hans Peter,"SVP, International",M - OptEx,$43.50,20606,28695,+255%,"+$896,361",1.0,1.0,7.0,-2.0,BIIB
1279,D,2007-08-29 12:06:51,2007-08-27,BIIB,Hasler Hans Peter,"SVP, International",S - Sale+OE,$63.50,-20606,28695,-42%,"-$1,308,481",1.0,1.0,7.0,-2.0,BIIB
1280,D,2007-08-29 12:04:35,2007-08-27,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$43.50,8750,20778,+73%,"+$380,625",1.0,1.0,7.0,-2.0,BIIB
1281,D,2007-08-29 12:04:35,2007-08-27,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$63.50,-8750,20778,-30%,"-$555,625",1.0,1.0,7.0,-2.0,BIIB
1282,D,2007-08-29 12:01:56,2007-08-27,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$59.39,18750,12911,-321%,"+$1,113,563",1.0,1.0,7.0,-2.0,BIIB
1283,D,2007-08-29 12:01:56,2007-08-27,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$64.00,-18750,12911,-59%,"-$1,200,000",1.0,1.0,7.0,-2.0,BIIB
1284,D,2007-08-27 09:18:49,2007-08-24,BIIB,Keller Thomas F,Dir,M - OptEx,$26.80,6900,4470,-284%,"+$184,920",0.0,1.0,8.0,-2.0,BIIB
1285,D,2007-08-27 09:18:49,2007-08-24,BIIB,Keller Thomas F,Dir,S - Sale+OE,$62.00,-6900,4470,-61%,"-$427,800",0.0,1.0,8.0,-2.0,BIIB
1286,D,2007-08-27 09:15:56,2007-08-24,BIIB,Ross Bruce,Dir,M - OptEx,$36.94,6250,6850,>999%,"+$230,875",0.0,1.0,8.0,-2.0,BIIB
1287,D,2007-08-27 09:15:56,2007-08-24,BIIB,Ross Bruce,Dir,S - Sale+OE,$62.00,-6250,6850,-48%,"-$387,500",0.0,1.0,8.0,-2.0,BIIB
1288,D,2007-08-21 10:22:04,2007-08-17,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$45.46,28750,20778,-361%,"+$1,306,975",-1.0,5.0,13.0,2.0,BIIB
1289,D,2007-08-21 10:22:04,2007-08-17,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$60.46,-28750,20778,-58%,"-$1,738,238",-1.0,5.0,13.0,2.0,BIIB
1290,D,2007-08-16 09:44:14,2007-08-15,BIIB,Ross Bruce,Dir,M - OptEx,$36.94,6250,6850,>999%,"+$230,875",1.0,2.0,12.0,8.0,BIIB
1291,D,2007-08-16 09:44:14,2007-08-15,BIIB,Ross Bruce,Dir,S - Sale+OE,$60.00,-6250,6850,-48%,"-$375,000",1.0,2.0,12.0,8.0,BIIB
1292,D,2007-08-15 10:17:03,2007-08-14,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$45.93,57500,18906,-149%,"+$2,640,975",-2.0,0.0,10.0,6.0,BIIB
1293,D,2007-08-15 10:17:03,2007-08-14,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$59.90,-57500,18906,-75%,"-$3,444,250",-2.0,0.0,10.0,6.0,BIIB
1294,D,2007-07-27 11:04:13,2007-07-25,BIIB,Hasler Hans Peter,"SVP, International",M - OptEx,$37.45,34500,28695,-594%,"+$1,292,025",-2.0,-3.0,8.0,1.0,BIIB
1295,D,2007-07-27 11:04:13,2007-07-25,BIIB,Hasler Hans Peter,"SVP, International",S - Sale+OE,$57.45,-34500,28695,-55%,"-$1,982,025",-2.0,-3.0,8.0,1.0,BIIB
1296,D,2007-07-27 11:01:45,2007-07-25,BIIB,Ross Bruce,Dir,M - OptEx,$34.34,5000,6850,+270%,"+$171,700",-2.0,-3.0,8.0,1.0,BIIB
1297,D,2007-07-27 11:01:45,2007-07-25,BIIB,Ross Bruce,Dir,S - Sale+OE,$58.00,-5000,6850,-42%,"-$290,000",-2.0,-3.0,8.0,1.0,BIIB
1298,D,2007-07-27 10:59:54,2007-07-25,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$43.50,20000,17629,-844%,"+$870,000",-2.0,-3.0,8.0,1.0,BIIB
1299,D,2007-07-27 10:59:54,2007-07-25,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$57.75,-20000,17629,-53%,"-$1,155,000",-2.0,-3.0,8.0,1.0,BIIB
1300,D,2007-07-27 10:57:54,2007-07-25,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",M - OptEx,$42.14,20507,18124,-861%,"+$864,094",-2.0,-3.0,8.0,1.0,BIIB
1301,D,2007-07-27 10:57:54,2007-07-25,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",S - Sale+OE,$58.00,-20507,18124,-53%,"-$1,189,406",-2.0,-3.0,8.0,1.0,BIIB
1302,DM,2007-07-27 10:55:05,2007-07-25,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$47.90,144000,20778,-117%,"+$6,897,075",-2.0,-3.0,8.0,1.0,BIIB
1303,DM,2007-07-27 10:55:05,2007-07-25,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$59.30,-144000,20778,-87%,"-$8,539,575",-2.0,-3.0,8.0,1.0,BIIB
1304,D,2007-07-25 11:36:00,2007-07-24,BIIB,Ross Bruce,Dir,M - OptEx,$34.34,5000,6850,+270%,"+$171,700",5.0,1.0,6.0,5.0,BIIB
1305,D,2007-07-25 11:36:00,2007-07-24,BIIB,Ross Bruce,Dir,S - Sale+OE,$56.00,-5000,6850,-42%,"-$280,000",5.0,1.0,6.0,5.0,BIIB
1306,D,2007-07-13 11:54:23,2007-07-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.21,41128,12911,-146%,"+$1,448,047",1.0,-1.0,4.0,7.0,BIIB
1307,D,2007-07-13 11:54:23,2007-07-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$55.00,-41128,12911,-76%,"-$2,262,040",1.0,-1.0,4.0,7.0,BIIB
1308,D,2007-07-13 11:52:44,2007-07-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$42.94,124057,18906,-118%,"+$5,327,266",1.0,-1.0,4.0,7.0,BIIB
1309,D,2007-07-13 11:52:44,2007-07-12,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$54.90,-124057,18906,-87%,"-$6,810,729",1.0,-1.0,4.0,7.0,BIIB
1310,D,2007-07-10 18:22:33,2007-07-09,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",M - OptEx,$40.21,28443,18906,-298%,"+$1,143,647",1.0,2.0,7.0,9.0,BIIB
1311,D,2007-07-10 18:22:33,2007-07-09,BIIB,Schneier Craig Eric,"EVP, HR, Public Affairs, Comm",S - Sale+OE,$54.90,-28443,18906,-60%,"-$1,561,521",1.0,2.0,7.0,9.0,BIIB
1312,D,2007-07-03 16:04:20,2007-07-03,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,15697,12911,-564%,"+$555,203",0.0,0.0,2.0,4.0,BIIB
1313,DM,2007-07-03 16:04:20,2007-07-02,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$53.98,-16430,12911,-56%,"-$886,854",0.0,0.0,2.0,4.0,BIIB
1314,D,2007-07-03 16:03:23,2007-07-03,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",M - OptEx,$44.24,10225,20778,+97%,"+$452,354",0.0,0.0,2.0,4.0,BIIB
1315,D,2007-07-03 16:03:23,2007-07-03,BIIB,Adelman Burt A,"EVP, Portfolio Strategy",S - Sale+OE,$54.24,-10225,20778,-33%,"-$554,604",0.0,0.0,2.0,4.0,BIIB
1316,D,2007-06-28 17:36:31,2007-06-27,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$44.24,11925,13644,+694%,"+$527,562",0.0,2.0,6.0,11.0,BIIB
1317,D,2007-06-28 17:36:31,2007-06-27,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$53.00,-11925,13644,-47%,"-$632,076",0.0,2.0,6.0,11.0,BIIB
1318,D,2007-06-28 17:34:27,2007-06-27,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,15352,17629,+674%,"+$543,000",0.0,2.0,6.0,11.0,BIIB
1319,D,2007-06-28 17:34:27,2007-06-27,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$52.90,-15352,17629,-47%,"-$812,121",0.0,2.0,6.0,11.0,BIIB
1320,,2007-06-21 09:50:12,2007-06-20,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$51.75,-5825,13644,-30%,"-$301,446",1.0,4.0,7.0,9.0,BIIB
1321,,2007-06-18 17:02:33,2007-06-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$51.33,-4175,19469,-18%,"-$214,303",0.0,0.0,6.0,12.0,BIIB
1322,D,2007-06-01 17:24:34,2007-05-31,BIIB,Young William,Dir,A - Grant,$0.00,2300,3550,+184%,+$0,0.0,-3.0,2.0,34.0,BIIB
1323,D,2007-06-01 17:23:04,2007-05-31,BIIB,Sharp Philip A,Dir,A - Grant,$0.00,2300,465983,0%,+$0,0.0,-3.0,2.0,34.0,BIIB
1324,D,2007-06-01 17:21:30,2007-05-31,BIIB,Schenk Lynn,Dir,A - Grant,$0.00,2300,5550,+71%,+$0,0.0,-3.0,2.0,34.0,BIIB
1325,D,2007-06-01 17:19:59,2007-05-31,BIIB,Pangia Robert W,Dir,A - Grant,$0.00,2300,4050,+131%,+$0,0.0,-3.0,2.0,34.0,BIIB
1326,D,2007-06-01 17:16:22,2007-05-30,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$43.50,6869,23644,+41%,"+$298,802",0.0,-3.0,2.0,34.0,BIIB
1327,D,2007-06-01 17:16:22,2007-05-30,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$51.54,-6869,23644,-23%,"-$354,028",0.0,-3.0,2.0,34.0,BIIB
1328,D,2007-06-01 17:14:35,2007-05-31,BIIB,Best Lawrence C,Dir,A - Grant,$0.00,2300,3550,+184%,+$0,0.0,-3.0,2.0,34.0,BIIB
1329,D,2007-06-01 17:12:33,2007-05-31,BIIB,Ross Bruce,Dir,A - Grant,$0.00,4600,6850,+204%,+$0,0.0,-3.0,2.0,34.0,BIIB
1330,D,2007-06-01 17:12:33,2007-05-31,BIIB,Ross Bruce,Dir,S - Sale+OE,$51.91,-1500,6850,-18%,"-$77,865",0.0,-3.0,2.0,34.0,BIIB
1331,D,2007-06-01 17:09:34,2007-05-31,BIIB,Glassberg Alan,Dir,A - Grant,$0.00,2300,3550,+184%,+$0,0.0,-3.0,2.0,34.0,BIIB
1332,D,2007-06-01 17:09:34,2007-05-30,BIIB,Glassberg Alan,Dir,M - OptEx,$31.08,20000,3550,-122%,"+$621,666",0.0,-3.0,2.0,34.0,BIIB
1333,D,2007-06-01 17:09:34,2007-05-30,BIIB,Glassberg Alan,Dir,S - Sale+OE,$51.54,-20000,3550,-85%,"-$1,030,800",0.0,-3.0,2.0,34.0,BIIB
1334,D,2007-06-01 17:07:54,2007-05-31,BIIB,Dekkers Marijn E,Dir,A - Grant,$0.00,2300,2300,New,+$0,0.0,-3.0,2.0,34.0,BIIB
1335,D,2007-06-01 17:03:25,2007-05-31,BIIB,Keller Thomas F,Dir,A - Grant,$0.00,2300,4470,+106%,+$0,0.0,-3.0,2.0,34.0,BIIB
1336,D,2007-05-30 18:07:11,2006-05-25,BIIB,Pangia Robert W,Dir,M - OptEx,$0.00,1250,1750,+250%,+$0,0.0,0.0,3.0,32.0,BIIB
1337,D,2007-05-30 17:32:45,2007-05-25,BIIB,Glassberg Alan,Dir,M - OptEx,$0.00,1250,1250,New,+$0,0.0,0.0,3.0,32.0,BIIB
1338,D,2007-05-30 17:25:49,2007-05-25,BIIB,Best Lawrence C,Dir,M - OptEx,$0.00,1250,1250,New,+$0,0.0,0.0,3.0,32.0,BIIB
1339,D,2007-05-30 17:24:40,2007-05-25,BIIB,Good Mary L,Dir,M - OptEx,$0.00,1250,1250,New,+$0,0.0,0.0,3.0,32.0,BIIB
1340,D,2007-05-30 17:24:02,2007-05-25,BIIB,Sharp Philip A,Dir,M - OptEx,$0.00,1250,463683,0%,+$0,0.0,0.0,3.0,32.0,BIIB
1341,D,2007-05-30 17:23:15,2007-05-25,BIIB,Schenk Lynn,Dir,M - OptEx,$0.00,1250,3250,+63%,+$0,0.0,0.0,3.0,32.0,BIIB
1342,D,2007-05-30 17:20:57,2007-05-25,BIIB,Keller Thomas F,Dir,M - OptEx,$0.00,1250,2170,+136%,+$0,0.0,0.0,3.0,32.0,BIIB
1343,D,2007-05-30 17:18:41,2007-05-25,BIIB,Belzer Alan,Dir,M - OptEx,$0.00,1250,53000,+2%,+$0,0.0,0.0,3.0,32.0,BIIB
1344,D,2007-05-30 17:17:43,2007-05-25,BIIB,Ross Bruce,Dir,M - OptEx,$0.00,3750,3750,New,+$0,0.0,0.0,3.0,32.0,BIIB
1345,D,2007-05-30 17:16:41,2007-05-25,BIIB,Young William,Dir,M - OptEx,$0.00,1250,1250,New,+$0,0.0,0.0,3.0,32.0,BIIB
1346,A,2007-05-24 16:33:19,2007-05-23,BIIB,Hasnain Faheem,"SVP, Oncology SBU",S - Sale,$49.00,-7446,26205,-22%,"-$364,854",3.0,9.0,8.0,46.0,BIIB
1347,,2007-05-24 14:57:16,2007-05-23,BIIB,Hasnain Faheem,"SVP, Oncology SBU",S - Sale,$49.00,-7446,25897,-22%,"-$364,854",0.0,8.0,7.0,46.0,BIIB
1348,D,2007-05-24 14:54:46,2007-05-23,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.21,10000,23644,+73%,"+$352,083",0.0,8.0,7.0,46.0,BIIB
1349,D,2007-05-24 14:54:46,2007-05-23,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$49.00,-10000,23644,-30%,"-$490,000",0.0,8.0,7.0,46.0,BIIB
1350,D,2007-05-18 17:16:39,2007-05-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,5000,23644,+27%,"+$176,850",1.0,3.0,11.0,51.0,BIIB
1351,D,2007-05-18 17:16:39,2007-05-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$46.31,-5000,23644,-17%,"-$231,548",1.0,3.0,11.0,51.0,BIIB
1352,D,2007-04-25 14:11:50,2007-04-23,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,15000,17629,+571%,"+$530,550",-1.0,-1.0,0.0,66.0,BIIB
1353,D,2007-04-25 14:11:50,2007-04-23,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$48.90,-18760,17629,-52%,"-$917,364",-1.0,-1.0,0.0,66.0,BIIB
1354,D,2007-04-25 14:08:21,2007-04-23,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$37.89,43737,23644,-218%,"+$1,657,043",-1.0,-1.0,0.0,66.0,BIIB
1355,D,2007-04-25 14:08:21,2007-04-23,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$47.59,-43737,23644,-65%,"-$2,081,601",-1.0,-1.0,0.0,66.0,BIIB
1356,,2007-04-25 14:04:11,2007-04-23,BIIB,Hamm Robert A,"SVP, Neurology SBU",S - Sale,$47.34,-3731,15306,-20%,"-$176,633",-1.0,-1.0,0.0,66.0,BIIB
1357,,2007-04-23 13:51:12,2007-04-20,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$46.02,-7519,21389,-26%,"-$345,997",5.0,3.0,1.0,70.0,BIIB
1358,D,2007-04-17 16:41:37,2007-04-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,5000,23644,+27%,"+$176,850",0.0,7.0,2.0,52.0,BIIB
1359,D,2007-04-17 16:41:37,2007-04-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$45.57,-5000,23644,-17%,"-$227,850",0.0,7.0,2.0,52.0,BIIB
1360,,2007-03-22 09:43:08,2007-03-20,BIIB,Adelman Burt A,"EVP, Development",S - Sale,$44.48,-6634,20778,-24%,"-$295,073",-1.0,-2.0,2.0,47.0,BIIB
1361,,2007-03-22 09:42:18,2007-03-20,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",S - Sale,$44.48,-5077,19037,-21%,"-$225,819",-1.0,-2.0,2.0,47.0,BIIB
1362,,2007-03-22 09:39:54,2007-03-20,BIIB,Hasler Hans Peter,"SVP, International",S - Sale,$44.48,-5910,28695,-17%,"-$262,870",-1.0,-2.0,2.0,47.0,BIIB
1363,,2007-03-22 09:38:32,2007-03-20,BIIB,Kellogg Peter N,"EVP, Finance, CFO",S - Sale,$44.48,-7252,18966,-28%,"-$322,561",-1.0,-2.0,2.0,47.0,BIIB
1364,,2007-03-22 09:37:51,2007-03-20,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",S - Sale,$44.48,-3756,17966,-17%,"-$167,063",-1.0,-2.0,2.0,47.0,BIIB
1365,,2007-03-22 09:37:01,2007-03-20,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale,$44.48,-6526,18172,-26%,"-$290,269",-1.0,-2.0,2.0,47.0,BIIB
1366,,2007-03-22 09:34:13,2007-03-20,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$44.48,-5929,22911,-21%,"-$263,715",-1.0,-2.0,2.0,47.0,BIIB
1367,,2007-03-16 16:01:38,2007-03-14,BIIB,Adelman Burt A,"EVP, Development",A - Grant,$0.00,11205,27412,+69%,+$0,2.0,4.0,4.0,50.0,BIIB
1368,,2007-03-16 16:01:38,2007-03-14,BIIB,Adelman Burt A,"EVP, Development",F - Tax,$44.11,-4571,27412,-14%,"-$201,627",2.0,4.0,4.0,50.0,BIIB
1369,,2007-03-16 16:00:42,2007-03-14,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,7346,59402,+14%,+$0,2.0,4.0,4.0,50.0,BIIB
1370,,2007-03-16 16:00:42,2007-03-14,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$44.11,-3053,59402,-5%,"-$134,668",2.0,4.0,4.0,50.0,BIIB
1371,,2007-03-16 15:59:26,2007-03-14,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",A - Grant,$0.00,8715,24114,+57%,+$0,-1.0,3.0,3.0,48.0,BIIB
1372,,2007-03-16 15:59:26,2007-03-14,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",F - Tax,$44.11,-3638,24114,-13%,"-$160,472",-1.0,3.0,3.0,48.0,BIIB
1373,,2007-03-16 15:57:47,2007-03-14,BIIB,Hasler Hans Peter,"SVP, International",A - Grant,$0.00,6225,34605,+22%,+$0,-1.0,3.0,3.0,48.0,BIIB
1374,,2007-03-16 15:57:47,2007-03-14,BIIB,Hasler Hans Peter,"SVP, International",F - Tax,$44.11,-315,34605,-1%,"-$13,895",-1.0,3.0,3.0,48.0,BIIB
1375,,2007-03-16 15:55:44,2007-03-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",A - Grant,$0.00,6225,33343,+23%,+$0,-1.0,3.0,3.0,48.0,BIIB
1376,,2007-03-16 15:55:44,2007-03-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",F - Tax,$44.11,-2226,33343,-6%,"-$98,189",-1.0,3.0,3.0,48.0,BIIB
1377,,2007-03-16 15:54:31,2007-03-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",A - Grant,$0.00,6225,33343,+23%,+$0,-1.0,3.0,3.0,48.0,BIIB
1378,,2007-03-16 15:54:31,2007-03-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",F - Tax,$44.11,-2226,33343,-6%,"-$98,189",-1.0,3.0,3.0,48.0,BIIB
1379,,2007-03-16 15:53:40,2007-03-14,BIIB,Kellogg Peter N,"EVP, Finance, CFO",A - Grant,$0.00,12450,26218,+90%,+$0,-1.0,3.0,3.0,48.0,BIIB
1380,,2007-03-16 15:53:40,2007-03-14,BIIB,Kellogg Peter N,"EVP, Finance, CFO",F - Tax,$44.11,-5198,26218,-17%,"-$229,284",-1.0,3.0,3.0,48.0,BIIB
1381,,2007-03-16 15:52:52,2007-03-14,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",A - Grant,$0.00,6225,21722,+40%,+$0,-1.0,3.0,3.0,48.0,BIIB
1382,,2007-03-16 15:52:52,2007-03-14,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",F - Tax,$44.11,-2469,21722,-10%,"-$108,908",-1.0,3.0,3.0,48.0,BIIB
1383,,2007-03-16 15:51:50,2007-03-14,BIIB,Schneier Craig Eric,"EVP, HR",A - Grant,$0.00,11205,24698,+83%,+$0,-1.0,3.0,3.0,48.0,BIIB
1384,,2007-03-16 15:51:50,2007-03-14,BIIB,Schneier Craig Eric,"EVP, HR",F - Tax,$44.11,-4679,24698,-16%,"-$206,391",-1.0,3.0,3.0,48.0,BIIB
1385,D,2007-03-16 15:50:57,2007-03-14,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",A - Grant,$0.00,9960,28840,+53%,+$0,-1.0,3.0,3.0,48.0,BIIB
1386,D,2007-03-16 15:50:57,2007-03-14,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$44.11,-4031,28840,-12%,"-$177,807",-1.0,3.0,3.0,48.0,BIIB
1387,D,2007-03-16 15:50:57,2007-03-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,5000,28840,+21%,"+$176,850",-1.0,3.0,3.0,48.0,BIIB
1388,D,2007-03-16 15:50:57,2007-03-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$44.05,-5000,28840,-15%,"-$220,260",-1.0,3.0,3.0,48.0,BIIB
1389,D,2007-02-16 17:00:18,2007-02-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,5000,22911,+28%,"+$176,850",-2.0,-3.0,-8.0,23.0,BIIB
1390,D,2007-02-16 17:00:18,2007-02-15,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$50.17,-5000,22911,-18%,"-$250,862",-2.0,-3.0,-8.0,23.0,BIIB
1391,D,2007-02-16 15:54:13,2007-02-15,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$48.00,-847,15512,-5%,"-$40,656",1.0,-2.0,-8.0,23.0,BIIB
1392,D,2007-02-16 15:54:13,2007-02-15,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,2667,15512,+21%,+$0,1.0,-2.0,-8.0,23.0,BIIB
1393,D,2007-02-15 17:25:12,2007-02-13,BIIB,Mullen James C,"CEO, Pres",A - Grant,$0.00,170000,218960,+347%,+$0,1.0,-2.0,-9.0,21.0,BIIB
1394,D,2007-02-15 17:25:12,2007-02-13,BIIB,Mullen James C,"CEO, Pres",F - Tax,$49.17,-41750,218960,-16%,"-$2,052,848",1.0,-2.0,-9.0,21.0,BIIB
1395,,2007-02-15 15:22:47,2007-02-13,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$49.22,-10595,22911,-32%,"-$521,444",-5.0,-7.0,-14.0,16.0,BIIB
1396,,2007-02-15 15:22:07,2007-02-13,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale,$49.22,-15290,18172,-46%,"-$752,513",-5.0,-7.0,-14.0,16.0,BIIB
1397,,2007-02-15 15:21:32,2007-02-13,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",S - Sale,$49.22,-8828,17966,-33%,"-$434,479",-5.0,-7.0,-14.0,16.0,BIIB
1398,,2007-02-15 15:20:55,2007-02-13,BIIB,Kellogg Peter N,"EVP, Finance, CFO",S - Sale,$49.22,-10202,18966,-35%,"-$502,102",-5.0,-7.0,-14.0,16.0,BIIB
1399,,2007-02-15 15:20:19,2007-02-13,BIIB,Hasler Hans Peter,"SVP, International",S - Sale,$49.22,-5190,28695,-15%,"-$255,431",-5.0,-7.0,-14.0,16.0,BIIB
1400,,2007-02-15 15:19:45,2007-02-13,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",S - Sale,$49.22,-6188,19037,-25%,"-$304,549",-5.0,-7.0,-14.0,16.0,BIIB
1401,,2007-02-15 15:19:11,2007-02-13,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$49.22,-2334,23882,-9%,"-$114,870",-5.0,-7.0,-14.0,16.0,BIIB
1402,,2007-02-15 15:18:33,2007-02-13,BIIB,Adelman Burt A,"EVP, Development",S - Sale,$49.22,-11871,20778,-36%,"-$584,243",-5.0,-7.0,-14.0,16.0,BIIB
1403,D,2007-02-14 14:42:19,2007-02-12,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",A - Grant,$0.00,17500,26794,+188%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1404,D,2007-02-14 14:41:05,2007-02-12,BIIB,Maclean Michael F,"SVP, Chief Accounting Officer",A - Grant,$0.00,10000,10000,New,+$0,3.0,-4.0,-10.0,21.0,BIIB
1405,D,2007-02-14 14:40:14,2007-02-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",A - Grant,$0.00,4300,63603,+7%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1406,D,2007-02-14 14:36:57,2007-02-12,BIIB,Schneier Craig Eric,"EVP, HR",A - Grant,$0.00,15000,33462,+81%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1407,D,2007-02-14 14:35:40,2007-02-12,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",A - Grant,$0.00,11500,33506,+52%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1408,D,2007-02-14 14:34:57,2007-02-12,BIIB,Kellogg Peter N,"EVP, Finance, CFO",A - Grant,$0.00,11500,29168,+65%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1409,D,2007-02-14 14:34:10,2007-02-12,BIIB,Hasnain Faheem,"SVP, Oncology SBU",A - Grant,$0.00,15000,29344,+105%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1410,D,2007-02-14 14:33:26,2007-02-12,BIIB,Hasler Hans Peter,"SVP, International",A - Grant,$0.00,20000,33885,+144%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1411,D,2007-02-14 14:32:40,2007-02-12,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",A - Grant,$0.00,15000,25225,+147%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1412,D,2007-02-14 14:31:58,2007-02-12,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,15000,26216,+134%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1413,D,2007-02-14 14:31:08,2007-02-12,BIIB,Alexander Susan H,"EVP, GC",A - Grant,$0.00,11500,13692,+525%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1414,D,2007-02-14 14:30:21,2007-02-12,BIIB,Adelman Burt A,"EVP, Development",A - Grant,$0.00,12500,32649,+62%,+$0,3.0,-4.0,-10.0,21.0,BIIB
1415,D,2007-02-08 16:25:19,2007-02-06,BIIB,Hasnain Faheem,"SVP, Oncology SBU",F - Tax,$48.94,-2020,14344,-12%,"-$98,859",0.0,2.0,-13.0,19.0,BIIB
1416,D,2007-02-08 16:25:19,2007-02-06,BIIB,Hasnain Faheem,"SVP, Oncology SBU",M - OptEx,$0.00,5467,14344,+62%,+$0,0.0,2.0,-13.0,19.0,BIIB
1417,D,2007-02-08 16:01:44,2007-02-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$48.94,-4930,22006,-18%,"-$241,274",0.0,2.0,-13.0,19.0,BIIB
1418,D,2007-02-08 16:01:44,2007-02-06,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$0.00,6367,22006,+41%,+$0,0.0,2.0,-13.0,19.0,BIIB
1419,D,2007-02-08 16:01:16,2007-02-06,BIIB,Schneier Craig Eric,"EVP, HR",F - Tax,$48.94,-7710,18462,-29%,"-$377,327",0.0,2.0,-13.0,19.0,BIIB
1420,D,2007-02-08 16:01:16,2007-02-06,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$0.00,8000,18462,+76%,+$0,0.0,2.0,-13.0,19.0,BIIB
1421,DM,2007-02-08 16:00:44,2007-02-06,BIIB,Mullen James C,"CEO, Pres",F - Tax,$49.08,-30209,90710,-25%,"-$1,482,659",0.0,2.0,-13.0,19.0,BIIB
1422,D,2007-02-08 16:00:44,2007-02-07,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$0.00,26667,90710,+42%,+$0,0.0,2.0,-13.0,19.0,BIIB
1423,D,2007-02-08 16:00:08,2007-02-06,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",F - Tax,$48.94,-5868,59303,-9%,"-$287,180",0.0,2.0,-13.0,19.0,BIIB
1424,D,2007-02-08 16:00:08,2007-02-06,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$0.00,1834,59303,+3%,+$0,0.0,2.0,-13.0,19.0,BIIB
1425,D,2007-02-08 15:54:25,2007-02-06,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",F - Tax,$48.94,-4206,9294,-31%,"-$205,842",1.0,2.0,-12.0,19.0,BIIB
1426,D,2007-02-08 15:54:25,2007-02-06,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",M - OptEx,$0.00,4534,9294,+95%,+$0,1.0,2.0,-12.0,19.0,BIIB
1427,D,2007-02-08 15:53:53,2007-02-06,BIIB,Kellogg Peter N,"EVP, Finance, CFO",F - Tax,$48.94,-7953,17668,-31%,"-$389,220",1.0,2.0,-12.0,19.0,BIIB
1428,D,2007-02-08 15:53:53,2007-02-06,BIIB,Kellogg Peter N,"EVP, Finance, CFO",M - OptEx,$0.00,8534,17668,+93%,+$0,1.0,2.0,-12.0,19.0,BIIB
1429,D,2007-02-08 15:53:17,2007-02-06,BIIB,Hasler Hans Peter,"SVP, International",F - Tax,$48.94,-740,13885,-5%,"-$36,216",1.0,2.0,-12.0,19.0,BIIB
1430,D,2007-02-08 15:53:17,2007-02-06,BIIB,Hasler Hans Peter,"SVP, International",M - OptEx,$0.00,5467,13885,+65%,+$0,1.0,2.0,-12.0,19.0,BIIB
1431,D,2007-02-08 15:52:43,2007-02-06,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",F - Tax,$48.94,-4706,10255,-31%,"-$230,312",1.0,2.0,-12.0,19.0,BIIB
1432,D,2007-02-08 15:52:43,2007-02-06,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",M - OptEx,$0.00,5467,10255,+114%,+$0,1.0,2.0,-12.0,19.0,BIIB
1433,D,2007-02-08 15:52:12,2007-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$48.94,-5304,11216,-32%,"-$259,578",1.0,2.0,-12.0,19.0,BIIB
1434,D,2007-02-08 15:52:12,2007-02-06,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$0.00,3634,11216,+48%,+$0,1.0,2.0,-12.0,19.0,BIIB
1435,D,2007-02-08 15:51:35,2007-02-06,BIIB,Adelman Burt A,"EVP, Development",F - Tax,$48.94,-5596,20149,-22%,"-$273,868",1.0,2.0,-12.0,19.0,BIIB
1436,D,2007-02-08 15:51:35,2007-02-06,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$0.00,5467,20149,+37%,+$0,1.0,2.0,-12.0,19.0,BIIB
1437,AD,2007-02-08 14:40:38,2006-10-31,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,15000,13023,-759%,"+$530,550",1.0,2.0,-12.0,19.0,BIIB
1438,AD,2007-02-08 14:40:38,2006-10-31,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$46.77,-28104,13023,-68%,"-$1,314,444",1.0,2.0,-12.0,19.0,BIIB
1439,D,2007-01-31 12:42:50,2007-01-30,BIIB,Alexander Susan H,"EVP, GC",F - Tax,$48.05,-1142,2192,-34%,"-$54,873",1.0,2.0,-7.0,18.0,BIIB
1440,D,2007-01-31 12:42:50,2007-01-30,BIIB,Alexander Susan H,"EVP, GC",M - OptEx,$0.00,3334,2192,-292%,+$0,1.0,2.0,-7.0,18.0,BIIB
1441,D,2007-01-18 11:07:32,2007-01-16,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.46,24823,63337,+64%,"+$185,189",-1.0,-6.0,-8.0,6.0,BIIB
1442,D,2007-01-18 11:07:32,2007-01-16,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$50.83,-24823,63337,-28%,"-$1,261,696",-1.0,-6.0,-8.0,6.0,BIIB
1443,D,2007-01-18 11:06:10,2007-01-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.37,5000,20569,+32%,"+$176,850",-1.0,-6.0,-8.0,6.0,BIIB
1444,D,2007-01-18 11:06:10,2007-01-16,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale+OE,$50.73,-6353,20569,-24%,"-$322,315",-1.0,-6.0,-8.0,6.0,BIIB
1445,,2007-01-05 13:39:41,2006-10-02,BIIB,Pickett Cecil B,"Pres, R, D",A - Grant,$0.00,164400,164400,New,+$0,0.0,1.0,-1.0,10.0,BIIB
1446,,2007-01-04 15:35:54,2006-11-20,BIIB,Dunn John Michael,"EVP, New Ventures",G - Gift,$0.00,-137,25990,-1%,-$0,1.0,0.0,0.0,10.0,BIIB
1447,D,2006-11-28 17:01:45,2006-11-27,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$36.09,12500,94252,+15%,"+$451,125",1.0,1.0,-4.0,2.0,BIIB
1448,D,2006-11-28 17:01:45,2006-11-27,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$50.99,-12500,94252,-12%,"-$637,336",1.0,1.0,-4.0,2.0,BIIB
1449,D,2006-11-27 11:16:02,2006-11-22,BIIB,Ross Bruce,Dir,M - OptEx,$31.08,7500,0,-100%,"+$233,125",-1.0,1.0,-5.0,1.0,BIIB
1450,D,2006-11-27 11:16:02,2006-11-22,BIIB,Ross Bruce,Dir,S - Sale+OE,$52.00,-7500,0,-100%,"-$390,000",-1.0,1.0,-5.0,1.0,BIIB
1451,D,2006-11-21 14:00:53,2006-11-20,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$36.09,159000,94252,-246%,"+$5,738,310",-1.0,0.0,-4.0,-7.0,BIIB
1452,D,2006-11-21 14:00:53,2006-11-20,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$51.18,-159000,94252,-63%,"-$8,137,482",-1.0,0.0,-4.0,-7.0,BIIB
1453,D,2006-11-20 15:50:55,2006-11-17,BIIB,Ross Bruce,Dir,M - OptEx,$31.08,7500,0,-100%,"+$233,125",1.0,1.0,-3.0,-5.0,BIIB
1454,D,2006-11-20 15:50:55,2006-11-17,BIIB,Ross Bruce,Dir,S - Sale+OE,$50.00,-7500,0,-100%,"-$375,000",1.0,1.0,-3.0,-5.0,BIIB
1455,DM,2006-11-17 16:57:27,2006-11-16,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$35.94,300000,94252,-146%,"+$10,780,770",1.0,1.0,-1.0,-8.0,BIIB
1456,DM,2006-11-17 16:57:27,2006-11-16,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$49.95,-300000,94252,-76%,"-$14,985,201",1.0,1.0,-1.0,-8.0,BIIB
1457,D,2006-11-16 10:28:01,2006-11-15,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,7850,26127,+43%,"+$277,655",2.0,6.0,5.0,-4.0,BIIB
1458,D,2006-11-16 10:28:01,2006-11-15,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$49.00,-7850,26127,-23%,"-$384,650",2.0,6.0,5.0,-4.0,BIIB
1459,A,2006-11-08 14:01:57,2005-01-25,BIIB,Schenk Lynn,Dir,M - OptEx,$31.08,2000,2000,New,"+$62,167",0.0,-1.0,5.0,-4.0,BIIB
1460,A,2006-11-08 13:37:55,2004-10-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,920,-110%,"+$156,906",0.0,-1.0,5.0,-4.0,BIIB
1461,A,2006-11-08 13:37:55,2004-10-01,BIIB,Keller Thomas F,Dir,S - Sale,$61.00,-10350,920,-92%,"-$631,350",0.0,-1.0,5.0,-4.0,BIIB
1462,AM,2006-11-08 13:37:14,2004-05-24,BIIB,Good Mary L,Dir,M - OptEx,$14.48,14500,0,-100%,"+$209,960",0.0,-1.0,5.0,-4.0,BIIB
1463,AM,2006-11-08 13:37:14,2004-05-24,BIIB,Good Mary L,Dir,S - Sale,$61.90,-14500,0,-100%,"-$897,550",0.0,-1.0,5.0,-4.0,BIIB
1464,A,2006-11-08 13:35:34,2004-08-04,BIIB,Glassberg Alan,Dir,M - OptEx,$7.79,1860,0,-100%,"+$14,493",0.0,-1.0,5.0,-4.0,BIIB
1465,A,2006-11-08 13:35:34,2004-08-04,BIIB,Glassberg Alan,Dir,S - Sale,$58.02,-1860,0,-100%,"-$107,917",0.0,-1.0,5.0,-4.0,BIIB
1466,A,2006-11-08 13:34:41,2004-05-26,BIIB,Glassberg Alan,Dir,M - OptEx,$5.65,1860,0,-100%,"+$10,506",0.0,-1.0,5.0,-4.0,BIIB
1467,A,2006-11-08 13:34:41,2004-05-26,BIIB,Glassberg Alan,Dir,S - Sale,$63.38,-1860,0,-100%,"-$117,883",0.0,-1.0,5.0,-4.0,BIIB
1468,A,2006-11-08 13:32:32,2004-07-30,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$23.74,16318,19158,+575%,"+$387,356",0.0,-1.0,5.0,-4.0,BIIB
1469,A,2006-11-08 13:32:32,2004-07-30,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$60.03,-16318,19158,-46%,"-$979,496",0.0,-1.0,5.0,-4.0,BIIB
1470,A,2006-11-08 13:21:19,2004-11-19,BIIB,Ross Bruce,Dir,M - OptEx,$31.08,15000,0,-100%,"+$466,250",0.0,-1.0,5.0,-4.0,BIIB
1471,A,2006-11-08 13:21:19,2004-11-19,BIIB,Ross Bruce,Dir,S - Sale,$55.91,-15000,0,-100%,"-$838,650",0.0,-1.0,5.0,-4.0,BIIB
1472,A,2006-11-08 13:20:04,2006-01-25,BIIB,Schenk Lynn,Dir,M - OptEx,$31.08,2000,2000,New,"+$62,167",0.0,-1.0,5.0,-4.0,BIIB
1473,A,2006-11-07 16:50:11,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,2177,16021,+16%,"+$99,990",0.0,-1.0,6.0,-6.0,BIIB
1474,A,2006-11-07 16:50:11,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale,$60.00,-2177,16021,-12%,"-$130,620",0.0,-1.0,6.0,-6.0,BIIB
1475,A,2006-11-07 16:47:44,2004-06-07,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3875,15601,+33%,"+$145,119",0.0,-1.0,6.0,-6.0,BIIB
1476,A,2006-11-07 16:47:44,2004-06-07,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale,$61.98,-3875,15601,-20%,"-$240,178",0.0,-1.0,6.0,-6.0,BIIB
1477,A,2006-11-06 15:40:09,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$9.67,12953,12269,-1894%,"+$125,256",2.0,0.0,8.0,-1.0,BIIB
1478,A,2006-11-06 15:40:09,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale,$63.00,-12953,12269,-51%,"-$816,039",2.0,0.0,8.0,-1.0,BIIB
1479,A,2006-11-06 15:30:03,2004-12-13,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.77,5500,94252,+6%,"+$86,716",2.0,0.0,8.0,-1.0,BIIB
1480,A,2006-11-06 15:30:03,2004-12-13,BIIB,Mullen James C,"CEO, Pres",S - Sale,$65.59,-5500,94252,-6%,"-$360,724",2.0,0.0,8.0,-1.0,BIIB
1481,A,2006-11-06 15:29:00,2004-10-11,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.33,5500,94252,+6%,"+$84,290",2.0,0.0,8.0,-1.0,BIIB
1482,A,2006-11-06 15:29:00,2004-10-11,BIIB,Mullen James C,"CEO, Pres",S - Sale,$60.11,-5500,94252,-6%,"-$330,600",2.0,0.0,8.0,-1.0,BIIB
1483,A,2006-11-06 15:27:53,2004-07-06,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$10.06,5500,94252,+6%,"+$55,344",2.0,0.0,8.0,-1.0,BIIB
1484,A,2006-11-06 15:27:53,2004-07-06,BIIB,Mullen James C,"CEO, Pres",S - Sale,$62.54,-5500,94252,-6%,"-$343,990",2.0,0.0,8.0,-1.0,BIIB
1485,A,2006-11-06 15:27:11,2004-05-24,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,94252,+6%,"+$40,205",2.0,0.0,8.0,-1.0,BIIB
1486,A,2006-11-06 15:27:11,2004-05-24,BIIB,Mullen James C,"CEO, Pres",S - Sale,$61.31,-5500,94252,-6%,"-$337,198",2.0,0.0,8.0,-1.0,BIIB
1487,A,2006-11-06 15:26:05,2004-05-18,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$6.92,60000,170274,+54%,"+$415,002",2.0,0.0,8.0,-1.0,BIIB
1488,A,2006-11-06 15:26:05,2004-05-18,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale,$59.04,-60000,170274,-26%,"-$3,542,600",2.0,0.0,8.0,-1.0,BIIB
1489,A,2006-11-06 15:25:02,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,38771,11667,-143%,"+$299,266",2.0,0.0,8.0,-1.0,BIIB
1490,A,2006-11-06 15:25:02,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale,$36.49,-38771,11667,-77%,"-$1,414,625",2.0,0.0,8.0,-1.0,BIIB
1491,A,2006-11-06 15:23:59,2004-05-18,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,15000,11609,-442%,"+$530,550",2.0,0.0,8.0,-1.0,BIIB
1492,A,2006-11-06 15:23:59,2004-05-18,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$59.05,-15000,11609,-56%,"-$885,800",2.0,0.0,8.0,-1.0,BIIB
1493,A,2006-11-06 15:21:38,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$9.67,12953,12269,-1894%,"+$125,256",2.0,0.0,8.0,-1.0,BIIB
1494,A,2006-11-06 15:21:38,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale,$63.00,-12953,12269,-51%,"-$816,039",2.0,0.0,8.0,-1.0,BIIB
1495,A,2006-11-06 15:21:05,2005-01-03,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",M - OptEx,$35.21,12500,19835,+170%,"+$440,104",2.0,0.0,8.0,-1.0,BIIB
1496,A,2006-11-06 15:21:05,2005-01-03,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$66.84,-12500,19835,-39%,"-$835,500",2.0,0.0,8.0,-1.0,BIIB
1497,D,2006-11-02 10:07:51,2006-10-31,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,13104,26127,+101%,"+$463,488",0.0,2.0,9.0,-1.0,BIIB
1498,D,2006-11-02 10:07:51,2006-10-31,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$46.79,-13104,26127,-33%,"-$613,119",0.0,2.0,9.0,-1.0,BIIB
1499,D,2006-11-02 10:05:46,2006-11-01,BIIB,Keller Thomas F,Dir,M - OptEx,$26.80,3450,920,-136%,"+$92,460",0.0,2.0,9.0,-1.0,BIIB
1500,D,2006-11-02 10:05:46,2006-11-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$48.00,-3450,920,-79%,"-$165,600",0.0,2.0,9.0,-1.0,BIIB
1501,D,2006-10-18 10:00:19,2006-10-16,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,40000,63337,+171%,"+$308,752",1.0,-1.0,8.0,3.0,BIIB
1502,D,2006-10-18 10:00:19,2006-10-16,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$45.51,-40000,63337,-39%,"-$1,820,354",1.0,-1.0,8.0,3.0,BIIB
1503,,2006-10-03 14:34:27,2006-10-02,BIIB,Hasnain Faheem,"SVP, Oncology SBU",S - Sale,$44.63,-11244,10793,-51%,"-$501,767",1.0,3.0,8.0,2.0,BIIB
1504,D,2006-10-03 14:27:01,2006-10-02,BIIB,Glassberg Alan,Dir,M - OptEx,$7.79,13140,0,-100%,"+$102,383",1.0,3.0,8.0,2.0,BIIB
1505,D,2006-10-03 14:27:01,2006-10-02,BIIB,Glassberg Alan,Dir,S - Sale+OE,$44.62,-13140,0,-100%,"-$586,338",1.0,3.0,8.0,2.0,BIIB
1506,,2006-09-20 16:06:22,2006-09-19,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",S - Sale,$42.78,-18186,21922,-45%,"-$777,965",0.0,2.0,5.0,4.0,BIIB
1507,,2006-09-20 16:05:39,2006-09-19,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale,$42.78,-20176,18165,-53%,"-$863,092",0.0,2.0,5.0,4.0,BIIB
1508,,2006-09-20 16:02:35,2006-09-19,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",S - Sale,$42.78,-11943,8899,-57%,"-$510,899",0.0,2.0,5.0,4.0,BIIB
1509,,2006-09-20 16:01:27,2006-09-19,BIIB,Kellogg Peter N,"EVP, Finance, CFO",S - Sale,$42.78,-22033,17087,-56%,"-$942,533",0.0,2.0,5.0,4.0,BIIB
1510,,2006-09-20 16:00:33,2006-09-19,BIIB,Adelman Burt A,"EVP, Development",S - Sale,$42.78,-18348,0,-100%,"-$784,894",0.0,2.0,5.0,4.0,BIIB
1511,,2006-09-20 15:59:26,2006-09-19,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",S - Sale,$42.78,-16207,9494,-63%,"-$693,307",1.0,3.0,6.0,5.0,BIIB
1512,,2006-09-15 16:16:25,2006-09-14,BIIB,Schneier Craig Eric,"EVP, HR",A - Grant,$0.00,31500,38341,+460%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1513,,2006-09-15 16:16:25,2006-09-14,BIIB,Schneier Craig Eric,"EVP, HR",F - Tax,$43.39,-11324,38341,-23%,"-$491,348",-1.0,-1.0,4.0,1.0,BIIB
1514,,2006-09-15 16:14:30,2006-09-14,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",A - Grant,$0.00,17500,63337,+38%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1515,,2006-09-15 16:14:30,2006-09-14,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",F - Tax,$43.39,-8006,63337,-11%,"-$347,380",-1.0,-1.0,4.0,1.0,BIIB
1516,,2006-09-15 16:13:38,2006-09-14,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",A - Grant,$0.00,17500,20842,+524%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1517,,2006-09-15 16:13:38,2006-09-14,BIIB,Kowolenko Michael,"SVP, Pharm Ops, Technology",F - Tax,$43.39,-5557,20842,-21%,"-$241,118",-1.0,-1.0,4.0,1.0,BIIB
1518,,2006-09-15 16:12:47,2006-09-14,BIIB,Kellogg Peter N,"EVP, Finance, CFO",A - Grant,$0.00,35000,39120,+849%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1519,,2006-09-15 16:12:47,2006-09-14,BIIB,Kellogg Peter N,"EVP, Finance, CFO",F - Tax,$43.39,-12967,39120,-25%,"-$562,638",-1.0,-1.0,4.0,1.0,BIIB
1520,,2006-09-15 16:11:51,2006-09-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",A - Grant,$0.00,17500,21947,+394%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1521,,2006-09-15 16:11:51,2006-09-14,BIIB,Hasnain Faheem,"SVP, Oncology SBU",F - Tax,$43.39,-6256,21947,-22%,"-$271,448",-1.0,-1.0,4.0,1.0,BIIB
1522,,2006-09-15 16:10:55,2006-09-14,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",A - Grant,$0.00,24500,25701,>999%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1523,,2006-09-15 16:10:55,2006-09-14,BIIB,Hamm Robert A,"SVP, Immunology Business Unit",F - Tax,$43.39,-8293,25701,-24%,"-$359,833",-1.0,-1.0,4.0,1.0,BIIB
1524,,2006-09-15 16:09:09,2006-09-14,BIIB,Dunn John Michael,"EVP, New Ventures",A - Grant,$0.00,20650,26127,+377%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1525,,2006-09-15 16:09:09,2006-09-14,BIIB,Dunn John Michael,"EVP, New Ventures",F - Tax,$43.39,-7546,26127,-22%,"-$327,421",-1.0,-1.0,4.0,1.0,BIIB
1526,,2006-09-15 16:08:15,2006-09-14,BIIB,Adelman Burt A,"EVP, Development",A - Grant,$0.00,31500,18348,-240%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1527,,2006-09-15 16:08:15,2006-09-14,BIIB,Adelman Burt A,"EVP, Development",F - Tax,$43.39,-13152,18348,-42%,"-$570,665",-1.0,-1.0,4.0,1.0,BIIB
1528,,2006-09-15 16:07:40,2006-09-14,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",A - Grant,$0.00,28000,40108,+231%,+$0,-1.0,-1.0,4.0,1.0,BIIB
1529,,2006-09-15 16:07:40,2006-09-14,BIIB,Wiggins Mark C,"EVP Corp., Bus. Dev.",F - Tax,$43.39,-9814,40108,-20%,"-$425,829",-1.0,-1.0,4.0,1.0,BIIB
1530,D,2006-09-05 14:56:33,2006-09-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,6900,920,-115%,"+$104,604",1.0,-1.0,1.0,-1.0,BIIB
1531,D,2006-09-05 14:56:33,2006-09-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$44.60,-6900,920,-88%,"-$307,740",1.0,-1.0,1.0,-1.0,BIIB
1532,D,2006-07-27 13:45:29,2006-07-26,BIIB,Belzer Alan,Dir,M - OptEx,$15.16,29000,51750,+127%,"+$439,640",1.0,3.0,7.0,16.0,BIIB
1533,D,2006-07-27 13:45:29,2006-07-26,BIIB,Belzer Alan,Dir,S - Sale+OE,$41.01,-29000,51750,-36%,"-$1,189,275",1.0,3.0,7.0,16.0,BIIB
1534,DM,2006-07-26 11:08:12,2006-07-24,BIIB,Belzer Alan,Dir,M - OptEx,$15.16,40000,51750,+340%,"+$606,400",-1.0,-1.0,3.0,15.0,BIIB
1535,DM,2006-07-26 11:08:12,2006-07-24,BIIB,Belzer Alan,Dir,S - Sale+OE,$41.20,-40000,51750,-44%,"-$1,647,967",-1.0,-1.0,3.0,15.0,BIIB
1536,D,2006-07-18 17:12:50,2006-07-17,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,40000,53110,+305%,"+$308,752",2.0,0.0,3.0,26.0,BIIB
1537,D,2006-07-18 17:12:50,2006-07-17,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$42.66,-40000,53110,-43%,"-$1,706,568",2.0,0.0,3.0,26.0,BIIB
1538,AD,2006-06-07 14:52:03,2006-01-03,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$37.45,34500,0,-100%,"+$1,292,025",0.0,-2.0,2.0,12.0,BIIB
1539,AD,2006-06-07 14:52:03,2006-01-03,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$45.64,-34500,0,-100%,"-$1,574,580",0.0,-2.0,2.0,12.0,BIIB
1540,D,2006-05-02 12:07:44,2006-04-28,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,8675,94252,+10%,"+$134,810",1.0,2.0,3.0,-3.0,BIIB
1541,D,2006-05-02 12:07:44,2006-04-28,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$45.19,-8675,94252,-8%,"-$392,004",1.0,2.0,3.0,-3.0,BIIB
1542,D,2006-05-02 12:07:14,2006-04-28,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,40000,149935,+36%,"+$308,752",1.0,2.0,3.0,-3.0,BIIB
1543,D,2006-05-02 12:07:14,2006-04-28,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$45.17,-40000,149935,-21%,"-$1,806,700",1.0,2.0,3.0,-3.0,BIIB
1544,D,2006-05-02 12:06:36,2006-04-28,BIIB,Good Mary L,Dir,M - OptEx,$14.48,10000,0,-100%,"+$144,800",1.0,2.0,3.0,-3.0,BIIB
1545,D,2006-05-02 12:06:36,2006-04-28,BIIB,Good Mary L,Dir,S - Sale+OE,$45.24,-10000,0,-100%,"-$452,400",1.0,2.0,3.0,-3.0,BIIB
1546,D,2006-04-04 09:54:46,2006-03-31,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,7820,-409%,"+$156,906",-2.0,-3.0,-1.0,-5.0,BIIB
1547,D,2006-04-04 09:54:46,2006-03-31,BIIB,Keller Thomas F,Dir,S - Sale+OE,$46.95,-10350,7820,-57%,"-$485,967",-2.0,-3.0,-1.0,-5.0,BIIB
1548,D,2006-01-05 16:52:25,2006-01-03,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$31.68,103500,31778,-144%,"+$3,278,765",0.0,1.0,-5.0,0.0,BIIB
1549,D,2006-01-05 16:52:25,2006-01-03,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$45.52,-103500,31778,-77%,"-$4,711,320",0.0,1.0,-5.0,0.0,BIIB
1550,,2006-01-05 16:50:11,2006-01-03,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale,$35.21,-14920,20512,-42%,"-$525,308",0.0,1.0,-5.0,0.0,BIIB
1551,AD,2006-01-05 16:49:34,2005-01-03,BIIB,Wiggins Mark C,EVP - Business Development,M - OptEx,$35.21,12500,95883,+15%,"+$440,104",0.0,1.0,-5.0,0.0,BIIB
1552,AD,2006-01-05 16:49:34,2005-01-03,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale+OE,$66.84,-12500,95883,-12%,"-$835,500",0.0,1.0,-5.0,0.0,BIIB
1553,,2006-01-05 12:44:28,2005-12-23,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",G - Gift,$0.00,-2289,93199,-2%,-$0,0.0,1.0,-5.0,0.0,BIIB
1554,AD,2006-01-05 12:42:11,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,38771,231157,+20%,"+$299,266",0.0,1.0,-5.0,0.0,BIIB
1555,AD,2006-01-05 12:42:11,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$36.49,-75000,231157,-24%,"-$2,736,971",0.0,1.0,-5.0,0.0,BIIB
1556,D,2005-12-28 14:25:06,2005-12-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$16.90,20500,20278,-9234%,"+$346,450",1.0,5.0,1.0,0.0,BIIB
1557,D,2005-12-28 14:25:06,2005-12-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$44.63,-20500,20278,-50%,"-$914,915",1.0,5.0,1.0,0.0,BIIB
1558,D,2005-12-20 11:13:56,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$7.72,38771,137992,+39%,"+$299,266",-1.0,2.0,2.0,3.0,BIIB
1559,D,2005-12-20 11:13:56,2005-10-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$36.49,-38771,137992,-22%,"-$1,414,625",-1.0,2.0,2.0,3.0,BIIB
1560,D,2005-10-04 16:26:43,2005-10-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,18170,+132%,"+$156,906",-3.0,-7.0,0.0,15.0,BIIB
1561,D,2005-10-04 16:26:43,2005-10-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$38.79,-3300,18170,-15%,"-$127,995",-3.0,-7.0,0.0,15.0,BIIB
1562,D,2005-10-04 16:26:21,2005-10-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,21470,+93%,"+$156,906",-3.0,-7.0,0.0,15.0,BIIB
1563,D,2005-10-04 16:26:21,2005-10-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$39.29,-7050,21470,-25%,"-$276,992",-3.0,-7.0,0.0,15.0,BIIB
1564,D,2005-09-30 16:28:21,2005-09-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$12.91,18000,28078,+179%,"+$232,380",1.0,-6.0,-3.0,20.0,BIIB
1565,D,2005-09-30 16:28:21,2005-09-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$38.67,-10200,28078,-27%,"-$394,444",1.0,-6.0,-3.0,20.0,BIIB
1566,D,2005-09-30 16:24:34,2005-09-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$13.40,20500,40778,+101%,"+$274,630",1.0,-6.0,-3.0,20.0,BIIB
1567,D,2005-09-30 16:24:34,2005-09-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$38.34,-10300,40778,-20%,"-$394,881",1.0,-6.0,-3.0,20.0,BIIB
1568,,2005-07-13 13:03:25,2005-07-12,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale,$36.22,-80000,90951,-47%,"-$2,897,573",0.0,5.0,14.0,32.0,BIIB
1569,ADM,2005-07-01 11:35:33,2004-05-04,BIIB,Sharp Philip A,Dir,M - OptEx,$11.73,73000,1625800,+5%,"+$856,290",-1.0,3.0,17.0,30.0,BIIB
1570,ADM,2005-07-01 11:35:33,2004-05-04,BIIB,Sharp Philip A,Dir,S - Sale+OE,$58.99,-78900,1625800,-5%,"-$4,654,510",-1.0,3.0,17.0,30.0,BIIB
1571,D,2005-06-30 12:49:05,2005-06-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$12.91,20500,38278,+115%,"+$264,655",-1.0,0.0,13.0,30.0,BIIB
1572,D,2005-06-30 12:49:05,2005-06-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$33.89,-300,38278,-1%,"-$10,167",-1.0,0.0,13.0,30.0,BIIB
1573,D,2005-06-30 12:47:53,2005-06-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$12.91,20500,38578,+113%,"+$264,655",-1.0,0.0,13.0,30.0,BIIB
1574,D,2005-06-30 12:47:53,2005-06-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$34.31,-20200,38578,-34%,"-$693,082",-1.0,0.0,13.0,30.0,BIIB
1575,D,2005-02-22 15:29:20,2005-02-18,BIIB,Bucknum Thomas J,"EVP, GC",M - OptEx,$45.51,89700,14750,-120%,"+$4,082,569",-2.0,-42.0,-43.0,-40.0,BIIB
1576,D,2005-02-22 15:29:20,2005-02-18,BIIB,Bucknum Thomas J,"EVP, GC",S - Sale+OE,$67.12,-89700,14750,-86%,"-$6,021,032",-2.0,-42.0,-43.0,-40.0,BIIB
1577,D,2005-02-17 13:36:18,2005-02-15,BIIB,Rastetter William H,Exec COB,M - OptEx,$3.35,120313,422306,+40%,"+$403,554",0.0,-1.0,-43.0,-40.0,BIIB
1578,D,2005-02-17 13:36:18,2005-02-15,BIIB,Rastetter William H,Exec COB,S - Sale+OE,$67.73,-120313,422306,-22%,"-$8,149,071",0.0,-1.0,-43.0,-40.0,BIIB
1579,D,2005-02-15 09:02:25,2005-02-14,BIIB,Pangia Robert W,Dir,M - OptEx,$6.38,16250,1000,-107%,"+$103,594",0.0,-2.0,-44.0,-38.0,BIIB
1580,D,2005-02-15 09:02:25,2005-02-14,BIIB,Pangia Robert W,Dir,S - Sale+OE,$67.00,-15750,1000,-94%,"-$1,055,250",0.0,-2.0,-44.0,-38.0,BIIB
1581,D,2005-02-15 08:39:18,2005-02-14,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,45512,+8%,"+$131,075",0.0,-2.0,-44.0,-38.0,BIIB
1582,D,2005-02-15 08:39:18,2005-02-14,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$66.60,-3500,45512,-7%,"-$233,100",0.0,-2.0,-44.0,-38.0,BIIB
1583,D,2005-02-02 12:37:25,2005-01-31,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,49012,+8%,"+$131,075",1.0,2.0,-39.0,-37.0,BIIB
1584,D,2005-02-02 12:37:25,2005-01-31,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$63.50,-3500,49012,-7%,"-$222,251",1.0,2.0,-39.0,-37.0,BIIB
1585,D,2005-01-27 16:37:20,2005-01-25,BIIB,Schenk Lynn,Dir,M - OptEx,$31.08,2000,30000,+7%,"+$62,167",-2.0,3.0,6.0,-38.0,BIIB
1586,M,2005-01-27 16:22:59,2004-12-14,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",G - Gift,$0.00,-162729,166513,-49%,-$0,-2.0,3.0,6.0,-38.0,BIIB
1587,D,2005-01-26 16:39:06,2005-01-24,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,102927,+6%,"+$85,470",0.0,2.0,5.0,-39.0,BIIB
1588,D,2005-01-26 16:39:06,2005-01-24,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$63.94,-5500,102927,-5%,"-$351,697",0.0,2.0,5.0,-39.0,BIIB
1589,D,2005-01-20 16:14:39,2005-01-18,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,52512,+7%,"+$131,075",0.0,-2.0,4.0,-38.0,BIIB
1590,D,2005-01-20 16:14:39,2005-01-18,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$65.97,-3500,52512,-6%,"-$230,895",0.0,-2.0,4.0,-38.0,BIIB
1591,D,2005-01-20 16:12:40,2005-01-18,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,108427,+5%,"+$85,470",0.0,-2.0,4.0,-38.0,BIIB
1592,D,2005-01-20 16:12:40,2005-01-18,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$67.80,-5500,108427,-5%,"-$372,910",0.0,-2.0,4.0,-38.0,BIIB
1593,D,2005-01-12 13:26:00,2005-01-10,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,113927,+5%,"+$85,470",2.0,2.0,0.0,-45.0,BIIB
1594,D,2005-01-12 13:26:00,2005-01-10,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$66.43,-5500,113927,-5%,"-$365,374",2.0,2.0,0.0,-45.0,BIIB
1595,D,2005-01-04 18:41:48,2005-01-03,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$12.91,20500,58778,+54%,"+$264,655",0.0,3.0,1.0,-46.0,BIIB
1596,D,2005-01-04 18:41:48,2005-01-03,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$67.03,-20500,58778,-26%,"-$1,374,155",0.0,3.0,1.0,-46.0,BIIB
1597,D,2005-01-04 18:40:11,2005-01-03,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,119427,+5%,"+$85,470",0.0,3.0,1.0,-46.0,BIIB
1598,D,2005-01-04 18:40:11,2005-01-03,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$67.32,-5500,119427,-4%,"-$370,238",0.0,3.0,1.0,-46.0,BIIB
1599,D,2005-01-04 18:38:45,2005-01-03,BIIB,Wiggins Mark C,EVP - Business Development,M - OptEx,$35.21,12500,95883,+15%,"+$440,104",0.0,3.0,1.0,-46.0,BIIB
1600,D,2005-01-04 18:38:45,2005-01-03,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale+OE,$66.84,-12500,95883,-12%,"-$835,500",0.0,3.0,1.0,-46.0,BIIB
1601,D,2005-01-04 18:37:11,2005-01-03,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3875,56012,+7%,"+$145,119",0.0,3.0,1.0,-46.0,BIIB
1602,D,2005-01-04 18:37:11,2005-01-03,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$66.84,-3875,56012,-6%,"-$259,005",0.0,3.0,1.0,-46.0,BIIB
1603,D,2005-01-04 18:35:16,2005-01-03,BIIB,Good Mary L,Dir,M - OptEx,$14.48,5000,10000,+100%,"+$72,400",0.0,3.0,1.0,-46.0,BIIB
1604,D,2005-01-04 18:35:16,2005-01-03,BIIB,Good Mary L,Dir,S - Sale+OE,$66.90,-5000,10000,-33%,"-$334,500",0.0,3.0,1.0,-46.0,BIIB
1605,D,2005-01-03 07:57:44,2004-12-28,BIIB,Gilman Michael,EVP - Research,M - OptEx,$44.95,12750,36176,+54%,"+$573,175",0.0,-1.0,-3.0,-49.0,BIIB
1606,D,2005-01-03 07:57:44,2004-12-28,BIIB,Gilman Michael,EVP - Research,S - Sale+OE,$67.50,-12750,36176,-26%,"-$860,628",0.0,-1.0,-3.0,-49.0,BIIB
1607,D,2004-12-28 11:08:58,2004-12-27,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$9.67,12593,20278,+164%,"+$121,774",4.0,1.0,-3.0,-48.0,BIIB
1608,D,2004-12-28 11:08:58,2004-12-27,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$65.18,-12593,20278,-38%,"-$820,839",4.0,1.0,-3.0,-48.0,BIIB
1609,D,2004-12-28 09:59:54,2004-12-27,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,124927,+5%,"+$85,470",4.0,1.0,-3.0,-48.0,BIIB
1610,D,2004-12-28 09:59:54,2004-12-27,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$66.05,-5500,124927,-4%,"-$363,274",4.0,1.0,-3.0,-48.0,BIIB
1611,D,2004-12-21 11:41:13,2004-12-20,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.54,5500,130427,+4%,"+$85,470",0.0,3.0,-2.0,-46.0,BIIB
1612,D,2004-12-21 11:41:13,2004-12-20,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$65.02,-5500,130427,-4%,"-$357,606",0.0,3.0,-2.0,-46.0,BIIB
1613,D,2004-12-17 16:23:37,2004-12-15,BIIB,Wiggins Mark C,EVP - Business Development,F - Tax,$64.91,-3225,34755,-8%,"-$209,335",2.0,2.0,5.0,-44.0,BIIB
1614,D,2004-12-17 16:23:37,2004-12-15,BIIB,Wiggins Mark C,EVP - Business Development,M - OptEx,$23.26,9004,34755,+35%,"+$209,418",2.0,2.0,5.0,-44.0,BIIB
1615,D,2004-12-16 11:38:25,2004-12-13,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.83,5500,135927,+4%,"+$87,068",2.0,1.0,3.0,-44.0,BIIB
1616,D,2004-12-16 11:38:25,2004-12-13,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$65.59,-5500,135927,-4%,"-$360,724",2.0,1.0,3.0,-44.0,BIIB
1617,D,2004-12-13 09:44:07,2004-12-09,BIIB,Gilman Michael,EVP - Research,M - OptEx,$40.93,15263,28700,+114%,"+$624,774",1.0,-1.0,0.0,-47.0,BIIB
1618,D,2004-12-13 09:44:07,2004-12-09,BIIB,Gilman Michael,EVP - Research,S - Sale+OE,$65.00,-15263,28700,-35%,"-$992,095",1.0,-1.0,0.0,-47.0,BIIB
1619,D,2004-12-13 09:19:51,2004-12-09,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,5000,65083,+8%,"+$176,850",1.0,-1.0,0.0,-47.0,BIIB
1620,D,2004-12-13 09:19:51,2004-12-09,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$65.00,-5000,65083,-7%,"-$325,000",1.0,-1.0,0.0,-47.0,BIIB
1621,D,2004-12-08 08:43:57,2004-12-06,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,74166,+8%,"+$264,098",5.0,8.0,6.0,-46.0,BIIB
1622,D,2004-12-08 08:43:57,2004-12-06,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$61.05,-5750,74166,-7%,"-$351,038",5.0,8.0,6.0,-46.0,BIIB
1623,D,2004-12-08 08:42:08,2004-12-06,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,5500,95427,+6%,"+$92,950",5.0,8.0,6.0,-46.0,BIIB
1624,D,2004-12-08 08:42:08,2004-12-06,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.06,-5500,95427,-5%,"-$335,812",5.0,8.0,6.0,-46.0,BIIB
1625,M,2004-12-06 13:20:33,2004-12-02,BIIB,Sharp Philip A,Dir,G - Gift,$0.00,-14397,421633,-3%,-$0,0.0,6.0,5.0,-43.0,BIIB
1626,D,2004-12-03 13:16:26,2004-12-02,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,1000,100927,+1%,"+$16,900",-1.0,7.0,7.0,-41.0,BIIB
1627,D,2004-12-03 13:16:26,2004-12-02,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.00,-1000,100927,-1%,"-$60,000",-1.0,7.0,7.0,-41.0,BIIB
1628,D,2004-12-03 13:14:34,2004-12-01,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,79916,+8%,"+$264,098",-1.0,7.0,7.0,-41.0,BIIB
1629,D,2004-12-03 13:14:34,2004-12-01,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.00,-5750,79916,-7%,"-$345,000",-1.0,7.0,7.0,-41.0,BIIB
1630,D,2004-12-01 12:28:10,2004-11-30,BIIB,Glassberg Alan,Dir,M - OptEx,$7.79,10000,13140,+318%,"+$77,917",3.0,5.0,15.0,-32.0,BIIB
1631,D,2004-12-01 12:28:10,2004-11-30,BIIB,Glassberg Alan,Dir,S - Sale+OE,$58.05,-10000,13140,-43%,"-$580,500",3.0,5.0,15.0,-32.0,BIIB
1632,D,2004-12-01 12:25:46,2004-11-30,BIIB,Bucknum Thomas J,"EVP, GC",M - OptEx,$14.77,33900,9000,-136%,"+$500,568",3.0,5.0,15.0,-32.0,BIIB
1633,D,2004-12-01 12:25:46,2004-11-30,BIIB,Bucknum Thomas J,"EVP, GC",S - Sale+OE,$59.00,-33900,9000,-79%,"-$2,000,100",3.0,5.0,15.0,-32.0,BIIB
1634,D,2004-12-01 12:04:44,2004-11-29,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,101927,+5%,"+$76,050",3.0,5.0,15.0,-32.0,BIIB
1635,D,2004-12-01 12:04:44,2004-11-29,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.69,-4500,101927,-4%,"-$264,109",3.0,5.0,15.0,-32.0,BIIB
1636,D,2004-11-23 11:02:03,2004-11-22,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,106427,+4%,"+$76,050",1.0,3.0,15.0,-33.0,BIIB
1637,D,2004-11-23 11:02:03,2004-11-22,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.72,-4500,106427,-4%,"-$264,250",1.0,3.0,15.0,-33.0,BIIB
1638,D,2004-11-23 10:41:21,2004-11-19,BIIB,Ross Bruce,Dir,M - OptEx,$31.08,15000,15000,New,"+$466,250",1.0,3.0,15.0,-33.0,BIIB
1639,D,2004-11-23 10:41:21,2004-11-19,BIIB,Ross Bruce,Dir,S - Sale+OE,$55.91,-15000,15000,-50%,"-$838,650",1.0,3.0,15.0,-33.0,BIIB
1640,D,2004-11-19 14:09:11,2004-11-17,BIIB,Rohn William R,COO,S - Sale+OE,$58.29,-2700,469152,-1%,"-$157,393",-4.0,2.0,14.0,-32.0,BIIB
1641,D,2004-11-19 14:07:36,2004-11-17,BIIB,Rohn William R,COO,M - OptEx,$6.92,75000,471852,+19%,"+$518,753",-4.0,2.0,14.0,-32.0,BIIB
1642,D,2004-11-19 14:07:36,2004-11-17,BIIB,Rohn William R,COO,S - Sale+OE,$58.10,-72300,471852,-13%,"-$4,200,426",-4.0,2.0,14.0,-32.0,BIIB
1643,A,2004-11-17 16:55:50,2004-11-15,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale,$58.80,-5000,28976,-15%,"-$294,000",1.0,1.0,15.0,-31.0,BIIB
1644,D,2004-11-17 16:45:27,2004-11-15,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,110927,+4%,"+$76,050",1.0,1.0,15.0,-31.0,BIIB
1645,D,2004-11-17 16:45:27,2004-11-15,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.72,-4500,110927,-4%,"-$264,250",1.0,1.0,15.0,-31.0,BIIB
1646,,2004-11-17 16:43:59,2004-11-15,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale,$58.80,-5000,28976,-15%,"-$294,000",1.0,1.0,15.0,-31.0,BIIB
1647,D,2004-11-09 14:50:02,2004-11-08,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,5500,115427,+5%,"+$92,950",0.0,-3.0,7.0,-36.0,BIIB
1648,D,2004-11-09 14:50:02,2004-11-08,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.19,-5500,115427,-5%,"-$336,518",0.0,-3.0,7.0,-36.0,BIIB
1649,D,2004-11-09 14:47:01,2004-11-08,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,85666,+7%,"+$264,098",0.0,-3.0,7.0,-36.0,BIIB
1650,D,2004-11-09 14:47:01,2004-11-08,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$61.43,-5750,85666,-6%,"-$353,204",0.0,-3.0,7.0,-36.0,BIIB
1651,,2004-11-09 14:44:50,2004-11-08,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale,$62.00,-571,11881,-5%,"-$35,402",0.0,-3.0,7.0,-36.0,BIIB
1652,D,2004-11-04 16:01:39,2004-11-03,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,1000,120927,+1%,"+$16,900",1.0,-1.0,3.0,-36.0,BIIB
1653,D,2004-11-04 16:01:39,2004-11-03,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.00,-1000,120927,-1%,"-$60,002",1.0,-1.0,3.0,-36.0,BIIB
1654,D,2004-11-02 11:46:57,2004-11-01,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,121927,+4%,"+$76,050",-1.0,5.0,5.0,-35.0,BIIB
1655,D,2004-11-02 11:46:57,2004-11-01,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.02,-4500,121927,-4%,"-$261,096",-1.0,5.0,5.0,-35.0,BIIB
1656,D,2004-11-01 10:53:52,2004-10-28,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,1000,126427,+1%,"+$16,900",-1.0,5.0,1.0,-36.0,BIIB
1657,D,2004-11-01 10:53:52,2004-10-28,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.00,-1000,126427,-1%,"-$60,000",-1.0,5.0,1.0,-36.0,BIIB
1658,D,2004-11-01 10:52:34,2004-10-28,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,91416,+7%,"+$264,098",-1.0,5.0,1.0,-36.0,BIIB
1659,D,2004-11-01 10:52:34,2004-10-28,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.00,-5750,91416,-6%,"-$345,000",-1.0,5.0,1.0,-36.0,BIIB
1660,AD,2004-11-01 10:51:16,2004-10-11,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,97166,+6%,"+$264,098",-1.0,5.0,1.0,-36.0,BIIB
1661,AD,2004-11-01 10:51:16,2004-10-11,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.04,-5750,97166,-6%,"-$345,230",-1.0,5.0,1.0,-36.0,BIIB
1662,D,2004-10-26 08:45:00,2004-10-25,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,127427,+4%,"+$76,050",2.0,3.0,3.0,-35.0,BIIB
1663,D,2004-10-26 08:45:00,2004-10-25,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$55.95,-4500,127427,-3%,"-$251,761",2.0,3.0,3.0,-35.0,BIIB
1664,AD,2004-10-26 08:42:26,2004-10-18,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,4500,131927,+4%,"+$76,050",2.0,3.0,3.0,-35.0,BIIB
1665,AD,2004-10-26 08:42:26,2004-10-18,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$57.79,-4500,131927,-3%,"-$260,034",2.0,3.0,3.0,-35.0,BIIB
1666,D,2004-10-20 11:31:46,2004-10-18,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$16.90,3825,131927,+3%,"+$64,643",2.0,-1.0,0.0,-39.0,BIIB
1667,D,2004-10-20 11:31:46,2004-10-18,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$57.79,-4500,131927,-3%,"-$260,034",2.0,-1.0,0.0,-39.0,BIIB
1668,D,2004-10-13 13:49:15,2004-10-11,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,97416,+6%,"+$264,098",-3.0,-5.0,0.0,-39.0,BIIB
1669,D,2004-10-13 13:49:15,2004-10-11,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.04,-5750,97416,-6%,"-$345,230",-3.0,-5.0,0.0,-39.0,BIIB
1670,D,2004-10-13 13:43:33,2004-10-11,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$15.33,5500,136427,+4%,"+$84,290",-3.0,-5.0,0.0,-39.0,BIIB
1671,D,2004-10-13 13:43:33,2004-10-11,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.11,-5500,136427,-4%,"-$330,600",-3.0,-5.0,0.0,-39.0,BIIB
1672,D,2004-10-06 10:40:34,2004-10-04,BIIB,Wiggins Mark C,EVP - Business Development,M - OptEx,$35.21,12500,88818,+16%,"+$440,104",1.0,-3.0,-3.0,-43.0,BIIB
1673,D,2004-10-06 10:40:34,2004-10-04,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale+OE,$62.49,-12500,88818,-12%,"-$781,125",1.0,-3.0,-3.0,-43.0,BIIB
1674,D,2004-10-05 16:48:35,2004-10-04,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,95927,+6%,"+$64,515",1.0,-3.0,-8.0,-43.0,BIIB
1675,D,2004-10-05 16:48:35,2004-10-04,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$62.64,-5500,95927,-5%,"-$344,529",1.0,-3.0,-8.0,-43.0,BIIB
1676,D,2004-10-05 10:49:57,2004-10-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,28520,+57%,"+$156,906",-1.0,-3.0,-9.0,-44.0,BIIB
1677,D,2004-10-05 10:49:57,2004-10-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$61.00,-10350,28520,-27%,"-$631,350",-1.0,-3.0,-9.0,-44.0,BIIB
1678,D,2004-10-05 10:47:48,2004-10-01,BIIB,Good Mary L,Dir,M - OptEx,$14.48,5000,15000,+50%,"+$72,400",-1.0,-3.0,-9.0,-44.0,BIIB
1679,D,2004-10-05 10:47:48,2004-10-01,BIIB,Good Mary L,Dir,S - Sale+OE,$61.00,-5000,15000,-25%,"-$305,000",-1.0,-3.0,-9.0,-44.0,BIIB
1680,D,2004-09-29 09:52:34,2004-09-27,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,102756,+6%,"+$264,098",1.0,3.0,-2.0,-36.0,BIIB
1681,D,2004-09-29 09:52:34,2004-09-27,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.00,-5750,102756,-5%,"-$345,000",1.0,3.0,-2.0,-36.0,BIIB
1682,D,2004-09-29 09:24:03,2004-09-27,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$9.67,12592,32871,+62%,"+$121,765",1.0,3.0,-2.0,-36.0,BIIB
1683,D,2004-09-29 09:24:03,2004-09-27,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$59.21,-12592,32871,-28%,"-$745,572",1.0,3.0,-2.0,-36.0,BIIB
1684,D,2004-09-29 09:11:45,2004-09-27,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,101427,+6%,"+$64,515",1.0,3.0,-2.0,-36.0,BIIB
1685,D,2004-09-29 09:11:45,2004-09-27,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$59.59,-5500,101427,-5%,"-$327,750",1.0,3.0,-2.0,-36.0,BIIB
1686,D,2004-09-21 14:49:56,2004-09-20,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,106927,+5%,"+$64,515",0.0,-4.0,-7.0,-38.0,BIIB
1687,D,2004-09-21 14:49:56,2004-09-20,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$62.11,-5500,106927,-5%,"-$341,630",0.0,-4.0,-7.0,-38.0,BIIB
1688,D,2004-09-15 16:38:43,2004-09-13,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,108506,+6%,"+$264,098",-1.0,0.0,-6.0,-37.0,BIIB
1689,D,2004-09-15 16:38:43,2004-09-13,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$61.75,-5750,108506,-5%,"-$355,063",-1.0,0.0,-6.0,-37.0,BIIB
1690,AD,2004-09-15 16:38:06,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,2177,129329,+2%,"+$99,990",-1.0,0.0,-6.0,-37.0,BIIB
1691,AD,2004-09-15 16:38:06,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.00,-2177,129329,-2%,"-$130,620",-1.0,0.0,-6.0,-37.0,BIIB
1692,D,2004-09-15 16:37:36,2004-09-13,BIIB,Gilman Michael,EVP - Research,M - OptEx,$44.54,30000,27561,-1230%,"+$1,336,200",-1.0,0.0,-6.0,-37.0,BIIB
1693,D,2004-09-15 16:37:36,2004-09-13,BIIB,Gilman Michael,EVP - Research,S - Sale+OE,$62.50,-30000,27561,-52%,"-$1,875,000",-1.0,0.0,-6.0,-37.0,BIIB
1694,D,2004-09-15 12:30:15,2004-09-13,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,112427,+5%,"+$64,515",-1.0,-1.0,-7.0,-39.0,BIIB
1695,D,2004-09-15 12:30:15,2004-09-13,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.79,-5500,112427,-5%,"-$339,860",-1.0,-1.0,-7.0,-39.0,BIIB
1696,D,2004-09-08 11:55:06,2004-09-07,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,117927,+5%,"+$64,515",-1.0,2.0,2.0,-37.0,BIIB
1697,D,2004-09-08 11:55:06,2004-09-07,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.30,-5500,117927,-4%,"-$337,150",-1.0,2.0,2.0,-37.0,BIIB
1698,D,2004-09-02 16:29:27,2004-08-31,BIIB,Rohn William R,COO,M - OptEx,$6.92,25000,544152,+5%,"+$172,918",-1.0,0.0,3.0,-36.0,BIIB
1699,D,2004-09-02 16:29:27,2004-08-31,BIIB,Rohn William R,COO,S - Sale+OE,$58.54,-25000,544152,-4%,"-$1,463,541",-1.0,0.0,3.0,-36.0,BIIB
1700,AD,2004-09-02 16:28:07,2004-08-30,BIIB,Rohn William R,COO,M - OptEx,$6.79,50000,403690,+14%,"+$339,438",-1.0,0.0,3.0,-36.0,BIIB
1701,AD,2004-09-02 16:28:07,2004-08-30,BIIB,Rohn William R,COO,S - Sale+OE,$58.59,-50000,403690,-11%,"-$2,929,252",-1.0,0.0,3.0,-36.0,BIIB
1702,D,2004-09-01 16:35:48,2004-08-30,BIIB,Rohn William R,COO,M - OptEx,$6.79,50000,403013,+14%,"+$339,438",2.0,1.0,2.0,-32.0,BIIB
1703,D,2004-09-01 16:35:48,2004-08-30,BIIB,Rohn William R,COO,S - Sale+OE,$58.59,-50000,403013,-11%,"-$2,929,252",2.0,1.0,2.0,-32.0,BIIB
1704,M,2004-08-31 12:51:15,2004-07-16,BIIB,Sharp Philip A,Dir,G - Gift,$0.00,-41970,436030,-9%,-$0,1.0,4.0,4.0,-30.0,BIIB
1705,D,2004-08-31 09:11:36,2004-08-30,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,123427,+5%,"+$64,515",1.0,4.0,4.0,-30.0,BIIB
1706,D,2004-08-31 09:11:36,2004-08-30,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$59.58,-5500,123427,-4%,"-$327,664",1.0,4.0,4.0,-30.0,BIIB
1707,D,2004-08-31 09:06:17,2004-08-30,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,5750,114231,+5%,"+$264,098",1.0,4.0,4.0,-30.0,BIIB
1708,D,2004-08-31 09:06:17,2004-08-30,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.28,-5750,114231,-5%,"-$346,599",1.0,4.0,4.0,-30.0,BIIB
1709,D,2004-08-27 09:38:14,2004-08-25,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,1000,128927,+1%,"+$11,730",1.0,3.0,-1.0,13.0,BIIB
1710,D,2004-08-27 09:38:14,2004-08-25,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.00,-1000,128927,-1%,"-$60,003",1.0,3.0,-1.0,13.0,BIIB
1711,D,2004-08-24 12:08:07,2004-08-23,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,129927,+4%,"+$52,785",0.0,-1.0,1.0,11.0,BIIB
1712,D,2004-08-24 12:08:07,2004-08-23,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$59.61,-4500,129927,-3%,"-$268,242",0.0,-1.0,1.0,11.0,BIIB
1713,D,2004-08-24 12:07:33,2004-08-20,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$6.92,80000,178272,+81%,"+$553,336",0.0,-1.0,1.0,11.0,BIIB
1714,D,2004-08-24 12:07:33,2004-08-20,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$59.03,-80000,178272,-31%,"-$4,722,780",0.0,-1.0,1.0,11.0,BIIB
1715,D,2004-08-19 12:59:22,2004-08-18,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,1000,134427,+1%,"+$11,730",-2.0,0.0,3.0,12.0,BIIB
1716,D,2004-08-19 12:59:22,2004-08-18,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.00,-1000,134427,-1%,"-$60,000",-2.0,0.0,3.0,12.0,BIIB
1717,D,2004-08-19 12:57:56,2004-08-18,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,9323,119981,+8%,"+$428,205",-2.0,0.0,3.0,12.0,BIIB
1718,D,2004-08-19 12:57:56,2004-08-18,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.05,-9323,119981,-7%,"-$559,806",-2.0,0.0,3.0,12.0,BIIB
1719,D,2004-08-18 13:06:35,2004-08-16,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,135427,+3%,"+$52,785",3.0,1.0,5.0,15.0,BIIB
1720,D,2004-08-18 13:06:35,2004-08-16,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.42,-4500,135427,-3%,"-$262,890",3.0,1.0,5.0,15.0,BIIB
1721,D,2004-08-11 12:41:27,2004-08-10,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,139927,+3%,"+$52,785",2.0,3.0,8.0,17.0,BIIB
1722,D,2004-08-11 12:41:27,2004-08-10,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$55.90,-4500,139927,-3%,"-$251,561",2.0,3.0,8.0,17.0,BIIB
1723,AD,2004-08-11 08:37:22,2004-08-04,BIIB,Glassberg Alan,Dir,M - OptEx,$6.38,20000,23140,+637%,"+$127,637",2.0,3.0,8.0,17.0,BIIB
1724,AD,2004-08-11 08:37:22,2004-08-04,BIIB,Glassberg Alan,Dir,S - Sale+OE,$58.12,-20000,23140,-46%,"-$1,162,400",2.0,3.0,8.0,17.0,BIIB
1725,D,2004-08-05 15:20:18,2004-08-04,BIIB,Glassberg Alan,Dir,M - OptEx,$5.91,15000,28140,+114%,"+$88,678",0.0,1.0,6.0,14.0,BIIB
1726,D,2004-08-05 15:20:18,2004-08-04,BIIB,Glassberg Alan,Dir,S - Sale+OE,$58.16,-15000,28140,-35%,"-$872,400",0.0,1.0,6.0,14.0,BIIB
1727,,2004-08-05 15:18:31,2004-08-04,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale,$57.82,-22500,33976,-40%,"-$1,300,900",0.0,1.0,6.0,14.0,BIIB
1728,D,2004-08-04 14:58:56,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$45.93,2177,129304,+2%,"+$99,990",0.0,-2.0,4.0,12.0,BIIB
1729,D,2004-08-04 14:58:56,2004-08-02,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$60.00,-2177,129304,-2%,"-$130,620",0.0,-2.0,4.0,12.0,BIIB
1730,D,2004-08-04 13:58:02,2004-08-02,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,144427,+3%,"+$52,785",0.0,-2.0,4.0,12.0,BIIB
1731,D,2004-08-04 13:58:02,2004-08-02,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$58.61,-4500,144427,-3%,"-$263,727",0.0,-2.0,4.0,12.0,BIIB
1732,D,2004-08-03 12:58:44,2004-07-30,BIIB,Wiggins Mark C,EVP - Business Development,M - OptEx,$23.74,16318,60108,+37%,"+$387,356",-1.0,-5.0,2.0,11.0,BIIB
1733,D,2004-08-03 12:58:44,2004-07-30,BIIB,Wiggins Mark C,EVP - Business Development,S - Sale+OE,$60.03,-16318,60108,-21%,"-$979,496",-1.0,-5.0,2.0,11.0,BIIB
1734,D,2004-08-02 15:03:54,2004-06-15,BIIB,Gilman Michael,EVP - Research,A - Grant,$0.00,4000,12966,+45%,+$0,-3.0,-7.0,-2.0,4.0,BIIB
1735,D,2004-08-02 14:03:49,2004-07-30,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,1000,148927,+1%,"+$11,730",-3.0,-7.0,-2.0,4.0,BIIB
1736,D,2004-08-02 14:03:49,2004-07-30,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$59.86,-1000,148927,-1%,"-$59,859",-3.0,-7.0,-2.0,4.0,BIIB
1737,D,2004-07-27 11:00:06,2004-07-26,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,149927,+3%,"+$52,785",5.0,8.0,10.0,17.0,BIIB
1738,DM,2004-07-27 11:00:06,2004-07-26,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$53.43,-4500,149927,-3%,"-$240,442",5.0,8.0,10.0,17.0,BIIB
1739,D,2004-07-20 11:26:34,2004-07-19,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,4500,154427,+3%,"+$52,785",1.0,-5.0,3.0,18.0,BIIB
1740,D,2004-07-20 11:26:34,2004-07-19,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$57.92,-4500,154427,-3%,"-$260,659",1.0,-5.0,3.0,18.0,BIIB
1741,D,2004-07-19 15:58:50,2004-07-19,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,59186,+6%,"+$131,075",-1.0,-3.0,3.0,13.0,BIIB
1742,D,2004-07-19 15:58:50,2004-07-19,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$57.96,-3500,59186,-6%,"-$202,859",-1.0,-3.0,3.0,13.0,BIIB
1743,D,2004-07-15 16:14:33,2004-07-13,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$11.73,5500,158927,+4%,"+$64,515",-4.0,-7.0,-2.0,11.0,BIIB
1744,D,2004-07-15 16:14:33,2004-07-13,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.58,-5500,158927,-3%,"-$333,215",-4.0,-7.0,-2.0,11.0,BIIB
1745,D,2004-07-09 08:58:47,2004-07-06,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$10.06,5500,164427,+3%,"+$55,344",-1.0,-5.0,-10.0,4.0,BIIB
1746,D,2004-07-09 08:58:47,2004-07-06,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$62.54,-5500,164427,-3%,"-$343,990",-1.0,-5.0,-10.0,4.0,BIIB
1747,D,2004-07-08 13:54:48,2004-07-06,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,62686,+6%,"+$131,075",-1.0,-4.0,-9.0,3.0,BIIB
1748,D,2004-07-08 13:54:48,2004-07-06,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$58.32,-3500,62686,-5%,"-$204,105",-1.0,-4.0,-9.0,3.0,BIIB
1749,AD,2004-07-08 13:53:37,2004-06-29,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,96327,+6%,"+$40,205",-1.0,-4.0,-9.0,3.0,BIIB
1750,AD,2004-07-08 13:53:37,2004-06-29,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$63.07,-5500,96327,-5%,"-$346,893",-1.0,-4.0,-9.0,3.0,BIIB
1751,D,2004-06-30 11:08:46,2004-06-29,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,96327,+6%,"+$40,205",1.0,0.0,-5.0,8.0,BIIB
1752,D,2004-06-30 11:08:46,2004-06-29,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$63.07,-5500,96327,-5%,"-$346,893",1.0,0.0,-5.0,8.0,BIIB
1753,D,2004-06-29 10:51:40,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$9.67,12593,45463,+38%,"+$121,774",0.0,-2.0,-7.0,5.0,BIIB
1754,D,2004-06-29 10:51:40,2004-06-28,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$63.00,-12593,45463,-22%,"-$793,359",0.0,-2.0,-7.0,5.0,BIIB
1755,D,2004-06-28 10:23:04,2004-06-24,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,1000,101827,+1%,"+$7,310",1.0,-1.0,-9.0,6.0,BIIB
1756,D,2004-06-28 10:23:04,2004-06-24,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.09,-1000,101827,-1%,"-$60,094",1.0,-1.0,-9.0,6.0,BIIB
1757,D,2004-06-23 13:24:39,2004-06-21,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,4500,102827,+5%,"+$32,895",3.0,8.0,-5.0,13.0,BIIB
1758,D,2004-06-23 13:24:39,2004-06-21,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$57.53,-4500,102827,-4%,"-$258,881",3.0,8.0,-5.0,13.0,BIIB
1759,D,2004-06-21 15:54:51,2004-06-21,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3500,66186,+6%,"+$131,075",-1.0,7.0,-2.0,14.0,BIIB
1760,D,2004-06-21 15:54:51,2004-06-21,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$58.30,-3500,66186,-5%,"-$204,039",-1.0,7.0,-2.0,14.0,BIIB
1761,D,2004-06-15 16:25:08,2004-06-14,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,107327,+5%,"+$40,205",1.0,-3.0,2.0,10.0,BIIB
1762,D,2004-06-15 16:25:08,2004-06-14,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$60.02,-5500,107327,-5%,"-$330,109",1.0,-3.0,2.0,10.0,BIIB
1763,D,2004-06-08 13:07:21,2004-06-07,BIIB,Schneier Craig Eric,"EVP, HR",M - OptEx,$37.45,3875,69686,+6%,"+$145,119",-2.0,-6.0,-1.0,-3.0,BIIB
1764,D,2004-06-08 13:07:21,2004-06-07,BIIB,Schneier Craig Eric,"EVP, HR",S - Sale+OE,$61.98,-3875,69686,-5%,"-$240,178",-2.0,-6.0,-1.0,-3.0,BIIB
1765,D,2004-06-08 13:03:42,2004-06-07,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,112827,+5%,"+$40,205",-2.0,-6.0,-1.0,-3.0,BIIB
1766,D,2004-06-08 13:03:42,2004-06-07,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.79,-5500,112827,-5%,"-$339,865",-2.0,-6.0,-1.0,-3.0,BIIB
1767,D,2004-06-04 13:48:47,2004-06-02,BIIB,Rohn William R,COO,S - Sale+OE,$63.67,-18700,515088,-4%,"-$1,190,588",0.0,-3.0,1.0,1.0,BIIB
1768,D,2004-06-04 13:47:59,2004-06-02,BIIB,Rohn William R,COO,A - Grant,$7.72,50000,533788,+10%,"+$385,940",0.0,-3.0,1.0,1.0,BIIB
1769,D,2004-06-04 13:47:59,2004-06-02,BIIB,Rohn William R,COO,S - Sale+OE,$63.32,-31300,533788,-6%,"-$1,981,808",0.0,-3.0,1.0,1.0,BIIB
1770,D,2004-06-02 16:27:51,2004-06-01,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,118327,+5%,"+$40,205",-3.0,-1.0,-1.0,-6.0,BIIB
1771,D,2004-06-02 16:27:51,2004-06-01,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$62.01,-5500,118327,-4%,"-$341,051",-3.0,-1.0,-1.0,-6.0,BIIB
1772,D,2004-05-26 14:04:41,2004-05-25,BIIB,Young William,Dir,M - OptEx,$16.26,52500,0,-100%,"+$853,671",-1.0,-1.0,-2.0,-10.0,BIIB
1773,D,2004-05-26 14:04:41,2004-05-25,BIIB,Young William,Dir,S - Sale+OE,$62.52,-52500,0,-100%,"-$3,282,300",-1.0,-1.0,-2.0,-10.0,BIIB
1774,D,2004-05-26 14:03:58,2004-05-24,BIIB,Rastetter William H,Exec COB,M - OptEx,$3.35,29081,500710,+6%,"+$97,543",-1.0,-1.0,-2.0,-10.0,BIIB
1775,D,2004-05-26 14:03:58,2004-05-24,BIIB,Rastetter William H,Exec COB,S - Sale+OE,$62.51,-29081,500710,-5%,"-$1,817,714",-1.0,-1.0,-2.0,-10.0,BIIB
1776,D,2004-05-26 14:03:07,2004-05-24,BIIB,Mullen James C,"CEO, Pres",M - OptEx,$7.31,5500,123827,+5%,"+$40,205",-1.0,-1.0,-2.0,-10.0,BIIB
1777,D,2004-05-26 14:03:07,2004-05-24,BIIB,Mullen James C,"CEO, Pres",S - Sale+OE,$61.31,-5500,123827,-4%,"-$337,198",-1.0,-1.0,-2.0,-10.0,BIIB
1778,DM,2004-05-26 14:02:34,2004-05-24,BIIB,Good Mary L,Dir,M - OptEx,$14.48,14500,20000,+264%,"+$209,960",-1.0,-1.0,-2.0,-10.0,BIIB
1779,DM,2004-05-26 14:02:34,2004-05-24,BIIB,Good Mary L,Dir,S - Sale+OE,$61.90,-14500,20000,-42%,"-$897,550",-1.0,-1.0,-2.0,-10.0,BIIB
1780,D,2004-05-26 14:01:44,2004-05-25,BIIB,Bucknum Thomas J,"EVP, GC",M - OptEx,$13.04,30000,24500,-545%,"+$391,200",-1.0,-1.0,-2.0,-10.0,BIIB
1781,D,2004-05-26 14:01:44,2004-05-25,BIIB,Bucknum Thomas J,"EVP, GC",S - Sale+OE,$62.52,-30000,24500,-55%,"-$1,875,450",-1.0,-1.0,-2.0,-10.0,BIIB
1782,D,2004-05-26 14:01:06,2004-05-26,BIIB,Glassberg Alan,Dir,M - OptEx,$4.36,10000,13140,+318%,"+$43,570",-1.0,-1.0,-2.0,-10.0,BIIB
1783,D,2004-05-26 14:01:06,2004-05-26,BIIB,Glassberg Alan,Dir,S - Sale+OE,$63.38,-10000,13140,-43%,"-$633,780",-1.0,-1.0,-2.0,-10.0,BIIB
1784,D,2004-05-20 13:14:48,2004-05-19,BIIB,Rastetter William H,Exec COB,M - OptEx,$3.35,25000,529791,+5%,"+$83,855",2.0,7.0,-3.0,-4.0,BIIB
1785,D,2004-05-20 13:14:48,2004-05-19,BIIB,Rastetter William H,Exec COB,S - Sale+OE,$60.03,-25000,529791,-5%,"-$1,500,750",2.0,7.0,-3.0,-4.0,BIIB
1786,D,2004-05-19 08:26:08,2004-05-18,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",M - OptEx,$6.92,60000,258272,+30%,"+$415,002",0.0,7.0,-2.0,-2.0,BIIB
1787,D,2004-05-19 08:26:08,2004-05-18,BIIB,Matsui Connie,"EVP, Corp. Strategy, Comm.",S - Sale+OE,$59.04,-60000,258272,-19%,"-$3,542,600",0.0,7.0,-2.0,-2.0,BIIB
1788,D,2004-05-19 08:24:03,2004-05-18,BIIB,Dunn John Michael,"EVP, New Ventures",M - OptEx,$35.37,15000,69971,+27%,"+$530,550",0.0,7.0,-2.0,-2.0,BIIB
1789,D,2004-05-19 08:24:03,2004-05-18,BIIB,Dunn John Michael,"EVP, New Ventures",S - Sale+OE,$59.05,-15000,69971,-18%,"-$885,800",0.0,7.0,-2.0,-2.0,BIIB
1790,,2004-05-17 12:38:59,2004-05-14,BIIB,Sharp Philip A,Dir,S - Sale,$58.76,-294100,956000,-24%,"-$17,281,808",-1.0,5.0,2.0,1.0,BIIB
1791,D,2004-05-14 13:12:37,2004-05-13,BIIB,Sharp Philip A,Dir,M - OptEx,$11.73,65000,772100,+9%,"+$762,450",0.0,4.0,2.0,3.0,BIIB
1792,D,2004-05-14 13:12:37,2004-05-13,BIIB,Sharp Philip A,Dir,S - Sale+OE,$58.00,-65000,772100,-8%,"-$3,770,000",0.0,4.0,2.0,3.0,BIIB
1793,AD,2004-05-14 13:11:49,2004-05-04,BIIB,Sharp Philip A,Dir,M - OptEx,$11.73,23000,65000,+55%,"+$269,790",0.0,4.0,2.0,3.0,BIIB
1794,AD,2004-05-14 13:11:49,2004-05-04,BIIB,Sharp Philip A,Dir,S - Sale+OE,$59.00,-23000,65000,-26%,"-$1,357,000",0.0,4.0,2.0,3.0,BIIB
1795,D,2004-05-06 17:42:39,2004-05-04,BIIB,Rastetter William H,Exec COB,M - OptEx,$1.17,580222,788891,+278%,"+$676,493",-1.0,1.0,7.0,5.0,BIIB
1796,D,2004-05-06 17:42:39,2004-05-04,BIIB,Rastetter William H,Exec COB,S - Sale+OE,$58.74,-130000,788891,-14%,"-$7,635,900",-1.0,1.0,7.0,5.0,BIIB
1797,D,2004-05-06 15:09:05,2004-05-05,BIIB,Glassberg Alan,Dir,M - OptEx,$4.06,30000,8140,-137%,"+$121,875",-2.0,-2.0,4.0,2.0,BIIB
1798,D,2004-05-06 15:09:05,2004-05-05,BIIB,Glassberg Alan,Dir,S - Sale+OE,$59.00,-30000,8140,-79%,"-$1,770,000",-2.0,-2.0,4.0,2.0,BIIB
1799,D,2004-05-06 12:55:02,2004-05-05,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$12.91,10000,79278,+14%,"+$129,100",-2.0,-2.0,4.0,2.0,BIIB
1800,D,2004-05-06 12:55:02,2004-05-05,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$58.28,-10000,79278,-11%,"-$582,804",-2.0,-2.0,4.0,2.0,BIIB
1801,D,2004-05-06 11:30:38,2004-05-05,BIIB,Pangia Robert W,Dir,M - OptEx,$6.38,30000,17250,-235%,"+$191,250",-2.0,-2.0,4.0,2.0,BIIB
1802,D,2004-05-06 11:30:38,2004-05-05,BIIB,Pangia Robert W,Dir,S - Sale+OE,$58.57,-29000,17250,-63%,"-$1,698,400",-2.0,-2.0,4.0,2.0,BIIB
1803,D,2004-05-05 16:38:09,2004-05-04,BIIB,Sharp Philip A,Dir,M - OptEx,$11.73,23000,1544200,+2%,"+$269,790",-2.0,-2.0,4.0,-3.0,BIIB
1804,DM,2004-05-05 16:38:09,2004-05-04,BIIB,Sharp Philip A,Dir,S - Sale+OE,$58.99,-78900,1544200,-5%,"-$4,654,510",-2.0,-2.0,4.0,-3.0,BIIB
1805,D,2004-05-05 15:35:28,2004-05-04,BIIB,Bucknum Thomas J,"EVP, GC",M - OptEx,$13.40,35000,54500,+179%,"+$469,000",2.0,0.0,6.0,-1.0,BIIB
1806,D,2004-05-05 15:35:28,2004-05-04,BIIB,Bucknum Thomas J,"EVP, GC",S - Sale+OE,$58.61,-35000,54500,-39%,"-$2,051,500",2.0,0.0,6.0,-1.0,BIIB
1807,D,2004-04-05 21:19:07,2004-04-01,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,920,-110%,"+$156,906",-1.0,-2.0,0.0,8.0,BIIB
1808,D,2004-04-05 21:19:07,2004-04-01,BIIB,Keller Thomas F,Dir,S - Sale+OE,$55.53,-10350,920,-92%,"-$574,700",-1.0,-2.0,0.0,8.0,BIIB
1809,D,2004-04-05 19:24:30,2004-04-01,BIIB,Hanna Nabil,EVP Discovery Research,M - OptEx,$0.46,105000,450905,+30%,"+$48,817",-1.0,-2.0,0.0,8.0,BIIB
1810,D,2004-04-05 19:24:30,2004-04-01,BIIB,Hanna Nabil,EVP Discovery Research,S - Sale+OE,$55.23,-105000,450905,-19%,"-$5,799,000",-1.0,-2.0,0.0,8.0,BIIB
1811,D,2004-03-31 15:15:15,2004-03-29,BIIB,Adelman Burt A,EVP Development,M - OptEx,$8.85,12592,20278,+164%,"+$111,451",-1.0,2.0,2.0,8.0,BIIB
1812,D,2004-03-31 15:15:15,2004-03-29,BIIB,Adelman Burt A,EVP Development,S - Sale+OE,$53.37,-12592,20278,-38%,"-$672,035",-1.0,2.0,2.0,8.0,BIIB
1813,D,2004-03-19 18:58:34,2004-03-17,BIIB,Rastetter William H,Exec COB,M - OptEx,$0.60,8000,447669,+2%,"+$4,834",-1.0,3.0,14.0,17.0,BIIB
1814,D,2004-03-17 20:27:31,2004-03-16,BIIB,Hanna Nabil,EVP Discovery Research,M - OptEx,$0.60,5664,450289,+1%,"+$3,422",-1.0,-3.0,7.0,14.0,BIIB
1815,AD,2004-03-09 09:43:02,2004-02-06,BIIB,Rastetter William H,Exec COB,A - Grant,$0.00,50000,439669,+13%,+$0,-2.0,-8.0,-1.0,6.0,BIIB
1816,D,2004-03-04 18:05:51,2004-03-02,BIIB,Rohn William R,"EVP, COO",M - OptEx,$7.72,20200,403013,+5%,"+$155,920",0.0,-7.0,-4.0,2.0,BIIB
1817,D,2004-03-04 18:05:51,2004-03-02,BIIB,Rohn William R,"EVP, COO",S - Sale+OE,$55.71,-20200,403013,-5%,"-$1,125,299",0.0,-7.0,-4.0,2.0,BIIB
1818,,2004-03-04 17:59:25,2004-03-02,BIIB,Rohn William R,"EVP, COO",M - OptEx,$7.32,26800,19625,-374%,"+$196,298",0.0,-7.0,-4.0,2.0,BIIB
1819,,2004-03-04 17:59:25,2004-03-02,BIIB,Rohn William R,"EVP, COO",S - Sale,$55.75,-26800,19625,-58%,"-$1,494,091",0.0,-7.0,-4.0,2.0,BIIB
1820,,2004-03-04 17:51:00,2004-03-02,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.19,17800,19625,+975%,"+$110,138",0.0,-7.0,-4.0,2.0,BIIB
1821,,2004-03-04 17:51:00,2004-03-02,BIIB,Rohn William R,"EVP, COO",S - Sale,$55.59,-17800,19625,-48%,"-$989,537",0.0,-7.0,-4.0,2.0,BIIB
1822,,2004-03-04 17:42:39,2004-03-02,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.69,60200,19625,-148%,"+$402,960",0.0,-7.0,-4.0,2.0,BIIB
1823,,2004-03-04 17:42:39,2004-03-02,BIIB,Rohn William R,"EVP, COO",S - Sale,$55.69,-60200,19625,-75%,"-$3,352,662",0.0,-7.0,-4.0,2.0,BIIB
1824,D,2004-02-20 19:43:02,2004-02-18,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.19,25000,403013,+7%,"+$154,688",-2.0,-2.0,-7.0,4.0,BIIB
1825,D,2004-02-20 19:43:02,2004-02-18,BIIB,Rohn William R,"EVP, COO",S - Sale+OE,$51.90,-25000,403013,-6%,"-$1,297,613",-2.0,-2.0,-7.0,4.0,BIIB
1826,D,2004-02-20 19:30:05,2004-02-18,BIIB,Keller Thomas F,Dir,M - OptEx,$15.16,10350,920,-110%,"+$156,906",-2.0,-2.0,-7.0,4.0,BIIB
1827,D,2004-02-20 19:30:05,2004-02-18,BIIB,Keller Thomas F,Dir,S - Sale+OE,$51.80,-10350,920,-92%,"-$536,130",-2.0,-2.0,-7.0,4.0,BIIB
1828,D,2004-02-18 20:46:26,2004-02-18,BIIB,Schenk Lynn,Dir,M - OptEx,$5.22,112500,0,-100%,"+$587,344",11.0,5.0,3.0,12.0,BIIB
1829,D,2004-02-18 20:46:26,2004-02-18,BIIB,Schenk Lynn,Dir,S - Sale+OE,$51.06,-123000,0,-100%,"-$6,280,575",11.0,5.0,3.0,12.0,BIIB
1830,D,2004-02-10 15:52:45,2004-02-06,BIIB,Rohn William R,COO Offcier,A - Grant,$0.00,19625,403013,+5%,+$0,-1.0,0.0,25.0,29.0,BIIB
1831,D,2004-02-10 15:52:04,2004-02-06,BIIB,Schneier Craig Eric,EVP - HR,A - Grant,$0.00,15000,16061,>999%,+$0,-1.0,0.0,25.0,29.0,BIIB
1832,D,2004-02-10 15:51:19,2004-02-06,BIIB,Rastetter William H,Exec COB,A - Grant,$0.00,50000,439669,+13%,+$0,-1.0,0.0,25.0,29.0,BIIB
1833,D,2004-02-10 15:50:06,2004-02-06,BIIB,Matsui Connie,"EVP - Corp Comm, Strategy",A - Grant,$0.00,10990,170274,+7%,+$0,-1.0,0.0,25.0,29.0,BIIB
1834,D,2004-02-10 15:49:27,2004-02-06,BIIB,Kellogg Peter N,"EVP - Finance, CFO",A - Grant,$0.00,15000,15000,New,+$0,-1.0,0.0,25.0,29.0,BIIB
1835,D,2004-02-10 15:48:38,2004-02-06,BIIB,Mullen James C,"Pres, CEO",A - Grant,$0.00,50000,94252,+113%,+$0,-1.0,0.0,25.0,29.0,BIIB
1836,D,2004-02-10 15:47:43,2004-02-06,BIIB,Hanna Nabil,EVP - Discovery Research,A - Grant,$0.00,10990,444625,+3%,+$0,-1.0,0.0,25.0,29.0,BIIB
1837,D,2004-02-10 15:47:09,2004-02-06,BIIB,Dunn John Michael,EVP - New Ventures,A - Grant,$0.00,10990,11769,>999%,+$0,-1.0,0.0,25.0,29.0,BIIB
1838,D,2004-02-10 15:45:52,2004-02-06,BIIB,Bucknum Thomas J,EVP - GC,A - Grant,$0.00,9000,9000,New,+$0,-1.0,0.0,25.0,29.0,BIIB
1839,D,2004-02-10 15:45:21,2004-02-06,BIIB,Adelman Burt A,EVP - Development,A - Grant,$0.00,12000,12269,>999%,+$0,-1.0,0.0,25.0,29.0,BIIB
1840,A,2004-02-05 18:01:52,2004-01-08,BIIB,Hanna Nabil,"EVP, Research",M - OptEx,$0.50,10562,433635,+2%,"+$5,281",3.0,5.0,39.0,35.0,BIIB
1841,A,2004-02-05 18:01:52,2004-01-08,BIIB,Hanna Nabil,"EVP, Research",S - Sale,$41.05,-10562,433635,-2%,"-$433,542",3.0,5.0,39.0,35.0,BIIB
1842,D,2004-01-23 18:47:34,2004-01-21,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.19,25000,383388,+7%,"+$154,688",3.0,-2.0,26.0,25.0,BIIB
1843,D,2004-01-23 18:47:34,2004-01-21,BIIB,Rohn William R,"EVP, COO",S - Sale+OE,$45.01,-25000,383388,-6%,"-$1,125,191",3.0,-2.0,26.0,25.0,BIIB
1844,D,2004-01-09 20:39:25,2004-01-08,BIIB,Hanna Nabil,"EVP, Research",M - OptEx,$0.50,135000,433635,+45%,"+$67,500",-2.0,-1.0,4.0,46.0,BIIB
1845,D,2004-01-09 20:39:25,2004-01-08,BIIB,Hanna Nabil,"EVP, Research",S - Sale+OE,$41.00,-135000,433635,-24%,"-$5,535,000",-2.0,-1.0,4.0,46.0,BIIB
1846,D,2004-01-07 21:33:32,2004-01-07,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.19,25000,383388,+7%,"+$154,688",1.0,0.0,4.0,56.0,BIIB
1847,D,2004-01-07 21:33:32,2004-01-07,BIIB,Rohn William R,"EVP, COO",S - Sale+OE,$40.00,-25000,383388,-6%,"-$1,000,000",1.0,0.0,4.0,56.0,BIIB
1848,D,2004-01-05 18:53:55,2004-01-02,BIIB,Hanna Nabil,"EVP, Research",M - OptEx,$0.50,15000,433635,+4%,"+$7,500",4.0,14.0,21.0,67.0,BIIB
1849,D,2004-01-05 18:53:55,2004-01-02,BIIB,Hanna Nabil,"EVP, Research",S - Sale+OE,$37.00,-15000,433635,-3%,"-$555,000",4.0,14.0,21.0,67.0,BIIB
1850,,2003-12-11 14:06:29,2003-11-26,BIIB,Matsui Connie,"EVP, Corp Strategy, Comm",G - Gift,$0.00,-10051,159284,-6%,-$0,3.0,3.0,15.0,65.0,BIIB
1851,D,2003-12-08 14:02:26,2003-12-04,BIIB,Adelman Burt A,"EVP, Development",M - OptEx,$7.31,8625,8278,-2486%,"+$63,049",-2.0,-3.0,7.0,62.0,BIIB
1852,D,2003-12-08 14:02:26,2003-12-04,BIIB,Adelman Burt A,"EVP, Development",S - Sale+OE,$38.38,-8625,8278,-51%,"-$331,028",-2.0,-3.0,7.0,62.0,BIIB
1853,D,2003-12-03 20:03:55,2003-12-02,BIIB,Rohn William R,"EVP, COO",M - OptEx,$6.19,50000,383388,+15%,"+$309,375",0.0,-5.0,-4.0,58.0,BIIB
1854,D,2003-12-03 20:03:55,2003-12-02,BIIB,Rohn William R,"EVP, COO",S - Sale+OE,$39.00,-50000,383388,-12%,"-$1,949,850",0.0,-5.0,-4.0,58.0,BIIB
1855,D,2003-11-26 17:31:49,2003-11-25,BIIB,Matsui Connie,"Sr V P, Planning,Resource Dev",M - OptEx,$7.72,3938,169335,+2%,"+$30,397",0.0,1.0,-3.0,65.0,BIIB
1856,D,2003-11-20 15:34:05,2003-11-19,BIIB,Matsui Connie,"Sr V P, Planning,Resource Dev",M - OptEx,$5.42,40000,165397,+32%,"+$216,766",2.0,8.0,7.0,74.0,BIIB
1857,D,2003-11-20 15:34:05,2003-11-19,BIIB,Matsui Connie,"Sr V P, Planning,Resource Dev",S - Sale+OE,$35.04,-40000,165397,-19%,"-$1,401,780",2.0,8.0,7.0,74.0,BIIB
1858,,2003-11-14 20:45:17,2003-11-12,BIIB,Keller Thomas F,Dir,A - Grant,$0.00,920,920,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1859,,2003-11-14 20:42:33,2003-11-12,BIIB,Gregoire Sylvie L,"EVP, Bus. Dev, Program Mgmt.",A - Grant,$0.00,1304,1304,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1860,,2003-11-14 20:33:24,2003-11-12,BIIB,Schneier Craig Eric,"EVP, HR",A - Grant,$0.00,1022,1022,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1861,,2003-11-14 20:23:20,2003-11-12,BIIB,Belzer Alan,Dir,A - Grant,$0.00,51750,51750,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1862,,2003-11-14 20:20:00,2003-11-12,BIIB,Mullen James C,"CEO, Pres",A - Grant,$0.00,44252,44252,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1863,D,2003-11-14 20:05:53,2003-11-13,BIIB,Ross Bruce,Dir,M - OptEx,$4.67,25000,0,-100%,"+$116,668",-1.0,1.0,3.0,64.0,BIIB
1864,D,2003-11-14 20:05:53,2003-11-13,BIIB,Ross Bruce,Dir,S - Sale+OE,$35.14,-25000,0,-100%,"-$878,500",-1.0,1.0,3.0,64.0,BIIB
1865,,2003-11-14 19:50:53,2003-11-12,BIIB,Adelman Burt A,"EVP, Development",A - Grant,$0.00,8278,8278,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1866,,2003-11-14 18:30:49,2003-11-12,BIIB,Sharp Philip A,Dir,A - Grant,$0.00,828000,828000,New,+$0,-1.0,1.0,3.0,64.0,BIIB
1867,D,2003-11-07 14:34:20,2003-11-05,IDPH,Wiggins Mark C,"VP, Mktg, Bus Dev",G - Gift,$0.00,-6800,36641,+23%,-$0,,,,,BIIB
1868,D,2003-11-07 14:34:20,2003-11-05,IDPH,Wiggins Mark C,"VP, Mktg, Bus Dev",M - OptEx,$5.58,3400,36641,+10%,"+$18,983",,,,,BIIB
1869,D,2003-10-29 17:38:04,2003-10-28,IDPH,Glassberg Alan,Dir,M - OptEx,$4.06,16460,0,-100%,"+$66,869",,,,,BIIB
1870,D,2003-10-29 17:38:04,2003-10-28,IDPH,Glassberg Alan,Dir,S - Sale+OE,$33.45,-16460,0,-100%,"-$550,554",,,,,BIIB
1871,D,2003-10-06 18:48:15,2003-10-03,IDPH,Rohn William R,"Pres, COO",M - OptEx,$6.19,10000,383388,+3%,"+$61,875",,,,,BIIB
1872,D,2003-10-06 18:48:15,2003-10-03,IDPH,Rohn William R,"Pres, COO",S - Sale+OE,$35.34,-10000,383388,-3%,"-$353,440",,,,,BIIB
1873,D,2003-09-19 19:01:19,2003-09-18,IDPH,Hanna Nabil,Chief Scientific Officer,M - OptEx,$0.50,15000,433635,+4%,"+$7,500",,,,,BIIB
1874,D,2003-09-19 19:01:19,2003-09-18,IDPH,Hanna Nabil,Chief Scientific Officer,S - Sale+OE,$37.00,-15000,433635,-3%,"-$555,000",,,,,BIIB
1875,D,2003-09-18 16:40:41,2003-09-17,IDPH,Rohn William R,"Pres, COO",M - OptEx,$6.19,10000,383388,+3%,"+$61,875",,,,,BIIB
1876,D,2003-09-18 16:40:41,2003-09-17,IDPH,Rohn William R,"Pres, COO",S - Sale+OE,$36.57,-10000,383388,-3%,"-$365,650",,,,,BIIB
1877,D,2003-09-09 14:04:58,2003-09-08,IDPH,Rohn William R,"Pres, COO",M - OptEx,$6.19,10000,383388,+3%,"+$61,875",,,,,BIIB
1878,D,2003-09-09 14:04:58,2003-09-08,IDPH,Rohn William R,"Pres, COO",S - Sale+OE,$35.94,-10000,383388,-3%,"-$359,417",,,,,BIIB
1879,D,2003-09-04 16:07:07,2003-09-02,IDPH,Rohn William R,"Pres, COO",M - OptEx,$6.19,20000,383388,+6%,"+$123,750",,,,,BIIB
1880,D,2003-09-04 16:07:07,2003-09-02,IDPH,Rohn William R,"Pres, COO",S - Sale+OE,$35.09,-20000,383388,-5%,"-$701,898",,,,,BIIB
1881,D,2003-09-03 18:22:51,2003-08-29,IDPH,Rodriguez Edward,"VP, Controller",M - OptEx,$11.97,17625,12384,-336%,"+$211,026",,,,,BIIB
1882,DM,2003-09-03 18:22:51,2003-08-29,IDPH,Rodriguez Edward,"VP, Controller",S - Sale+OE,$34.38,-27520,12384,-69%,"-$946,039",,,,,BIIB
1883,D,2003-08-28 19:00:17,2003-08-28,IDPH,Rohn William R,"Pres, COO",F - Tax,$33.71,-2079,383388,-1%,"-$70,083",,,,,BIIB
1884,D,2003-08-28 19:00:17,2003-08-28,IDPH,Rohn William R,"Pres, COO",G - Gift,$0.00,24484,383388,+7%,+$0,,,,,BIIB
1885,D,2003-08-28 19:00:17,2003-08-28,IDPH,Rohn William R,"Pres, COO",M - OptEx,$6.90,10163,383388,+3%,"+$70,119",,,,,BIIB
1886,,2003-08-28 14:20:13,2003-08-20,IDPH,Matsui Connie,"Sr V P, Planning,Resource Dev",G - Gift,$0.00,-7000,165397,-4%,-$0,,,,,BIIB
1887,D,2003-08-14 14:45:13,2003-08-13,IDPH,Wiggins Mark C,"VP, Marketing, Business Dev",M - OptEx,$5.58,5000,33241,+18%,"+$27,917",,,,,BIIB
1888,D,2003-08-14 14:45:13,2003-08-13,IDPH,Wiggins Mark C,"VP, Marketing, Business Dev",S - Sale+OE,$32.89,-5000,33241,-13%,"-$164,456",,,,,BIIB
1889,D,2003-08-04 20:15:29,2003-08-01,IDPH,Wiggins Mark C,"VP, Marketing, Business Dev",M - OptEx,$5.58,5000,33241,+18%,"+$27,917",,,,,BIIB
1890,D,2003-08-04 20:15:29,2003-08-01,IDPH,Wiggins Mark C,"VP, Marketing, Business Dev",S - Sale+OE,$33.39,-5000,33241,-13%,"-$166,950",,,,,BIIB
